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Abstract  
Antibiotic resistance is a global problem and poses an alarming threat to public 
health. Microorganisms resistant to all commercially available antibiotics have emerged, 
undermining the ability to fight infectious diseases. The antibiotic resistance crisis has 
been attributed to the overuse of antibiotics, as well as a lack of new drug development.  
Coordinated efforts are needed to overcome this challenge, including discovery of 
alternative drugs.  
Bacteriocins are bacteria-produced, antimicrobial peptides that are potentially 
powerful antibiotic drug candidates. Despite considerable scientific interest around 
bacteriocins, and despite their promise as potent, latent antibiotics, their everyday 
medical value has been negligible. In order to more effectively utilize the full potential of 
bacteriocins as a platform to develop new antibacterial agents, a detailed understanding 
of their mechanism of action is required.  This mechanistic insight will offer ways to 
control and optimize their activity and selectivity against specific pathogens, greatly 
enhancing their potential for medical applications. The goal of this work is to elucidate 
the mechanism of action of class II bacteriocins by employing a variety of computational 
methods that are built around atomistic molecular dynamics simulations. 
First, we studied Plantaricin EF, a two-peptide class IIb bacteriocin. This bacteriocin 
was simulated in different environments including water, micelles, and lipid bilayers. The 
interaction between the two peptides that promotes dimerization, and the interaction 
between the dimer and the membrane were elucidated. Guided by experimental studies, 
a transmembrane model of the dimer embedded in the bilayer was additionally 
designed. Results obtained from a 1 μs long atomistic molecular dynamics simulation, 
demonstrated for the first time that a bacteriocin, with a narrow antimicrobial activity 
range, can by itself form a water (and potentially ion) permeable, toroidal pore in a lipid 
bilayer. This pore was characterized in detail. 
It is not unlikely that the mechanism of action of bacteriocins can involve poration of 
the membrane as well as receptor-mediation. Therefore, the interaction of a bacteriocin 
with its putative receptor was also examined. Lacking the structure of a receptor, we 
employed structure-prediction techniques in combination with docking calculations, and 
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molecular dynamics simulations. For the first time a class II bacteriocin-receptor complex 
was built, setting the ground for investigating the role that receptors play in the 
bactericidal activity of these antimicrobial peptides.   
We believe that our findings could be of importance to the designing of new 
antibiotic agents, as it would guide the search for better bacteriocins toward peptides 
with improved activity and specificity, that form stable pores, increase water or ion 
permeability, and interact more efficiently with a receptor.   
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Chapter 1  
Introduction 
1.1. Antibiotic resistance (AMR) on the rise 
Alexander Fleming’s 1928 discovery of penicillin and its introduction into clinical use 
in 1940 transformed modern medicine. Humanity entered a new era of improved public 
health and quality of life [1]. For a short while, deadly microbial infections were thought 
to be a problem of the past. It was not long, though, before the first signs of antimicrobial 
resistance (AMR) to antibiotics became apparent [2]. In response, new antibiotic agents 
were introduced that would, in turn, ultimately face the same fate of developed 
resistance. The circle of the development of new antibiotic drugs and the responding 
emergence of resistance to them has continued for the last 70 years. Now, however, the 
utility of antibiotics is diminishing more rapidly than ever because of the increasing 
frequency of resistance appearing in bacteria.  
In our times, it is an unfortunate reality that resistance has been found to all 
commercially available antibiotics, even to the so-called “last resort” ones like colistin [2–
4]. The Center for Disease Control and Prevention (CDC) estimates that antibiotic-
resistant bacteria infect 2,000,000 people each year in the US, while the global death toll 
of such infections reaches 700,000 annually [5,6]. In 2014, the World Health 
Organization (WHO) released a global report on surveillance of AMR, warning that we 
are approaching a “post-antibiotic” era where even minor bacterial infections could be 
deadly [7,8]. According to a review on AMR commissioned by the UK, the worldwide 
fatalities due to antibiotic resistant infections could reach 10 million by 2050 if the world 
takes no action to reverse the spread of these infections [5]. 
The potential impact of AMR not only increases the lethality of infectious diseases, 
but it also compromises the efficacy of treatments, surgeries, and other therapeutic 
procedures, including chemotherapy and transplantation [9]. In addition, AMR is already 
having significant economic impacts. In 2013, in the United States alone, $20 billion in 
increased medical expenses is attributed to AMR to pay for prolonged hospital stays, 
expanded health care needs, and the additional use of medications [6]. With such a 
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heavy economic burden, AMR is likely to devastate disproportionately lower-income 
countries [10]. Yet another significant problem caused by AMR is the stress inflicted 
upon the agricultural sector. New regulations for the use of antibiotics in food animals 
have been introduced in both the EU and the US over the last decade since the 
extensive use of antibiotics in farming has been identified as one of the most impactful 
sources of AMR’s ongoing evolution [11,12]. 
The debate over the appropriate use of antibiotics in the food production industry 
has been going on for several decades [13]. It comes as no surprise that bacteria would 
develop resistance to antibiotic-polluted environments, such as farms that extensively 
use antimicrobial drugs, or in healthcare where antibiotics are misused for ambiguous 
medical purposes [14,15]. Much of the widespread human consumption of antimicrobial 
agents is unnecessary [6]. The CDC estimates that 50% of antibiotics prescriptions are 
not needed, while 80% of consumed antibiotic drugs in the U.S. are used in livestock 
production [6,16]. Interestingly, 1 in 5 antibiotic resistant infections is caused by bacteria 
transferred to humans through the food chain [6].  
Despite the alarming increase of AMR around the globe, there has been a steady 
decline in the introduction of new antibacterial drugs to consumers [2]. For many years, 
pharmaceutical companies have not considered the development of new antibiotics to 
be a primary goal.  They have focused their research on more profitable drugs that treat 
chronic conditions, which offer better returns on investments [17]. An example is given 
by a cost-benefit analysis by the Office of Health Economics of London: it was estimated 
that developing a drug to be used to treat a chronic disease (in this case, a 
neuromuscular disease) would result in that drug having a net present value of $1 billion, 
compared to only a $50 million value for developing a new antibiotic [18]. Moreover, 
medical and scientific communities are not producing new knowledge regarding 
antibiotic drug development. Remarkably, most antibiotics introduced in the last 30 years 
are mere analogues of older drugs, with only two new classes of systemic antibacterial 
antibiotics being developed in that period of time [19].  
To encourage and expand antibiotic discovery in this barren era, we need to 
rekindle basic research, identify alternative sources, and develop new routes that could 
provide potential antibiotic agents. One promising alternative source of fresh antibiotic 
drugs that has been investigated extensively of late is the use of antimicrobial peptides. 
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1.2. Antimicrobial peptides (AMPs) as a solution  
Antimicrobial peptides are small proteins produced by virtually all forms of life. 
AMPs and are part of the innate immune response system of the producer organism, 
and they can be bacteriostatic (stopping bacterial growth) or bactericidal (killing bacteria) 
[20,21]. In the face of increasing antibiotic resistance, AMPs have attracted the interest 
of much research over the last 20 years. To date, more than 2600 naturally occurring 
AMPs have been identified [22]. Collectively they demonstrate a broad spectrum of 
antibacterial and antiviral activity; while some of them can be highly specific, others 
exhibit activity against a wide array of different organisms [23]. 
AMPs are often cationic and amphiphilic, and they are typically relatively short (12 
to 100 amino acids) [24]. When compared to larger proteins or immune cells, they offer 
many attractive features, such as diverse bactericidal mechanisms and a smaller size 
that leads to shorter production time and more rapid diffusion [25]. Although all AMPs 
share a few common features, they have a wide range of secondary structures and 
limited sequence homology among different groups. Most AMPs consist of two to four β-
sheets or amphiphilic α-helices, with occasional loop and coil regions [23].  
Antimicrobial peptides are produced by single-celled microorganisms as well as by 
more complex ones, such as plants and humans [24]. Production of AMPs in bacteria 
has been extensively studied and is the focus of paragraph 2.3. In plants, numerous 
genes encoding AMPs are present in leaves, flowers, seeds, and tubers and it is 
believed they play a significant role in defense against bacteria and fungi [23]. 
Invertebrates are the source of many AMPS that have been very well studied. A few 
examples are melittin (the key component of bee venom), and tachyplesin and 
polyphemusin (which are found in horseshoe crabs). Polyphemusin exhibits remarkably 
high antibacterial and antifungal activity, and it is also active against the human 
immunodeficiency virus (HIV) [23,26]. The immune system defense against microbial 
infections of vertebrates is quite sophisticated as it involves an interplay among various 
components such as B-cells, T-cells, and antibodies [23].  
Initially it was thought that the existence of AMPs in higher organisms is an 
evolutionary remnant of their primitive past; however, it is increasingly recognized that 
they play an integral part alongside the adaptive immune system [27]. In humans, in 
addition to direct bactericidal activity, AMPs are also involved in immunomodulatory 
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functions and are produced from a variety of cells and tissues, such as the epithelial 
cells and the ocular surface [27,28]. Amphibian skin is another rich source of AMPs, 
producing magainin, among others. Magainin was used as the first template of AMP-
based formulations that moved to clinical trials [29]. 
When the magainin analogue, known as pexiganan, was rejected by the Food and 
Drug Administration (FDA) in 1999, the hope that AMPs could reach the pharmaceutical 
shelf was shaken [30]. [30]. In spite of many attempts since, all  AMP-based drugs that 
have been developed and entered clinical trials have failed to produce fruitful results 
[31]. Manufacturing difficulties, toxicity in high doses, and failure to demonstrate better 
efficacy than conventional antibiotics are the main reasons behind these unsuccessful 
clinical trials [31].  
However, recent developments bring back the hope in using AMPs as therapeutics. 
The Generating Antibiotic Incentives Now (GAIN) Act of 2012 aims to encourage 
antibiotic drug development in response to the rise of AMR [32]. It is expected to ease 
the regulation and demands that stopped AMPs from being approved and succeeding in 
clinical trials - such as removing the requirement to demonstrate superior activity when 
compared to currently used antibiotics [31]. 
Although AMPs may potentially be a powerful weapon in our fight against infections, 
bacterial resistance to AMPs could still appear [33]. However, resistance to antimicrobial 
peptides is expected to develop less rapidly, as their antibiotic activity is not susceptible 
to any known mechanisms of resistance to conventional antibiotics - rather, it has 
emerged mostly due to random mutations [25]. In order to create effective antibacterial 
drugs based on AMPs that would be better shielded against resistance, we need to 
develop an early understanding of their mechanism of action (MOA). There has been a 
significant amount of work over the last decade aiming to decipher the several, often 
complicated mechanisms of action of different AMPs. 
1.2.1. Possible mechanism of action (MOA) of AMPs 
A large number of studies have been dedicated to understanding the mechanism of 
action of AMPs (a recent, comprehensive review can be found here: [34]). The 
hypothesized MOA of a large group of AMPs includes cell membrane permeabilization, 
however, there is increasing evidence that some AMPs may interact with intracellular or 
membrane proteins [23,35–40]. Regardless of the final target of AMPs, their activity is 
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considered to be strongly dependent on their interactions with the cell membrane 
[23,41]. It is possible that some AMPs use more than one MOA depending on the 
particular target or their local concentration at the membrane surface [23,42].  
AMPs often initially interact with the membrane surface through electrostatic 
attraction between the positively charged peptides and the negatively charged lipids, 
which are in abundance in bacterial membranes. Next, for some AMPs, permeabilization 
of the cell membrane might occur via the barrel-stave, the toroidal-pore or the carpet 
mechanisms (illustrated in Figure 1-1) [23]. In the barrel-stave model, the pore formation 
is created due to hydrophobic mismatch. The hydrophobic surface of the peptide faces 
toward the hydrophobic core of the membrane and the membrane’s curvature or 
hydration do not change significantly.  
 
In the toroidal model, the AMP interacts with the membrane electrostatically. A 
breach is induced in the hydrophobic region as the polar head groups of the lipids are 
dragged into the core region and surround the peptide, causing their displacement and 
the thinning of the membrane. This leads to increased membrane hydration and water 
permeation through the breach. In the carpet mechanism, the peptides lie on the surface 
of the membrane parallel to the lipid bilayer, with their hydrophilic surface facing the 
solvent and the hydrophobic one facing the lipids. At high concentrations, the AMPs that 
employ the carpet mechanism could act as a detergent, disrupting the membrane 
Figure 1-1: Possible mechanisms of action of membrane active AMPs  
Barrel-stave model Carpet model Toroidal pore model 
Bacterial membranes primarily consist of lipids forming a bilayer. In the absence of 
AMPs, the hydrophobic tails of the lipids face the center of the bilayer while the 
hydrophilic heads of the lipids face outwards. In the barrel-stave model, the peptide is 
inserted through the membrane without much alteration of the membranes structure. In 
the toroidal model, the peptide causes the bending of the head groups toward the center of 
the bilayer. In the carpet model, peptides accumulate on the surface where they form a 
carpet-like structure that disrupts the continuity of the surface of the membrane. 
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stability and cause holes in the surface or patches of the membrane to break up and 
then form micelles. 
Figure 1-2:  Suggested Mechanism of Action of Microcin J25 
 
Microcin J25, is initially recognized by the iron-sideophore receptor, FhuA, at the 
outer membrane (OM) of target cells. The internalization of MccJ25 requires the inner 
membrane (IM) proteins, SbmA, TonB, ExbD, and ExbD. The TonB/ExbD/ExbD 
complex uses the proton-motive force from the IM to transduce energy to the OM to 
allow MccJ25 translocation. SbmA then transports MccJ25 across the IM. Once inside, 
MccJ25 inhibits RNA polymerase by binding to the nucleotide uptake channel. (adapted 
from [43]). 
It has been established that some AMPs that are usually active at lower 
concentrations might not form pores on their own, but achieve their bactericidal function 
through interacting with one or more components of the membrane. Some peptides act 
via a receptor-mediated mode of action which involves the so-called membrane catalysis 
model [44]. This model suggests that the peptides interact with a membrane protein 
receptor via multiple steps, including the initial interaction of the peptide with the 
membrane, surface adsorption, translocation, and final binding to the receptor. Peptides 
that use this MOA could induce cell death by interacting with the receptor and either 
changing its structure in a way that induces water or ion leakage, or hindering some 
important function that the receptor was involved in [23]. Alternatively, an AMP could use 
the membrane protein receptor as a Trojan Horse to cross the membrane barrier and get 
imported in the cell, where it might disrupt essential cellular processes that would lead to 
the cell death. Different intracellular targets have been identified which includes 
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molecules involved in the nucleic acid synthesis, protein synthesis, enzymatic activity, 
and cell wall synthesis. A well-characterized peptide that exhibits a MOA involving 
several components is the lasso-peptide Microcin J25, and its mode of action is pictured 
in Figure 1-2.  
1.3. Bacteriocins: An interesting group of AMPs 
AMPs produced by bacteria are called bacteriocins and show a tremendous 
potential as novel antibiotic agents [45]. They are ribosomally synthesized by numerous 
prokaryotic microorganisms, including lactic acid bacteria (LAB), and are commonly 
active against closely related antagonistic strains, while a few exhibit a broader range of 
antibacterial activity  [46,47]. Bacteriocins demonstrate a higher specificity against 
sensitive species than other AMPs, and they are active at picomolar to nanomolar 
concentrations [25]. While bacteriocins were among the first AMPs to be isolated, there 
is an increasing number of new bacteriocins being reported, which indicates that this 
reservoir of unused potential antibacterial therapeutics will continue growing [48]. 
The history of bacteriocins dates to the early 1920s. Nisin, the first bacteriocin (and 
antibiotic in general) to be used commercially in the food industry, was discovered in the 
late 1930s and approved as a food preservative in 1969 [30,49]. Today, Nisin is even 
used in Japan under the brand name Oralpeace™ as a hand wash and oral hygiene gel 
[50,51]. Despite numerous other bacteriocins having been isolated,  50 years later, nisin 
is still the only bacteriocin that has been approved for commercial use [48]. 
Nevertheless, the potential of bacteriocins in many applications has been well-
documented [46,52,53]. Biopreservation might be the most well-established use of 
bacteriocins (a recent review can be found at [54]). However, numerous studies 
demonstrate the clinical potential of bacteriocins, as they are active against a variety of 
organisms, including antibiotic-resistant pathogens such as methicillin-
resistant Staphylococcus aureus (MRSA) strains and vancomycin-
resistant Enterococcus faecalis (VRE) strains [48]. The therapeutic application of 
bacteriocins is not limited just to antibiotics, though. In the last 15 years, there have been 
reports that colicins (a group of bacteriocins produced by Escherichia coli ) have strong 
anti-cancer activity against numerous types of tumor cells [55]. 
In addition to high antimicrobial activity, bacteriocins share many positive attributes 
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that make them attractive for all the applications mentioned above. Perhaps the most 
remarkable advantage of bacteriocins is that they are amenable to bioengineering, due 
to their peptide nature and their relatively simple biosynthetic mechanisms, compared to 
conventional antibiotics [53]. Due to this advantage, probiotic bacterial strains that are 
safe to consume can been modified to produce bacterioicins inside the GI tract of hosts, 
potentially easing the production and delivery challenges that many protein drugs face, 
due to their their reduced bioavailability [56–58]. 
Even though it is undesirable, resistance is an unavoidable outcome of evolution. 
Resistance to bacteriocins that has been reported so far arises from random mutations 
or adaptation through changes in the cell membrane composition. Fortuitously, the types 
of resistance to bacteriocins are expected to have comparatively lower potential to 
become wide-spread. Resistance to conventional antibiotics can often occur as a result 
of the modifications on genetically-transferable components of the target bacterium,  
which can be transmitted horizontally between different strains and even species [48]. 
This mechanism of resistance has not been observed against bacteriocins. 
Hereafter, we will focus on bacteriocins produced by lactic acid bacteria (LAB).  
These LAB bacteriocins are of particular interest since they have been characterized as 
food grade (or GRAS - generally recognized as safe) and thus are more likely to be 
approved as an antibiotic substitute [53]. Notably, toxicology studies have demonstrated 
that Nisin is not toxic to humans, which suggests that other LAB bacteriocins might not 
be toxic as well [46]. Moreover,  LAB bacteriocins are colorless, odorless, tasteless, 
mostly heat-stable, and they are active under different pH,  which further boosts their 
appeal as drug candidates [48]. 
1.3.1. Categories of bacteriocins produced by lactic acid bacteria (LAB)  
Various classification schemes have been suggested for bacteriocins [59]. We, as 
many in the field, follow the classification proposed by Heng et al. in 2007 where 
bacteriocins, produced by LAB, can be classified into three categories [60].  
Class I bacteriocins are called lantibiotics. They include small peptides that contain 
rare thermo-stable amino acids and post-translational modifications. The most important 
of these modifications is the introduction of a lanthionine non-natural amino acid, which 
results from cross-linkage of the β-carbon atoms of two alanine residues [25].  
Class II contains peptides that do not undergo extensive posttranslational 
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modification. They can be divided into four subgroups: the pediocin-like bacteriocins 
(class IIa), the two-peptide bacteriocins (class IIb) , the circular bacteriocins (class IIc), 
and all the rest (class IId) [60].  
Class III contains bacteriocins that are larger and heat-labile. They have complex 
structures and are often called “bacteriolysins” since studies have proposed that their 
mechanism is different from the other bacteriocins, in that they kill bacteria by promoting 
lysis of the cell wall as their N-terminal part is homologous to endopeptidases [61]. 
We focus on class II bacteriocins. In this group, four genes exist in the same operon 
in each case (five for those in class IIb) : one (or two) encoding for the peptides, one for 
an immunity protein (that protects the producer organism from the bactericidal activity of 
the peptide) and two that encode for transporting and secreting proteins [25]. Even 
though many of these immunity proteins have been isolated, it is not clear yet how they 
protect the host or how they interact with the peptides and/or the cell membrane. 
Paradoxically, even though all of these peptides share many characteristics, they 
demonstrate high selectivity against their targets. The simple explanations of cationic 
peptides forming pores in the anionic cell membranes cannot justify the extent of the 
diversity among their activities. Rather, they are assumed to interact at first with a target-
specific membrane protein (through the receptor-mediated mechanism of action), likely 
driven by electrostatic forces [39,40]. This interaction presumably results in the 
uncontrollable ion transfer observed during experiments and facilitates the collapse of 
the membrane potential, leading to cell death. However, this interaction is blocked while 
in the presence of the immunity protein [39,40] 
Class IIa bacteriocins 
Class IIa - pediocin-like bacteriocins - consists of proteins below 10 kDa with 35-48 
amino acids [62]. Their name is in reference to Pediocin PA1, the first peptide of this 
category that was well-characterized and identified [25]. The first class IIa peptides 
isolated were active only against Listeria species. However, there are numerous new 
class IIa peptides identified that are active against other bacteria such as Enterococcus, 
Carnobacterium, Lactobacillus, Pediococcus and Clostridium [62,63]. Some peptides 
belonging to this category are Enterocin A, Carnobacteriocin B2, Curvacin A, Leucocin 
A, and Sakacin P. 
The peptides belonging to this category are highly homologous (40-60%) [64]. All of 
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them share common secondary structure domains, as well as sequence motifs. Their N-
terminal region is conserved to a great degree and contains at least two cysteines, 
creating a disulfide bond, in the “Pediocin box” motif:  -Y-G-N-G-V-x-C-x-K/N-x-x-C-  ( x 
is any amino acid) [25]. Class IIa peptides have at least one disulfide bridge and there 
are studies suggesting that the activity of the peptides is proportional to the number of its 
disulfide bridges [65]. The structure of several pediocin-like bacteriocins has been 
determined either by Circular Dichroism (CD) or with Nuclear Magnetic Resonance 
(NMR) studies in membrane-mimicking environments. Two conserved structural 
domains have been observed during these studies: an N-terminal β-sheet-like structure 
that is stabilized by a disulfide bridge, and a C-terminal containing one or two 
hydrophobic or amphiphilic α-helices [63]. The Pediocin box is located at the N-terminal 
domain, which is highly conserved [63]. On the other hand, the C-terminus helices vary 
considerably among class IIa bacteriocins, and there is evidence that suggests the C-
terminal part is responsible for the high selectivity of class IIa bacteriocins [66,67].  
Figure 1-3:  Proposed MOA of class IIa bacteriocins 
 
Proposed model for the MOA of class IIa bacteriocins: a) Initially the β-sheet N-
terminal of the peptide interacts with the IIC domain extracellular loop (highlighted in 
yellow) of the Man-PTS IIC protein. b) Then the C-terminal helix binds to the 
transmembrane IIC and/or IID proteins, possibly causing conformational changes 
which lead to leakage of cellular components and the eventual cell death. (adapted 
from [63]) 
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The mechanism of action of class IIa bacteriocins is the most well-characterized so 
far among all the class II bacteriocins. Studies reveal that bacteriocin-resistant mutants 
of otherwise susceptible strains share alterations on genes relative to the sugar 
transporter mannose phosphotransferase system (Man-PTS), which indicates that there 
should be some interaction between the bacteriocin and Man-PTS [63]. Diep et al.  
presented evidence that class IIa bacteriocins bind and form a complex with a subunit of 
Man-PTS [68]. The detailed hypothesized mechanism of action of class IIa bacteriocins 
is shown in  Figure 1-3. The Man-PTS family is a large family of membrane proteins 
present in many bacteria, both Gram-negative and Gram-positive, but it is absent in 
eukaryotic cells, and therefore can serve as an ideal drug receptor that will allow 
selective targeting of the pathogen bacteria without demonstrating toxicity towards the 
mammalian cells [63].  
Class IIb bacteriocins  
Class IIb contains the two-peptide bacteriocins. Those heterodimeric bacteriocins 
require two different peptides, at an approximately equal concentration to exhibit their 
optimal activity [69]. Interestingly, each of the peptides from a two-peptide bacteriocin 
shows high bactericidal activity only when combined with its complementary peptide 
[70]. Moreover, there is only one immunity protein gene for every two-peptide 
bacteriocin, which strengthens the claim that the two peptides act as one antimicrobial 
unit [71]. The first two-peptide bacteriocin that was identified and well-studied was 
Lactococcin G, but other prominent peptides in the class IIb include Enterocin 7AB, 
Plantaricin EF, and Plantaricin JK [72–74]. Experiments have shown that these peptides 
form α-helical structures, however, their primary structures differ significantly [75]. 
An interesting structural characteristic of all class IIb bacteriocins characterized so 
far is that each contains GxxxG and GxxxG-like motifs. These are prevalent in 
transmembrane peptides and membrane proteins [75,76]. It has been suggested that 
these motifs facilitate helix-helix interactions and promote the oligomerization of 
transmembrane helical peptides or domains of membrane proteins. The hypothesis is 
that two glycine residues, when separated by three other amino acids, lie on the same 
face of the helix. Due to their small size, they create a relatively flat surface that may 
facilitate more pronounced helix-helix interactions (illustrated in Figure 1-4). Often, other 
small amino acids (like alanine or serine) replace either one or both glycines creating a 
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GxxxG-like motif [77]. Valine, leucine and isoleucine residue are frequently found 
neighboring the motifs [77]. 
It has been well-documented that class IIb bacteriocins induce cell death through 
membrane leakage [70]. However, the complete mechanism of action of class IIb 
bacteriocins is still unclear. Only recently (in 2014), Kjos et al. identified a possible 
receptor for Lactococcin G through whole genome sequencing of spontaneous resistant 
mutants [78]. All the mutations were in or near the uppP gene that encodes an 
undecaprenyl pyrophosphate phosphatase (UppP), which is a membrane-spanning 
protein involved in peptidoglycan synthesis. Moreover, they found that sensitivity to 
another class IIb bacteriocin, Enterocin 1071, which shows 57% identity to Lactococcin 
G, is directly linked to the expression of UppP in the target bacterium. However, we 
cannot assume that other class IIb bacteriocins use UppP as a target due to the 
significant differences in their sequences. Indeed, in 2016, Oppegård et al. identified the 
APC superfamily transporter as likely to serve as a receptor for Plantaricin JK [79]. In the 
same study, they concluded that the APC transporter is not the target of Plantaricin EF. 
Figure 1-4:  The GxxxG motif 
 
The GxxxG motif is hypothesized to induce high affinity in transmembrane helices 
[80]. Here the two helices are able to come into close proximity because the glycine 
residues, shown in red, create a flat surface due to their small size. 
Class IIc bacteriocins  
Class IIc bacteriocins are circular peptides, i.e. their C- and N- terminal backbones 
are covalently linked [81]. They show great stability, adopting a four- or five-α-helix 
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structure and encompassing a hydrophobic core [82]. It has been reported that they 
have high pH stability and are resistant to degradation, possibly due to their circular 
structure that increases their structural integrity [81]. Arguably, they are the most poorly 
understood subgroup of bacteriocins [48]. Nevertheless, the best-characterized class IIc 
bacteriocin is AS-48 [83]. 
Class IId  
The remaining class II bacteriocins are allocated to class IId. Those are one-
peptide, non-cyclic bacteriocins that do not contain the Pediocin box (as described at 0) 
in their primary structure [23].  The peptides in this category have a broad diversity, but 
some can be grouped further into two subgroups: the sec-dependent bacteriocins and 
the leaderless bacteriocins [84]. The former are peptides that contain a signal peptide 
(as almost all other bacteriocins) and are secreted through the general secretory (sec-) 
pathway; the latter do not have an N-terminal leader sequence or a signal peptide, which 
in other bacteriocins is cleaved off as they are transported outside the producer cell. It is 
speculated that the immunity protein for this peptide is involved in its secretion as well 
[85].  
Figure 1-5: “Huge Toroidal Pore (HTP)” model of Lacticin Q 
 
Lacticin Q interacts with the negatively-charged surface of the lipid bilayer (a). 
The peptides are inserted into the membrane and induce lipid flip-flop and pore 
formation (b). (adapted from [86]) 
The modes of action of class IId bacteriocins are as diverse as the primary 
sequence of these peptides. Lactococcin A, which cannot be included in either the sec-
dependent bacteriocins or the leaderless bacteriocins group, is thought to behave 
similarly to class IIa bacteriocins and interact with Man-PTS [68]. Lactococcin 972, a 
sec-dependent bacteriocin, has been shown to interact with lipid II among others, 
inhibiting peptidoglycan biosynthesis in the same way that nisin does [84]. A Zn 
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Metallopeptidase, YvjB, has been identified as a possible receptor for the class IId 
leaderless bacteriocin LsbB through whole genome sequencing of resistant mutants to 
this bacteriocin [39]. Five more class IId peptides that share substantial sequence 
homology with LsbB, by having a conserved C-terminal KxxxGxxPWE (where x can be 
any amino acid) motif, are presumed to interact with YvjB as well [87]. On the other 
hand, Lacticin Q, another leaderless bacteriocin, has a broad range of bactericidal 
activity and does not appear to require a receptor. Indeed, the proposed MOA for 
Lacticin Q is that accumulation of peptides on the membrane surface lead to pore 
formation through the “Huge Toroidal Pore (HTP)” model (Figure 1-5) [86].  
1.4. Molecular Simulation of Bacteriocins 
Due to their variety and complexity, elucidating the mechanisms of action of 
bacteriocins is a major challenge. However, a better understanding of the structure-
function relationship of their biological behavior could have a tremendous impact on the 
design of future antimicrobial agents. As computational power has increased 
dramatically in recent years, molecular simulations can now provide insights into the 
modes of activity and specificity of bacteriocins by studying them at atomistic resolution 
and nano- to millisecond timescales. Molecular dynamics (MD) simulations have evolved 
through the years, and as they now provide answers in an increasingly time and cost-
effective manner, they have now become a tool of choice for many researchers [88]. In 
the paragraphs that follow, we present a brief introduction to the theory of MD and the 
potential of MD as a tool to explore the MOA of bacteriocins. 
1.4.1. Theory on Molecular Dynamics (MD) Simulations 
Molecular dynamics (MD) is a method that calculates the time evolution of a system 
[89]. In its classical form, Newton’s equations of motion (which describe the interaction of 
N particles under a potential ܷ(ݎపሬԦ), i = 1,…,N) are solved numerically, propagating the 
system in time. A concise mathematical description could be the following: 
 FనሬሬሬԦ = m୧rనሬሬԦሷ  (1) 
where ݉௜ is the mass of particle i, ܨప ሬሬሬԦ is the force acting on particle, and can be 
described as: 
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 FనሬሬሬԦ = െ
∂ U(rనሬሬԦ)
∂ rనሬሬԦ
 (2) 
In atomistic MD simulations, each particle represents an atom as a point mass. The 
timestep for the integration should be sufficiently small to ensure numerical stability and 
thus is chosen to be smaller than the characteristic time of the fastest motion in the 
system (which typically is 1 fs). However, if constraints are applied to the bonds of this 
magnitude (which involves all covalent hydrogen bonds), the timestep can be increased 
to 2 fs, which reduces the computational resources and wall-clock time needed. The 
potential ܷ(ݎపሬԦ) is described empirically and is commonly called the force field. Many force 
fields exist for biomolecular simulations. For the work described here, we employ mostly 
the CHARMM force field that has the following functional form: 
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(3) 
The bonds, angles and improper dihedrals are described as simple springs with 
constant Ky, and equilibrium length yo (where y=b for bonds, θ for angles and φ for 
improper dihedrals). The dihedral angles are modeled with a periodic potential with force 
constant Kχ, which controls the rotation χ and a phase shift δ that corresponds to the 
equilibrium value. The non-bonded terms include the interaction between atoms that are 
separated by three or more covalent bonds and are described by Van der Waals 
dispersion forces and Coulombic interactions between point charges. The bonded 
interactions have been parameterized for each pair of atoms in a system, while the non-
bonded have been parameterized for individual types of atoms. The calculation of the 
non-bonded interactions overwhelms the computational time needed, and thus various 
techniques are applied to reduce this cost. The Van der Waals forces are truncated to 
zero with a smoothing function after a specified distance. The Particle Mesh Ewald 
method is used for the electrostatics, in that it interpolates the reciprocal space Ewald 
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summation, which in turn is described as the sum between the short-range interactions 
that are calculated in real space and the longer-range ones that converge quickly in 
Fourier space. 
To define the system, a unit “cell” is determined around the biomolecule, with 
boundaries set at a distance that will not influence its molecular behavior. The cell then 
repeats periodically at all edges, simulating a bulk system. It is important that the cell 
size is large enough so that each atom interacts with at most one copy of any other atom 
(this requirement is called minimum image convection). Energy is not conserved in a 
biological system of finite atoms (as Newton’s equation of motion dictates), rather, the 
pressure and the temperature are conserved (the so-called isothermal-isobaric 
ensemble, or NPT ensemble). Constant temperature and pressure simulations are 
possible with additional terms in the equation of motion.  
1.4.2. Previous MD on bacteriocins 
Molecular dynamics simulations have been employed over the past 15 years to 
elucidate the mechanism of action of numerous AMPs [90–93]. [90–93]. The majority of 
the peptides studied are pore-forming AMPs because significantly more is known about 
them, such as the structure of the peptides and, in some cases, the structure of the pore. 
In the case of bacteriocins, only the MOA of Nisin has been extensively investigated 
though MD simulations [94–96]. Both the structure of Nisin and the Nisin-lipid II complex 
have been solved experimentally, enabling their realistic representation in MD 
simulations [97]. Key interactions of the complex and its behavior in bacterial membrane 
models were revealed in these studies. The findings suggested that nisin interacts with 
the membrane as a first step for pore formation, which is mediated through the 
interaction with lipid-II [96]. In another study, researchers discussed how the degree of 
oligomerization of nisin affects the pore formation and the interaction with lipid-II [94].  
Moreover, the behavior of a few class II bacteriocins was investigated through 
molecular dynamics simulations. First, in 2004, Kaur et al. explored the structural 
relationship of four class IIa bacteriocins at different temperatures [98]. As a membrane-
mimicking model, they performed the simulation in TFE (2,2,2-trifluoroethanol), which is 
a common practice for experiments. Their simulations were 2 to 4 ns long. They 
concluded that the helical region is responsible for target recognition and it loses its 
structure at higher temperatures. The same group later studied the interaction between a 
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class IIa bacteriocin and its immunity protein in the presence of DPPC 
(dipalmitoylphosphatidycholine) or a POPG (palmitoyloleoylphosphatidylglycerol) lipid 
bilayer - this time, for up to 30 ns [99]. They observed that the peptide interacts with the 
immunity protein through specific ion-pair interactions. Later they investigated the 
possible dimer structures of the class IIb bacteriocin Plantaricin S in a mixed POPE 
(palmitoyloleoylphosphatidylethanolamine) and POPG bilayer for 400ns [100]. They 
found that the peptides interact strongly with each other when they are in an antiparallel 
orientation. Cruz et al. studied the binding of AS-48, a class IIc peptide, to a membrane 
and the resulting pore-formation dynamics; It is important to note that they used coarse-
grained MD, where each particle of the system represents more than one atom. This 
way, the simulation can reach longer timescales, at the cost of losing spatial resolution. 
Finally, da Hora et al, demonstrated recently that a hybrid peptide of two class IIa 
bacteriocins induces negative curvature in the target cell membrane and disrupts its 
integrity, instead of forming a pore [101]. They performed the MD simulations in pure 
and mixed POPG POPC (palmitoyloleoylphosphatidylcholine) bilayers for up to 500 ns. 
Up to date, there has been no study of a class II bacteriocin in complex with its proposed 
receptor (like Man-PTS, UppP or YvjB) because we are lacking important information 
about the structure of these receptors. 
1.5. Thesis Overview 
The goal of this thesis is to shed light onto the mechanism of action (MOA) of class 
II bacteriocins. To achieve this, we employ different computational tools, focusing on 
molecular dynamics simulations. The thesis aims to investigate the nature of the 
interaction of a class II bacteriocin with a cell membrane and the possibility that a 
bacteriocin forms a transmembrane pore. We also address the challenge of studying a 
receptor without having prior knowledge of its structure. We focus mainly on the different 
aspects of the MOA of the class IIb bacteriocin PlnEF (Chapters 2-5), while in Chapter 6 
we shift focus to the MOA of the class IId bacteriocin LsbB. 
In 0, we introduce PlnEF, a class IIb, two-peptide bacteriocin, and we review the 
experimental information regarding its MOA. We then employ molecular dynamics 
simulations to study the behavior of this bacteriocin in water and in DPC micelles (a 
membrane-mimicking environment). To our knowledge, we are the first in the scientific 
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community to study the possible dimer structures and the peptide-peptide interactions of 
PlnEF from a computational perspective. 
 The initial interaction of a bacteriocin with a membrane plays a key role in its MOA, 
as we discuss in Chapter 3. We support this assertion by studying the PlnEF dimer on 
the surface of a model lipid bilayer. We go on to investigate the residues that are 
responsible for the peptide-peptide and peptide-membrane interactions. Then, we 
simulate different PlnEF-mutants of known activity in order to address the question of 
how the computational observations correlate with the experimental bactericidal activity 
of PlnEF. This study was published in the peer-reviewed journal, Biochimica et 
Biophysica Acta (BBA) – Biomembranes [102]; the experiments were conducted by our 
collaborators B. Ekblad and P.E. Kristiansen at the department of Biosciences in the 
University of Oslo, Norway. 
In Chapter 4, we describe how we incorporated additional experimental studies into 
designing a transmembrane dimer model of PlnEF. We used extensive mutational 
analysis and fusion-peptide orientation experiments in order to computationally create 
the dimer model and position it in a lipid bilayer. Utilizing atomistic MD simulations, we 
studied the important motifs that were involved in the peptide association. The work 
described in Chapter 4, in combination with the experimental studies (presented in the 
appendix), led to a publication in the peer-reviewed journal, Biochemistry [103]. Our 
partners at the department of Biosciences in the University of Oslo, Norway, B. Ekblad, 
C. Oppegård, J. Nissen-Meyer, and P.E. Kristiansen, performed the experiments and 
coauthored the publication with us. 
Chapter 5 extends the studies from Chapter 4 to further elucidate the behavior of 
the PlnEF transmembrane dimer. Through a 1 μs long atomistic MD simulation, we 
describe in detail the dimerization motifs of the dimer. We then analyze the effect of the 
dimer’s presence in its environment, i.e. the membrane, water, and ions. Most 
importantly, we address the question about whether class IIb bacteriocins can form a 
transmembrane pore that allows water and ion permeation. We are preparing the 
submission of this study for publication in a peer-reviewed journal. 
It has been suggested that the MOA of class II bacteriocins is associated with the 
presence of specific transmembrane receptors - therefore, we could not omit discussing 
the possibility of a receptor-mediated MOA. In Chapter 6, we introduce the idea of 
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employing protein structure prediction techniques to determine the structure of a 
bacteriocin receptor. We suggest a topology and we predict a structure for YvjB, which is 
a Zinc metallopeptidase that was identified as a possible receptor for the class IId 
bacteriocin LsbB. We proceed by designing an LsbB-YvjB complex through MD and 
docking calculations. We conclude Chapter 6 by detailing the next steps that are 
required to complete this study in the future. 
In the last chapter (Chapter 7), we summarize the conclusions of this thesis, and we 
outline the future direction for further elucidating the mechanism of action of class II 
bacteriocins.  
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Chapter 2  
Simulation of a Class IIb Bacteriocin in 
water and on micelles 
The mechanism of action of class II bacteriocins is complex and diverse. Lacking 
information about their receptor or a pore structure renders it difficult to create an image 
of the system that would represent the direct bactericidal mechanism of the peptides. 
However, the interactions of the membrane with the peptides is another important, albeit 
indirect, aspect of the MOA that can be simulated. In the case of class IIb bacteriocins, 
one can additionally study through MD, the interactions between the peptides, which is 
presumed to be crucial for their activity. In this chapter, we start our journey of 
unraveling the mechanism of action of class IIb bacteriocins.  
2.1. Introduction  
The class IIb model bacteriocin we use is Plantaricin EF (PlnEF); that is comprised 
of Plantaricin E (PlnE) and Plantaricin F (PlnF). The sequence of Plantaricin EF can be 
found at Table 2-1. PlnE, a 34 residue peptide and PlnF, a 33 residue peptide are 
produced by Lactobacillus plantarum C11, alongside PlantaricinJK, another two-peptide 
bacteriocin [104]. Lactobacillus plantarum C11 was first isolated from a cucumber 
fermentation in 1990, while different Lactobacillus plantarum strains that produce PlnEF 
have been found in other fermented foods, such as meat and grains [105–107]. 
Table 2-1: Aminoacid sequence of the two peptide bacteriocin, Plantaricin EF 
PlnE FNRGG  YNFGK  SVRHV  VDAIG  SVAGI  RGILK  SIR 
PlnF VFHAY  SARGV  RNNYK  SAVGP  ADWVI  SAVRG  FIHG 
 
Initially, the complementary antimicrobial action of Plantaricin E and Plantaricin F 
was studied against L. plantarum 965, and it was shown that they are 1000-fold more 
active when administrated together at equimolar concentrations (at 5 to 10 nM each) 
[73,104].  However, none of them is active in combination with Plantaricin J or K. PlnEF 
itself or strains producing PlnEF found to be active against a broader range of enteric 
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bacterial and fungal pathogens, such as Escherichia Coli [108,109] . 
The hypothesis that they form pores in the cell membranes was tested by 
calculating the pH gradient (ΔpH) and the transmembrane electrical potential (Δψ) [73]. 
Through that study, it was found that they dissipate both ΔpH and Δψ and that PlnEF 
induces the conduction of small monocovalent cations, while PlnJK seems to lead to 
efflux of anions. Thus, it can be concluded that the mode of action of both PlnEF and 
PlnJK is connected to membrane permeabilization, which however is attained through 
different paths. Recently, Zhang et al. verified the membrane permeabilization 
hypothesis with scanning electron microscopy and transmission electron microscopy 
(Figure 2-1) [110].  
Figure 2-1: Microscopy images of cells treated with PlnEF 
 
Scanning electron microscopy of bacterial cells treated without (a) or with (b) the class 
IIb bacteriocin, PlnEF for 30 min. It is evident that there is membrane disruption, while the 
yellow arrow points to blebs protruded in the cell surface. Scale bars: 500 nm. (Adapted 
from [110]) 
In order to explain the bactericidal mechanism and ion selectivity of PlnEF, 
structural analysis was conducted. Based on their aminoacid sequence, the Edmundson 
helical wheel representation suggests that both PlnE and PlnF have 18-24 residues, 
which will adopt α-helical structure, similar to other two-peptide bacteriocins [104,111]. 
CD studies provided a better insight in the secondary structure of PlnEF. The CD 
spectra of both peptides in aqueous solution has shown that they are unstructured with 
α-helical content less than 5%, while in presence of trifluoroethanol (TFE), that increases 
the hydrophobicity of the environment, the α-helical content of PlnE is 31%, while that of 
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PlnF 23%. In both cases, there was not any significant difference in the CD spectra of 
the individual peptides and when they were introduced together; indicating that adopting 
an α-helical structure precedes the interaction between the peptides [37].  
The presence of membrane mimicking moieties, such as dodecylphosphocholine 
(DPC) micelles and anionic dioleoylphosphoglycerol (DOPG) liposomes induced the 
formation of α-helical structures. Specifically, the α-helical content reached a maximum 
of 41% in the case of DPC micelles and 38% in the case of DOPG liposomes. 
Interestingly thought, the average spectra in DPC micelles followed the same pattern as 
the ones in aqueous and TFE solutions, e.g. being similar for individual peptides and 
dimer complexes [37]. In contrast, the complementary peptides increased the helical 
structure of each other upon exposure to anionic liposomes; either when they are 
premixed before their introduction to DOPG or when mixing liposomes that already 
contain at least one of the peptides [37].  The simultaneous addition of complementary 
peptides extended the helical content of PlnEF by 9 to 12%, while this rise was 
independent to the peptide concentration. The structure of the peptides was also 
investigated in the presence of zwitterionic dioleoylphosphocholine (DOPC) liposomes. It 
was shown that DOPC liposomes do not induce structure and mixing with anionic lipids 
is needed [37]. Thus, it can be conjured, that the peptides adopt α-helical structures 
upon arrival at the target membrane, where they interact individually with anionic 
membrane components. Then the peptides interact with each other in a structure-
inducing manner, possibly forming a membrane-associated dimer complex.  
  Recently the three dimension structures of the peptides PlnE and PlnF were 
analyzed by NMR spectroscopy in presence of DPC micelles [112]. Plantaricin E forms 
two α-helical-like regions (residues 10–21 and 25–31, pdb-id: 2jui, Figure 2-2a), while 
Plantaricin F forms one α-helix (residues 7 to 32, pdb-id: 2rlw, Figure 2-2b) with a kink 
around Pro-20, a common characteristic of many transmembrane proteins [112,113].  
The analysis of the sequence and structure of the two peptides Plantaricin E and F 
has pointed out several pieces of information. The importance of helical conformation in 
the class IIb bacteriocins has been highlighted as it mediates the insertion inside the 
membrane [114]. It is hypothesized that the two peptides interact with each other 
through the well conserved GxxxG motifs [112], either by creating flat surfaces enabling 
the nearby polar residues to approach each other and thus interact strongly forming 
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hydrogen bonds or salt bridges, or by having increased presence of acidic α-carbon 
hydrogens of glycines that can participate in hydrogen bonding. PlnF has one GxxxG 
motif (G30xxxG34), while PlnE has two: one at its N-terminus (G5xxxG9) and one near 
its middle section but closer to its C-terminus (G20xxxG24). Both peptides have multiple 
possible GxxxG like motifs, e.g. the GxxxG-like motif S26xxxG30 at the C-terminus of 
PlnF. Two dimer complexes can be drawn based on the possible combination of the 
GxxxG motifs (shown in Figure 2-3), taking into account that we assume that the 
peptides will interact in a staggered fashion similarly to what was proposed for 
Lactococcin G before [112].  
Figure 2-2: 3-D structure of Plantaricin E and F 
 
Cartoon representation of the NMR derived structures of PlnE (a) and PlnF (b) based 
on the STRIDE algorithm [151]. (magenta: α-helix, blue: 3-10-helix, cyan: turn, white: 
coil) 
Despite the detailed studies, a proposed mechanism of action for the antimicrobial 
activity of the two-peptide bacteriocin PlantaricinEF cannot be concluded. In order to 
shed light to the molecular basis for the behavior of PlnEF, we have performed 
molecular simulations of the peptides individually and in dimers inside aqueous solution 
to investigate their possible interactions, as well as their proposed lack of stability. Next, 
the dynamics of the peptides in the presence of DPC micelles was examined, to 
enlighten which residues are responsible for the interaction with a membrane-like 
system and compare directly with the CD and NMR results. 
2.2. Materials and methods 
All the molecular dynamics simulations were carried out using the NAMD 2.9 
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simulation engine [115] with the CHARMM param36 force field [116]. The analysis and 
visualization were performed using the program VMD [117] and Origin (OriginLab, 
Northampton, MA). The initial coordinates for the peptides were obtained from the 
protein data bank http://www.rcsb.org/ (pdb entries: 2jui for PlnE and 2rlw for PlnF).  
Figure 2-3: Possible models of the PlnEF  
 
Illustration of possible dimer models of the PlnEF, designed dimer based on the 
GxxxG motifs present in the bacteriocin. Model A: the C-terminal GxxxG motif of 
PlnE comes close to the GxxxG motif of PlnF enabling the polar amino acids in the 
center of the two peptides to interact. Model B: the N-terminal GxxxG motif of PlnE 
interacts this time with the GxxxG motif of PlnF, allowing the polar amino acids in the 
center to interact in a lesser degree. Yellow boxes denote the hypothesized GxxxG 
motifs. Proposed Hydrogen bonds are indicated with gray lines. Red: acidic residues; 
Blue: basic residues; Green: hydrophobic residues. The initial conceptual design of 
these models was performed by our collaborator P. E. Kristiansen. 
In order to generate initial dimer structures, e.g. possible conformations of the two 
peptides relative to each other, we used the online ZDOCK docking server [118]. 
ZDOCK performs docking simulations and searches for local energy minima of the 
system, employing fast Fourier transformation, while treating each peptide as a rigid 
body and exploring only its six-dimensional (rotational and translational) space. Two 
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different conformations were selected that would resemble as close as possible the 
suggested dimer models presented in Figure 2-3. In the first, the peptides are positioned 
parallel to each other, while in the second they are positioned in an antiparallel manner. 
Initially the z-dock server produced 2000 predictions of possible dimer structures. Those 
predictions were used as input to an in-house Matlab script that screened out the best 
dimers based on the GxxxG motifs complementarity. Three such GxxxG motifs are 
present in Plantaricin EF. We chose as the initial parallel conformation the dimer 
structure that brought closer the G20xxxG24 motif of PlnE with the G30xxxG34 motif of 
PlnF. We chose as the antiparallel one the structure that brought closer the G5xxxG9 
motif of PlnE with the G30xxxG34 motif of PlnF.  
The DPC micelle models were created using the online CHARMM-GUI server [119], 
that performs short molecular dynamics simulation using the CHARMM engine [120]. 
Next, we combined the micelles with the peptides using VMD, resulting in the initial 
peptide-micelle structures.  
The simulation parameters were kept the same for all the systems. Initially each 
system was minimized using the conjugate gradient algorithm provided in NAMD. This 
was followed by gradual heating to 303.15 K while the peptides and lipid atoms were 
subjected to positional harmonic restrains. Then numerous equilibration steps were 
performed while the restrains were gradually removed. Equilibration and production runs 
were carried out in the NPT ensemble at atmospheric pressure. A timestep of 2 fs was 
employed. Van der Waals potential was truncated at 10 Å introducing a switching 
function at 9 Å, while the real space cutoff distance of the PME electrostatics calculation 
was also set at 10 Å. Coordinate snapshots were recorded every 2 picoseconds. 
2.3. Results and Discussion 
2.3.1. Simulation of individual peptides in water 
Each of the two peptides was introduced in a separate box, which was created by 
surrounding the protein with a 30 Å water layer. This corresponds to ~25,000 molecules 
of water. Sodium and chloride ions were added to counter the charge of each peptide 
and to add 0.15M NaCl, which resembles the ion concentration of biological fluids. 
Production simulations (that are called E_w for PlnE and F_w for PlnF) were conducted 
for 85 ns. The stability of the peptide structures was accessed by calculating the dihedral 
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angles formed (Figure 2-4a) as well as their potential energy (Figure 2-4b).  
In contrast to the CD studies, Plantaricin E is very stable in a water box. One 
contiguous helix is observed through the simulations. In the model, there is no 
discernible curvature along the long axis of the peptide, indicating that the curvature 
observed in experiments may be the result of the interaction with the spherical micelle. 
The phi dihedral angle for aminoacids 10 to 32 is on average equal to -65.3±3.9 and 
their psi angle -38.02 ± 4.1 degrees. The values for dihedral angles that define an α-helix 
are -64±7 degrees for phi and -41±7 degrees for psi.  
Figure 2-4: Dihedral angles and Energy analysis for the individual peptides in 
aqueous solution 
 
a. Mean dihedral angles for each residue of Plantaricin E (E_w) and Plantaricin F 
(F_w) in a water box. The values for dihedral angles that define an α-helix are -64±7 
degrees for phi and -41±7 degrees for psi. 
 
b.   Energy of the peptides Plantaricin E (E_w) and Plantaricin F (F_w) in a water 
box 
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On the other hand, the helix of PlnF seems to be divided into two distinct helical 
substructures around the proline residue (aminoacids 7 to 17 and 23 to 31). 
Energetically PlnE seems to reach a minimum and to be stabilized, however PlnF is 
continuously increasing. The last snapshot of the simulations can be found in Figure 2-5. 
Figure 2-5: Final snapshots of the simulation of individual peptides in water 
 
Final snapshot of the simulation of individual peptides in water. Cartoon  
representation based on the STRIDE algorithm [121]. (magenta: α-helix, blue: 3-10-
helix, cyan: turn, white: coil) 
2.3.2. Simulation of proposed dimers in water 
The two proposed models of the dimer were solvated as described before. 
Production runs of 80 ns were performed. The energy and dihedral angles of each 
peptide were analyzed to evaluate their stability. Furthermore, we quantified the 
formation of hydrogen bonds, in order to identify peptide domains or residues involved in 
interactions  
Dihedral angle analysis revealed that the structure of both peptides deviates 
substantially from their NMR structure, apparently due to the peptide-peptide interaction. 
In both cases, short α-helical like domains are formed for each peptide (Figure 2-6a o 
Figure 2-6b).  
Interestingly, in both models Plantaricin F is the one that is most structured, in 
contrast to the case of single peptides in water. Moreover, the energies of the peptides 
fluctuate significantly in the second half of the simulation (Figure 2-6c); there is an 
increase of the energies of both complexes, followed by a sharp decrease. Although we 
cannot yet conclude to a possible structure of the dimer in water, analysis of the 
hydrogen bond propensity of each residue in the peptide can provide some useful first 
information.  
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Figure 2-6: Dihedral angles and energy analysis for the proposed complexes in 
aqueous solution 
 
a. Mean dihedral angles for each residue of Plantaricin E (E_w) and Plantaricin F 
(F_w) in Model A. The values for dihedral angles that define an α-helix are -
64±7 degrees for phi and -41±7 degrees for psi. 
 
b. Mean dihedral angles for each residue of Plantaricin E (E_w) and Plantaricin F 
(F_w) in Model B. The values for dihedral angles that define an α-helix are -
64±7 degrees for phi and -41±7 degrees for psi. 
 
c. Potential energy of the dimer PlnEF in water for models A and B 
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The hydrogen bonds (Hbonds) that were created between the two peptides were 
calculated in each simulation. Only those that are present in more than 10% of the 
snapshots taken are considered significant. In the case of model A, hydrogen bonds 
were present between the side chains of Arg13 of PlnE and Asp22 od PlnF, as well as 
Asp17 of PlnE and Arg29 of PlnF with an occurrence (occ.) of 82.76% and 70.38% 
respectively though the course of the simulation. 
These results agree with the proposed model. However, another hydrogen bond 
between the backbone atoms of Tyr6 of PlnE and Ala17 of PlnF is present with 
occ.=17.01%. This may be the reason of the disruption of the structure of the peptides 
around these residues. It is very interesting, that the Tyr residue lies inside the GxxxG 
domain on PlnE and this might be a first indication of how these motifs affect the 
interaction between the peptides. Focusing on the last 40 ns of the simulation we find 
that the hydrogens bonds between R13-D22 and D17-R29 prevail, with occ. 84.35% and 
65.15%, however the Y6-A17 hbond in no longer important. Conversely, an Hbond 
between Ser21 of PlnE and His33 of PlnF is beginning to have a strong presence with 
occurrence equal to 9.4%. 
During the simulation of model B, the hbond Arg13-Asp22 was present again, with 
an occurrence of 64.61%. Arg29 of PlnF interacts now with the side chain of Ser11 of 
PlnE (occ.=29.14%), in contrast with the proposed model that implies they should be in 
the outer surface of the dimer (Figure 2-3) and not interacting. Furthermore, a hydrogen 
bond is formed between the side chains of His14 of PlnE and Ser26 of PlnF 
(occ.=19.20%). However, what could be considered problematic is the connection with 
an internal hydrogen bond between the side chains of Arg13 and Asp17 of Plantaricin E 
that creates a bend on its structure and thus attenuates the interaction between the two 
peptides. The same hydrogen bonds are observed during the last half of the simulation, 
with only the occurrence of R13-D22 having increased slightly.  
2.3.3. Simulation of the individual peptides in the presence of DPC micelles 
Pre-equilibrated DPC micelle structures were obtained from the online server 
CHARMM-GUI. Each peptide was placed in different orientations with respect to the 
micelle surface in order to better examine the helical domains observed by the NMR 
experiments. Each orientation was chosen, so that a different surface of a helix, with 
similar hydrophobic character, faces the micelle (Figure 2-7).  
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In total, seven systems were created, four for PlnE and three for PlnF. In models 
Es3, Es1, and Fs1 mostly hydrophobic aminoacids face the micelle, so the peptides 
were expected to be inserted into the micelle leaving the polar aminoacids to interact 
with its surface. The production simulations have run for 20. Dihedral angle analysis, as 
well as energy calculations were performed to monitor the stability of the peptides and 
their interaction with the micelle. Snapshots of two of the systems can be found in Figure 
2-8. 
Figure 2-7: Definition of the different Peptide-micelle systems 
Pl
nE
 
  
Pl
nF
 
  
 
a) Definition of the residue groups 
that face the micelle: Es1:green, 
Es2:magenta, Es3:blue, Es4:red,  
Fs1:mageνta, Fs2:green, Fs3:blue 
b) Accessible surface area. Red: 
acidic residues; Blue: basic 
residues; Green: hydrophobic 
residues; Gray: polar uncharged 
residues  
The distance of the center of the mass of the Plantaricin E with respect to the 
micelle is reported in Figure 2-9. Only in the case of simulation Es1, does Plantaricin E 
enter the hydrophobic core of the micelle, while it keeps its initial orientation. The more it 
was inserted inside the micelle the more favorable the interaction became, as the energy 
of interaction between the peptide and the micelle was decreasing. Nonetheless, we see 
that the energy of the peptide increases during the last 5 ns. In simulations Es2 and Es3 
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the initial polar aminoacid placement near the polar heads of the lipid, forced the 
peptides to stay on the surface. There is a measurable increase of energy in ES3, 
because even though there are favorable interactions with the micelle, the peptide bends 
around Ser21 probably creating strains. In Es4 the peptide quickly departs and appears 
to not interact with the micelle. This could be because there were no polar residues 
facing the micelle originally, to initialize the interaction between them. In most 
simulations, the dihedral angles were considerably stable and agreed with the NMR 
measurements.  
Figure 2-8: Snapshots of systems Es1 and Es2 
 
Initial and final snapshots of systems Es1 and Es2. The peptides are colored based 
on the scheme in Figure 2-7. The hydrophobic core of the micelles is colored cyan, 
while its polar heads red and blue. 
 
Figure 2-9: Center of mass the peptides with respect to the micelle 
  
Each line shows the distance of the peptide from the center of the micelle for each 
simulation. The hydrophobic core of each micelle extends from 0 to ~19Å. 
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Regarding Plantaricin F, simulation of model Fs1 was the most prominent to result 
in insertion of the peptide in the micelle, however this event was not observed. The 
reasons are probably similar to the non-insertion of PlnE in ES4. On the other hand, in 
both Fs2 and Fs3 the peptide remained on the surface of the micelle, surrounded by the 
polar head groups of the DPC molecules, and exhibited similar behavior as PlnE in Es2 
and Es3. 
2.4. Conclusions 
The simulations we describe in this chapter indicate that the peptides interact 
strongly with each other, as well as with DPC micelles – a simple model of membrane 
environment. Based on experiments that have been conducted previously, it would be 
expected that they would not demonstrate structural elements in an aqueous 
environment. However, this is not the case. Plantaricin E seems to be quite stable in 
water in contrast to Plantaricin F. Nonetheless, one cannot come to conclusion with only 
85ns of simulation, since there would not be enough time for the peptides to unfold 
properly. However, the investigation of folding and unfolding dynamics of these peptides 
is not of primary interest for our research. When they are introduced together, it is 
observed that a lot of their initial structure is lost in favor of interaction between them.  
The simulations of the peptides in presence of a DPC micelle provided an insight on 
which parts of each peptide are more potent to interact with either the polar head groups 
or the hydrophobic core of a membrane mimicking system. It seems that the helix, 
formed by residues 8-24 of Plantaricin E has an amphiphilic character. The one side of 
the helix, which is consisted of hydrophobic residues, can interact strongly with a 
membrane core as shown in simulation Es1. Simultaneously, this enables the free polar 
residues on the other side of the helix (including Arg13 and Asp17) to interact potentially 
with PlnF. On the other hand, Plantaricin F forms two helical domains, which could 
interact with a membrane, as shown in simulations Fs2 and Fs3. The other side of the C-
terminal helix (where Asp22 and Arg29 are located) could form Hbonds with PlnE. 
Nonetheless, the insertion of PlnF reached only the polar surface and the outer level of 
the hydrophobic core of the micelle, suggesting that this peptide cannot serve as a 
transmembrane protein individually. However, interaction with Plantaricin E or a 
transmembrane protein may stabilize and facilitate the insertion of Plantaricin F in the 
membrane as well.  
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Chapter 3  
Behavior of a class IIb bacteriocin and 
its mutants on the surface of a model 
lipid bilayer 
3.1. Introduction 
The details of the mechanism of action of bacteriocins are unclear. As discussed in 
paragraph 1.2.1 the bactericidal activity of AMPs is linked to permeabilization of the cell 
membrane or disruption of a vital process of the target organism. In both cases, AMPs 
are hypothesized to interact with the bacterial membrane surface of their target host, 
mainly by electrostatic forces [34,122–124]. In many cases, AMPs are thought to form 
aggregates and pores, which induces an ion efflux that leads to cell death [124,125]. It 
has been shown that the activity of class II bacteriocins is similarly connected with the 
disruption of the membrane of the targeted bacteria [82]. However, there is no direct 
evidence that they form aggregates or pores on their own. On the other hand, 
experiments have revealed that their activity is often associated with the presence of 
specific transmembrane proteins that act as receptors [53]. Diep et al. reported that a 
class IIa bacteriocin, Lactococcin A, binds to the cytoplasmic component IIAB of man-
PTS. Upon binding, man-PTS likely undergoes a conformational change that results in 
unregulated flux of ions and eventual cell death [68]. Similarly, another transmembrane 
protein, UppP/BacA, has been identified as a potential receptor for Lactococcin G, a 
class IIb bacteriocin [78]. However, the detailed interaction of the class II bacteriocins 
with their transmembrane receptor is unknown. 
The receptor mediated mode-of-action apparently involves the so-called “membrane 
catalysis” [44]. First the bacteriocins interact with the bacterial membrane and then 
diffuse laterally until they encounter their receptor, rather than diffuse in the aqueous 
solution. In this manner, the rate of interacting with the target transmembrane protein is 
increased. The reduction of dimensionality has been dubbed “the nature’s trick” to 
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overcome the diffusion control barrier [126].  Nisin and other class I bacteriocins are 
thought to follow a dual mechanism of action. At micromolar concentrations, nisin 
peptides interact directly with the membrane and form target-independent pores, while at 
nanomolar concentrations they bind to lipid A, a component of Gram-negative bacterial 
membranes, and form target-mediated pores [42]. It could be speculated that class II 
bacteriocins have a dual MOA as well and the interaction of the peptides with the 
membrane could be presumed a key step underlying their mechanism of action.  
We are interested in class IIb bacteriocins, and particularly in Plantaricin EF 
(PlnEF). In paragraph 2.1 we summarized the experimental studies conducted 
previously about the behavior and MOA of PlnEF. We know that PlnEF kills the target 
organism by causing membrane disruption and uncontrollable leakage of the cell 
content. For the bactericidal activity, both peptides are needed at a 1:1 ratio, indicating 
that they form a dimer complex. It is not clear when the peptides interact with each other; 
however, structural studies and our results presented in 0 suggest that the peptides 
reach the membrane first as they are mostly unstructured in water.  
Based on the above results we imagine the mechanism of action of PlnEF as 
depicted in Figure 3-1. The two peptides interact first with the membrane and are 
adsorpted on the surface where they adopt α-helical structures (A). Then they either 
associate and form a surface dimer (D) or are inserted in the bilayer (B) and form a 
transmembrane dimer (C). In an unknown fashion the dimer then causes membrane 
permeabilization, possibly by disrupting the continuum of the membrane or by interacting 
with a membrane protein receptor (E).  
In the work described in this chapter, we employed atomistic molecular dynamics 
simulations to investigate the behavior of the class IIb bacteriocin PlnEF on the surface 
of lipid bilayer. We are interested in the specific amino acids or structural motifs that are 
responsible for the interaction between the peptides and the interaction of the peptides 
with a model membrane of Gram-positive bacteria. Additionally, we simulated peptides 
that contain a single amino acid substitution, and compare the results from simulations 
to the bactericidal activity. The work described in this chapter has been presented in a 
peer-reviewed publication [102]. 
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Figure 3-1: Possible steps of the MOA of PlnEF 
 
Previous experimental studies as well as our simulation (presented in 0) suggest that 
the peptides first interact with the membrane and adopt a α-helical structure. Therefore, 
we can assume that the first step of the mechanism of action of PlnEF is the adsorption 
of each peptide (PlnE in blue, PlnF in green) individually on the surface of the bilayer 
(A). Then the peptides could insert in the membrane (B) and upon interaction, form a 
transmembrane dimer (C). The dimer could cause membrane disruption or interact with a 
receptor (in pink) in a pore forming fashion (E). Alternatively, the peptides interact first 
on the surface (D) and enter the membrane as a dimer (C) or interact with a receptor (E) 
to cause cell death. 
3.2. Materials and methods  
Eigth different systems were studied with atomistic molecular dynamics (MD) 
simulations. Each system contains models of the two peptides (PlnE and PlnF), a lipid 
bilayer that mimics the bacterial membrane, water molecules, and ions. The first system 
contains the wild type peptides. In addition, we chose to simulate seven dimers that 
contain single amino acid mutations at key positions (simulations E(G20A), E(R13D), 
E(I32R), F(S26T), F(D22R), F(P20A), F(R29I)), in combination with the cognate wild 
type peptide, and compare the results to measured differences in activity.  
3.2.1. Simulation Methods and Parameters 
Molecular dynamics simulations were carried out using the NAMD 2.9 simulation 
engine [115] with the CHARMM param36 force field [116] under constant pressure and 
temperature (NPT ensemble). The simulation parameters were kept constant in all the 
simulations. Initially each system was minimized using the conjugate gradient algorithm 
provided in NAMD. This was followed by gradual heating to 310 K while the peptides 
and lipid atoms were subjected to positional harmonic restraints. Then numerous 
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equilibration steps were performed while the restraints were gradually removed. 
Equilibration and production runs were carried out at atmospheric pressure. A timestep 
of 2 fs was employed. Van der Waals potential was truncated at 12 Å, introducing a 
switching function at 10 Å, while the real space cutoff distance of the PME electrostatics 
calculation was also set at 12 Å. Coordinate snapshots were recorded every 10 
picoseconds. Both wild type configurations were simulated for 400 ns in total, while the 
simulations of the systems with the mutated peptides were run for 200 ns. 
3.2.2. Atomistic model of PlnEF, and a membrane 
The 3D structures of the two peptides that constitute the bacteriocin PlnEF, PlnE 
and PlnF were obtained from the PDB database (PDBID 2jui and 2rlw respectively) 
[112].  The structure of the mutated peptides was created using the VMD mutator plugin, 
employing the structure of the wild type peptides as a scaffold [117].  
A model lipid bilayer containing POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoglycerol) and POPE (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine) 
lipids at 3:1 ratio was used to simulate the membrane of Gram-positive bacteria. 
Analysis of the bacterial membranes of many Gram-positive bacteria reveals that PE 
and PG heads prevail at the ratio mentioned above [127]. It would be ideal to be able to 
simulate model bilayers as complex as real cell membranes, however due to 
computational cost we have to use a more simplistic model. The model used is a 
symmetric model since in an atomistic bilayer system one cannot differentiate between 
the inner and outer environment of a cell, that gives rise to the asymmetry of real cell 
membranes [128].  POPG and POPE lipids at a 3:1 ratio were used before to simulate a 
similar system as well [100]. The structure of the model bilayer was obtained from the 
online server CHARMM-GUI and was simulated for 50 ns before the insertion of the 
peptides to ensure the equilibration of the membrane features [119].  
 In total, each system contains the two peptides, 160 lipid molecules, more than 
8,000 molecules of water and enough NaCl ions to make the system electroneutral and 
to create an additional 0.15 M physiological salt solution. 
3.2.3. Positioning of the peptides on the surface of the membrane  
We used the methodology described at paragraph 2.2 to generate initial dimer 
structures. Then the dimer structures were positioned parallel to the surface of the 
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membrane, guided by our peptide-micelle simulation results presented in 0 and 
optimizing for the most polar surface of the dimers to face the polar surface of the 
membrane. The two different conformations were simulated only in the case of the wild 
type peptides. All the systems containing mutations were simulated only in the parallel 
conformation since it was found to be more energetically favorable for the case of the 
wild type peptides.  
3.2.4. Bacteriocin activity assay 
The experimental activity measurements described in this chapter were provided by 
B. Ekblad and P. E. Kristiansen at the Department of Biosciences, in the University of 
Oslo, Norway. The experimental methodology is described in the appendix A. We 
contributed to the choice of mutants to be tested and interpretation of the results, guided 
by our previous simulations as well as results of the simulation of the wild type peptides.  
3.3. Results and Discussion 
We focus on simulations of the wild type peptides adopting two conformations, a 
parallel one, and an antiparallel one. We are interested in the interactions between the 
peptides that comprise the dimer, as well as the interactions of the dimer with the 
membrane. In addition, we chose to simulate seven more dimers that contain mutations 
at key positions (simulations E(G20A), E(R13D), E(I32R), F(S26T), F(D22R), F(P20A), 
F(R29I)). The objective of these simulations is to investigate how different amino acids 
affect the nature and the strength of the interactions observed in simulations containing 
the wild type peptides and compare the results to the antimicrobial activity of the 
peptides. Our ultimate goal is to explore any possible connection between the 
experimental activity of the various mutants and the biophysical image observed during 
the simulations. We first report the experimentally observed activities of the wild type 
and mutant variants of PlnE and PlnF. The results of the molecular dynamics simulations 
follow.  
3.3.1. Experimental antimicrobial activity 
Antimicrobial activity of the wild type and mutant variants of the two peptides that 
constitute the bacteriocin PlnEF, were determined against three indicator strains in a 
microtiter plate assay system, essentially as described by Nissen-Meyer et al. [129] The 
relative activity of the different peptide combinations against the indicator strains is 
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shown in Table 3-1.  
Table 3-1: Antimicrobial activity of PlnEF 
Peptide combination LTH1174 NCDO 990 NCDO 521 
E + F 1 1 1 
E(R13D) + F >512 >64 >256 
E(D17R) + F >512 ≥ 32 ≥ 64 
E (G20A) + F ≤ 0.5 0.5 ± 0 0.3 ± 0.1 
E(I28R) + F 24 ± 9 - - 
E(I32R) + F 10 ± 4 - - 
E + F(P20A)  2 ± 1 9 ± 1 5 ± 2  
E + F(D22R) 40 ± 16 32 ± 0 16 ± 0 
E + F(S26T) 8 ± 6 7 ± 2 5 ± 2 
E + F(R29D) 20 ± 8 16 ± 0 21 ± 9 
E + F(R29I) 8 ± 3  - - 
E(R13D) + F(D22R) >256 >64 ≥ 128 
E(R13D) + F(R29D) >256 >64 >256 
E(D17R) + F(D22R) >256 >64 ≥ 64 
E(D17R) + F(R29D) >256 >64 >256 
E(I28R)+ F(R29I)  49 ± 19 - - 
E(I32R)+ F(R29I)  25 ± 11 - - 
E(R13D)   >2560 >320 >1280 
E(D17R)   >2560 >320 >1280 
F(D22R)   >2560 ≥ 160 90 ± 60 
F(S26T)   >2560 >320 ≥ 320 
F(R29D)   >2560 >320 >1280 
 
Relative mean MIC values and standard error of the mean of various wild type and 
mutant peptide combinations against three different indicator strains. The strains used 
were: Lactobacillus curvatus LTH1174, Pediococcus pentosaceus NCDO 990 and 
Pediococcus acidilactici NCDO 521. The MIC values were determined from three or 
more independent measurements. 
Several mutations have been tested. Most of the mutated peptides exhibited worst 
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or similar activity when compared to the wild type peptides (Table 3-1). Only the 
mutation of Gly 20 of PlnE to an Ala (G20A) contributed to an increase in activity. 
Substituting the Arg residue at position 13 in PlnE with an Asp (R13D) was very 
detrimental. The same trend was seen when substituting the Asp residue with an Arg at 
position 17 (D17R) in PlnE. Decreasing the hydrophobicity of the C-terminus of PlnE, by 
substituting Ile at positions 28 or 32 to an Arg (I28R and I32R), resulted in a significant 
reduction of activity.  
Figure 3-2: Snapshots from simulations of the wild type peptides 
 
Snapshots from simulations of the wild type peptides in a parallel conformation (top 
row) and in an antiparallel conformation (bottom row) at 0 ns, 100ns, 200ns and finally 
400ns. In the first snapshot, the structure of the peptides is similar to their NMR structure. 
PlnE is shown in blue and PlnF in green. Both peptides are shown in cartoon format. The 
lipids are shown as a sequence of spheres, using their van der Waals radius. The 
hydrophobic tails are colored light grey while the hydrophilic heads are colored dark 
grey. Red triangles point to the N-terminal of each peptide.) 
Substituting the Pro residue in PlnF with an Ala (P20A) did not have any marked 
effect on the activity. The Ser residue at position 26 in PlnF was substituted with a Thr 
residue (S26T), which resulted in approximately 8-fold reduction in activity. The activity 
is hence decreased compared to the wild type combination. Similar behavior was 
observed during the mutation of Arg at position 29 of PlnF to an Ile (R29I). The 
mutations R29D and D22R of PlnF reduced the activity approximately 20 to 40 times, 
respectively.  
Combinations of different mutants with opposite charge, such as the E(R13D) with 
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F(D22R) or E(D17R) with F(R29D), were also tested, to investigate if some of the wild 
type activity was retained (Table 3-1). All combinations were detrimental for the indicator 
strains tested. In all cases the mutated variants of the peptides tested without their 
complementary peptide, did not result in any activity against the indicator strains tested. 
3.3.2. Simulation of the wild type bacteriocin PlnEF 
The simulations were run for 400 ns each. In both the parallel and antiparallel 
conformations, the peptides adopted a stable structure after the first 50 ns (snapshots of 
the simulation can be found in Figure 3-2).  
Figure 3-3: RMSD analysis 
 
RMSD analysis of wild PlnE (blue) and wild PlnF (green) in the parallel and 
antiparallel conformations. Main figure: the analysis was performed from the 100th to the 
200th ns, with respect to the structure of the peptides at 100th ns. Both the peptides in both 
simulations are stable for 100 ns. They have backbone RMSD values 0.1-0.3 nm, which 
is comparable to the NMR analysis. Inlet figures: RMSD values are shown from the 200th 
to the 400ns, with respect to the structure of the peptides at the 200th ns. Further evolution 
of the simulations revealed that the structure do not deviate significantly over 200 extra 
ns. 
The peptide structures changed very little between 100 and 200 ns, with the root 
mean square deviation (RMSD) of the backbone atoms of the individual peptides only 
varying between 0.2-0.3 nm (Figure 3-3), which is comparable to the optimal rmsd 
values originated from NMR studies [112,130]. We continued the simulations, until 
reaching 400 ns, to ensure that the structure of the peptides did not change. The RMSD 
of PlnE was only 0.1-0.2 nm for the final 200 ns (Figure 3-3a insert). PlnF exhibited a 
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temporal increase in its RMSD value (picked at 0.5 nm) at the end of the simulations 
(Figure 3-3b insert). Further analysis was performed over a span of 100 ns (from the 
100th to the 200th ns). 
 
Figure 3-4: Structural analysis of wild type PlnEF 
 
Structural analysis of wild PlnE (blue) and wild PlnF (green) in the parallel and 
antiparallel conformations. The overall helicity (a) and helicity per residue (b) are 
shown for each peptide in the parallel and antiparallel conformation. In figure a, row 
data are plotted with light color, while the darker colored lines represent running 
averages over 10 frames. 
Secondary structure of the peptides 
NMR studies revealed that PlnE forms two α-helical regions (residues 10 to 21 and 
25 to 31) separated by the flexible G20xxxG24 motif, having a total of 51-57% helical 
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content, while PlnF forms one helix (residues 7 to 32) with a kink around P20 and has 
76% helical content [112]. During the simulation of the parallel dimer conformation, the 
helical contents, and distributions of both peptides are in great agreement with the NMR 
results (Figure 3-4). However, we notice a more distinct bending of PlnE around G20 
and a discontinuity of the α-helix of PlnF, which could explain the significant decrease of 
the helical content of PlnF (Figure 3-4). The flexibility of the peptides around these 
regions may be associated with the presence of amino acids that are known to disrupt 
helices, such as Glycine (G20 of PlnE) and Proline (P20 of PlnF) [131,132]. Moreover, 
hydrogen bonds are formed between polar amino acids and particularly the hydroxyl 
group of Serine (such as S26 and S16 of PlnF, Figure 3-5) with neighboring backbone 
amides. These hydrogen bonds could presumably enhance the flexibility of the α-helical 
domains and their bending angle, as suggested by various studies  [133–135].   
Figure 3-5: Serine contribution to multiple hydrogen bonds 
 
Example of the diverse role of Serine aminoacids that is suggested to modulate a 
Proline kink. Top: Serine residues form α-helical backbone hydrogen bonds with 
residues four positions earlier. Bottom: The hydroxyl of the functional group of Serine 
residues attacks the backbone amide four positions earlier. PlnF is shown as green 
cartoon. The Proline residue is colored yellow, while all the other residues are colored 
per atom. Carbon atoms are colored cyan, hydrogen atoms blue, oxygen atoms red and 
nitrogen atoms blue 
In the simulation of the antiparallel dimer conformation, we observed a different 
behavior (Figure 3-4). The helical content of PlnE is increased, as it now forms one 
continuous helix from residue 8 to 31. On the other hand, the helical content of PlnF is 
43 
 
markedly decreased and it forms two short α-helices.  
The difference between the NMR structures and the structures resulting from the 
simulations could be attributed to the following: i) the peptides were studied individually 
during the NMR studies, ii) the cell membrane model used for the NMR studies was 
DPC micelles while a lipid bilayer was used in the simulations. Thus, the presence of the 
complementary peptide, as well as the different membrane models could effectively alter 
the environment and may result in a different structure.  
Interaction of the peptides with the membrane 
In the simulation of the parallel dimer conformation, two regions of PlnE interact 
strongly with the membrane (Figure 3-6). The first region includes residues 4 to 10, with 
the interaction being mediated by salt bridges and hydrogen bonds between primarily 
residue K10 with the membrane and, to a lesser extent, between R8, Y6 and N7 with the 
membrane (Figure 3-6 and Figure 3-7). The second region includes amino acids 31 to 
33, where hydrogen bonds and a prevalent salt bridge are formed between R33 and the 
membrane. The first region inserts measurably into the lipid surface.   
Figure 3-6: Distance of the wild-type peptides from the membrane center 
 
The distance per residue of each peptide from the membrane center is shown, along 
the z-direction; the black line represents the local distance of the Phosphate groups of 
the leaflet containing the peptide from the center of the membrane 
PlnF interacts with the membrane only through its N-terminus, (residues 1 to 15). 
Three salt bridges are formed throughout the simulation between R8, R11 and K15 with 
the membrane, as well as multiple hydrogen bonds. Notably, bidentate hydrogen bonds 
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are formed between the side chains R8 and R11 with the membrane phosphate groups. 
These type of interactions have been reported previously in literature and are believed to 
increase the penetration of Arginine rich peptides in the membrane [136,137]. The total 
potential energy contribution of the interaction between the peptides and the membrane 
is approximately -1360 kcal/mol. However, these local interactions do not seem to 
disrupt the integrity of the membrane, as revealed by the homogeneity of the lipid 
density of the leaflet containing the peptides (Figure 3-8). 
Figure 3-7:  Membrane – peptide interactions 
 
Snapshot of the simulations of the parallel conformation (top) and antiparallel 
(bottom) showing the most representative interactions between the dimer and the 
membrane. Individual residues that take part in these interactions are colored red and 
named in black. PlnE is shown in blue and PlnF in green. Both peptides are shown in 
cartoon format. The lipids are shown as a sequence of spheres, using their van der 
Waals radius. The hydrophobic tails are colored light grey while the hydrophilic heads 
are colored dark grey. 
In the case of the antiparallel dimer conformation, on the other hand, there is a 
significant deformation of the leaflet containing the peptides (Figure 3-8). Indeed, the 
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potential energy of interaction between the peptides and the membrane is approximately 
-1800 kcal/mol. A closer look reveals that PlnE interacts with the membrane more 
strongly than in the parallel model (Figure 3-6 and Figure 3-7). Two regions of interaction 
between PlnE and the membrane can be distinguished. The first includes the N-terminal 
residues 1 to 10, forming various hydrogen bonds and salt bridges with the membrane, 
most importantly R3 and K10, and a second region that includes residues 28 to 33. PlnF 
exhibits similar behavior as in the parallel model.  
Figure 3-8: Membrane deformation 
 
The average area per lipid for the layer containing the peptides is shown. A 
transparent snapshot of an average structure of the dimer indicates where the peptides are 
positioned on the layer from a top view. The wild PlnE is colored blue, while the wild 
PlnF green. White arrows point to the N-terminal of each peptide. 
Peptide-peptide interactions 
The two peptides interact with each other around their middle section throughout the 
simulation of the parallel dimer conformation, forming various hydrogen bonds and salt 
bridges. Mainly, a salt bridge is formed between K10 of PlnE and D22 of PlnF initially, 
which is replaced later by a salt bridge between R13 of PlnE and D22 of PlnF. A 
hydrogen bond is formed strongly between R3 of PlnE and the backbone of V18 of PlnF. 
Interestingly, intramolecular hydrogen bonds are formed in PlnE, between amino acids 
F1, R3 and D17, which connect the N-terminal coil region of PlnE with its N-terminal α-
helix. Moreover, hydrophobic residues, located at the C-terminus of PlnF and the N-
terminus of PlnE, are buried in the area between the two peptides, presumably making 
the interaction between the two peptides more entropically favorable. 
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In contrast, the two peptides interact only weakly in the simulation of the antiparallel 
dimer conformation. The only salt bridge formed in this case, is the one between R13 of 
PlnE and D22 of PlnF. The potential energy of interaction between the peptides is 
positive (15.3 kcal/mol while in the case of the parallel this is -39.4 kcal/mol). 
In neither simulation do the GxxxG motifs bring the helices in close contact (Figure 
3-9). This behavior shows that the GxxxG motifs do not bring helical domains in 
proximity at the membrane surface. This observation is in agreement with the findings of 
recent computational and spectroscopic studies which revealed that the GxxxG motifs 
not always provide a dimerization surface [138,139].  
On the other hand, in the parallel conformation, the V12xxxV16 motif and the 
A23xxxG27 (both in PlnE) let the two helical domains of PlnE approach each other and 
intensify the bending around G20. In contrast, in the antiparallel conformation the 
Figure 3-9: The behavior of possible GxxxG motifs 
 
Evolution of important GxxxG and GxxxG like motifs through the simulations of the 
parallel and antiparallel conformations. In both models, the GxxxG motifs (parallel: 
G20xxxG24 of PlnE - G30xxxG34 of PlnF ; antiparallel:G5xxxG9 of PlnE - G30xxxG34 
of PlnF ) are located more than 1nm away, indicating that they do not contribute to the 
interaction between the peptides. On the other hand, we observed other GxxxG-like 
motifs that aid the interaction of helical domains of the peptides. In the parallel model: 
the distance between the V12xxxV16 motif and the A23xxxG27 (both belonging in PlnE) 
is ~0.7nm. While in the antiparallel model, the distance between the V12xxxV16 motif of 
PlnE and the V24xxxV28 of PlnF is ~0.9nm. Row data are plotted with light color, while 
the darker lines represent running averages over 10 frames. 
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V12xxxV16 of PlnE motif and the V24xxxV28 of PlnF allow the proximal contact of the N-
terminus of PlnE and the C-terminus of PlnF (Figure 3-9). 
3.3.3. Simulation of dimers of PlnE and PlnF that contain single amino acid 
substitutions  
The interaction of an antimicrobial peptide with a membrane model indicates which 
residues may be important for its activity. However, it is not obvious how a modification 
of these residues will affect the activity. We simulated various mutant dimers in order to 
examine how the biophysical key observations, originated from the simulations of the 
wild type peptides, might be connected with the bactericidal activity. The dimers were 
simulated only in the parallel conformation since we determined that under these 
conditions the peptides would be more likely to interact favorably with each other.  
All simulations were run for 200 ns. In only five of these systems (mutants E(G20A), 
E(R13D), E(I32R), F(S26T), F(D22R)), the structure of the peptides was stabilized after 
the first 50 ns and their rmsd value was 0.2-0.3 nm. Further analysis was performed 
between the 100th and 200th ns. During simulations on F(P20A) and F(R29I) the 
structure of the peptides continued to evolve throughout the simulation and the helices 
slowly unraveled (data not shown). Therefore, no further analysis is shown for systems 
F(P20A) and F(R29I). 
Simulation of the mutant E(G20A) 
The first system contains a mutation on Glycine 20 (G20) of PlnE to an Alanine. 
This residue was chosen as it plays an important role in the structure of PlnE. It is 
located in the middle of the peptide, dividing its structure into two α-helical regions. 
Glycine is a residue known to disrupt α-helices, while Alanine is an amino acid with high 
α-helical propensity [131]. Experimentally, this mutation increased the activity of the 
peptides slightly (Table 3-1). 
In the simulation of the E(G20A) mutant (Figure 3-10a and Figure 3-11a), PlnE 
forms one continuous α-helix as expected. The mutation of G20 to an Alanine enhanced 
the helical content of PlnE, prompting the creation of a stiff helix. This hinders the 
flexibility of the peptide and thus only one terminus of PlnE is able to interact with the 
membrane. Specifically, the residues K30 and R33 that are positioned in the C-terminus 
of PlnE, form salt bridges with the membrane phosphate oxygens. The mutation has no 
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effect on the structure of PlnF or its interactions with the membrane. Interestingly, the 
two peptides interact more strongly in the PlnE-G20A mutant. Mainly two stable salt 
bridges are formed between the peptides. The first is the one present in simulations of 
the wild type peptides as well, e.g. a salt bridge between R13 of PlnE and D22 of PlnF. 
The second salt bridge formed is between D17 of PlnE and R29 of PlnF. The release of 
the N-terminus of PlnE from the membrane (Figure 3-12a), which was presumably 
caused by the mutation, likely enabled the two latter residues to approach each other 
and interact.  
Figure 3-10: Snapshot of the systems with mutant peptides 
 
Final snapshots (at 200ns) from the simulations of the systems that contain a 
mutation. PlnE is shown in blue and PlnF in green. Both peptides are shown in cartoon 
format. The lipids are shown as a sequence of spheres, using their van der Waals radius. 
The hydrophobic tails are colored light grey while the hydrophilic heads are colored 
dark grey. 
Simulation of the mutant E(R13D) 
The next system we simulated includes a mutation from an Arginine to an Aspartic 
acid in position 13 of PlnE. R13 of PlnE was the primary source of electrostatic 
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interaction between the two wild type peptides forming a salt bridge with D22 of PlnF. 
We were interested in examining how this mutation affects the overall behavior of the 
peptides. We expected it to have significant effect on their interaction, since this 
mutation was detrimental to the antimicrobial activity. 
Figure 3-11: Structural analysis of the systems containing mutated peptides 
 
Structural analysis of the systems containing mutated peptides. The percent of the 
helicity per residue in each simulation is shown. PlnE is colored blue, while the PlnF 
green. 
As expected, the mutation caused a marked decrease in the strength of the 
interactions between the two peptides. The E(R13D) mutation (Figure 3-10b and Figure 
3-11b) caused a loss of secondary structure to the N-terminus of PlnE. Consequently, 
there is one helical region formed from amino acids 13 to 29. Initially, the unstructured 
region interacts with the membrane, luring the rest of the peptide towards the membrane 
(Figure 3-12b). The amount of salt bridges and hydrogen bonds between PlnE and the 
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membrane is significantly increased with respect to the wild type simulations. PlnF forms 
two helical regions divided around P20. In contrast to all the previous simulations, both 
termini of PlnF interact with the membrane. This could be attributed to the absence of 
interactions with PlnE, rendering PlnF more flexible.  
Simulation of the mutant E(I32R) 
A mutation of the hydrophobic amino acid I32 to R32 of PlnE believed to increase 
the interaction of PlnE with the membrane, based on the simulations of the wild type 
PlnEF bacteriocin. We were thus interested in exploring how such a mutation would 
modify the activity, the structure, dynamics, and interactions. Activity tests showed that 
this mutation decreases the bacteriocin activity.   
Contrary to the expectations, the C terminal of PlnE(I32R) moves away from the 
membrane allowing only the N terminal to approach the membrane (Figure 3-12c). The 
two opposite trends could be the reason that there is a loss of structure of PlnE around 
residues 20 to 24 (Figure 3-11c). Regarding PlnF, there are not significant deviations 
from its structure and interactions with the membrane comparing to the simulation of wild 
type peptides. 
There are some interactions between the two peptides (i.e. R13 of PlnE and D22 of 
PlnF) initially, that disappear later. Interestingly, hydrophobic residues at the C terminal 
of PlnF (V28, F31, I32) are buried among hydrophobic residues of both the helical 
regions of PlnE (V12, V15, I19 and I25, I28, L29) (Figure 3-10c). 
Simulation of the mutant F(S26T) 
The oxygen of the side chain of both Serine and Threonine form hydrogen bonds 
with the backbone amides of neighboring residues [133]. It has been suggested that 
when such hydrogen bonds are located close to Proline kinks, they can modulate the 
angle of the kink. Experimentally, this mutation resulted in a decrease in activity, 
revealing that Serine and Threonine are not interchangeable.  
In the simulation, the mutation of S26 to a Threonine affects the structure of PlnF 
(Figure 3-10d and Figure 3-11d). Despite the two helical regions, the curvature is 
smoother compared to the wild type simulations. This allows both termini of PlnF to 
interact with the membrane (Figure 3-12d). Moreover, T26 does not form a hydrogen 
bond with N22 of PlnF, but rather interacts with the membrane, likely driving the C-
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terminus onto the membrane. The two peptides interact with each other occasionally. 
However, the salt bridge between R13 of PlnE and D22 of PlnF is not present. As a 
probable consequence, PlnE, which adopts one continuous helix, is free to interact with 
the membrane through both its termini.  
Figure 3-12: Distance of the wild-type peptides from the membrane center 
The distance per residue of each peptide from the membrane center is shown, along 
the z-direction for the systems containing mutated peptides. The black line represents the 
local distance of the Phosphate groups of the leaflet containing the peptide from the 
center of the membrane. PlnE is colored blue, while the PlnF green. 
Simulation of the mutant F(D22R) 
The mutation on PlnF(D22R) (similarly to the PlnE(R13D)) was expected to affect 
the interaction between the peptides making up the bacteriocin PlnEF. In simulations, 
the mutation caused a termination of interactions between the two peptides. Thus, 
leading to increased interactions of each peptide with the membrane. Both the two 
distinct helical regions of PlnF approach the membrane (Figure 3-10e,Figure 3-11e and 
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Figure 3-12e). Remarkably, the effects of the mutation are more apparent on PlnE. 
Since the polar residues of PlnE do not longer interact with PlnF, they are free to 
approach the membrane (Figure 3-12e). We believe that this leads to the reduction of 
the helical content of PlnE, as there is a strong drive for its polar residues to face the 
surface of the membrane. Interestingly, the distance between the two peptides is 
decreased and various hydrophobic amino acids come close increasing non-favorable 
interactions and the potential energy of the system. 
3.3.4. Connection of simulated biophysical interactions with the experimental 
activity 
The few mutations that were simulated had a significant effect on the peptide-
peptide interactions as well as the interactions of the dimer with the membrane. We 
calculated the energy of these interactions by adding the contribution of the van der 
Waals and electrostatic forces between each participant. These values were calculated 
as the averages over the last 100ns of each simulation. We note that, of course, the 
internal energy is only one of two components dictating the relevant free energy of the 
system, the other being the entropic contribution. It is very challenging to accurately 
compute entropic contributions to free energies using molecular simulations, especially 
for the multiple systems studied herein. Nevertheless, we believe that it is useful to 
discuss the changes of internal energy upon mutation.  
We find that in antithesis to the canonical model of the antimicrobial peptide activity, 
which suggests that the peptides interact primarily with the membrane, increased such 
interactions are not favorable to the activity of PlnEF (Figure 3-13a). It is also notable 
that there are interactions that are consistently present, i.e. the C-terminus of PlnE and 
the N-terminus of PlnF interact with the membrane in all but one mutant.  
Interestingly, the peptides interact with each other stronger in systems that exhibit 
higher activity (Figure 3-13b). These two observations presumably are not independent. 
We noticed that there is a competitive nature between the two types of interactions. In 
other words, when a mutation prevented the interaction between the peptides, they 
interacted more with the membrane and vice versa.   
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Figure 3-13: Correlation between experimental activity and interactions in 
simulations 
 
Correlation between the experimentally observed activities of Plantaricin EF and 
its mutants with the energy of interactions calculated from the simulations. a. Negative 
potential energy of peptide-membrane interactions for each system. b. Negative 
potential energy of peptide-peptide interactions for each system. The bars are colored 
based on the activity of each system, ranging from high (dark blue) to low (light cyan) 
activity. 
3.4. Conclusions 
Little is known about how class II bacteriocins attack their targets. It has been 
suggested that they employ a receptor-mediated mode-of-action. Nevertheless, there 
are indications that they interact with the membrane initially. Therefore, we simulated the 
two-peptide bacteriocin PlnEF on the surface of a model lipid bilayer. The structure of 
each peptide was previously determined. However, their relative positioning on the 
membrane was unknown. Previous experiments, has shown that the presence of both 
peptides is required and it is assumed that the interaction between them is essential to 
function [140]. 
The simulations reveal that there are persistent structural regions and interactions 
with the membrane both in a parallel and antiparallel model of the bacteriocin. PlnE 
interacts with the membrane primarily through its N-terminal amino acids while there are 
few salt bridges formed between the last few residues of its C-terminus and the 
membrane. On the other hand, PlnF interacts with the membrane solely with its N-
terminus, while its C-terminus is mainly dissolved in the aqueous subphase. The 
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interesting difference between the parallel and antiparallel model of the bacteriocins is 
the reduction in peptide-peptide interactions observed in the simulation of the antiparallel 
dimer conformation compared to the parallel conformation. Based on our simulations 
and the activity measurements done here it is assumed that the interaction between the 
peptides is essential to function. Our findings indicate that the parallel model of the 
bacteriocin have stronger peptide-peptide interactions on the surface of the membrane 
than the antiparallel model, however an opposite trend could be possible in a 
transmembrane dimer. 
To explore two types of interactions: peptide-peptide and peptide-membrane 
interactions and connect them with the experimentally observed activity, we simulated 
the wild type peptides and seven mutants and tested their activity. The N-terminus of 
PlnF and C-terminus of PlnE interacted with the membrane in all but one systems. We 
observed an evident trend of decreasing interactions in models with higher activity. The 
middle section of the peptides is mainly responsible for the peptide-peptide interactions. 
Interestingly, when these interactions are diminished or even missing, the system 
exhibits a lower activity. This strengthens the argument that the interaction between 
complimentary peptides is vital for the bactericidal activity of class IIb bacteriocins. 
Additionally, we noticed that when the reduced interactions between the peptides led to 
lose of structure, a behavior observed in CD experiments before. This would make the 
dimer insertion to the membrane less probable, since α-helical structures have high 
prevalence in transmembrane proteins. Therefore, we could conclude that the peptides 
form a dimer on the surface of the membrane instead of being inserted individually. 
In this study, we simulated only a first step of the mechanism of action of PlnEF. 
Ideally, we would focus on the interaction of peptides with potential transmembrane 
protein receptors, but currently there is not sufficient information to build a reliable model 
for molecular dynamics simulations. In the next chapters, we explore the dynamics of a 
possible transmembrane dimer of the bacteriocin.  
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Chapter 4  
Designing the structure of a 
Transmembrane Class IIb Dimer 
4.1. Introduction 
Plantaricin EF is a two-peptide bacteriocin that depends on the complementary 
action of two different peptides (PlnE and PlnF) to function. The two peptides are 
assumed to form a dimer. The structures of the individual peptides have previously been 
solved by Nuclear Magnetic Resonance (NMR), but the dimer structure and how the two 
peptides interact have not been determined [112]. In 0, we examined the behavior of the 
peptides in water and in the presence of DPC micelles, a membrane mimic similar to 
what was used in the NMR experiments. Thus, we were able to have a first look at the 
behavior of the peptides through molecular dynamics simulations. In Chapter 3, we 
simulated possible dimers of PlnEF on the surface of a lipid bilayer as well as peptides 
that carried a single point mutation. We identified residues that engage in key 
interactions between the peptides and the membrane and we demonstrated that there is 
a correlation between such interactions and the experimentally-observed activity. In this 
chapter, we aim to further our understanding of the important residues of PlnEF through 
an extensive mutational analysis. We then use these results in addition to our 
conclusions from the previous chapters, to build a possible transmembrane dimer model 
for PlnEF that we evaluate with MD simulations. 
So far, all two-peptide bacteriocins identified contain GxxxG motifs. These motifs, 
together with GxxxG-like motifs, are known to mediate helix−helix interactions in 
membrane proteins [80]. Here we have analyzed the effect of substituting the various 
small amino acids (Gly, Ala and Ser) to assess whether any of these motifs are 
important for the interactions between PlnE and PlnF and, by extension, their 
antimicrobial activity. As described in Chapter 3, the GxxxG motifs do not seem to 
facilitate peptide-peptide interactions on the surface of the membrane, however this 
does not imply that they will not mediate the peptide association in a transmembrane 
conformation.  
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Additionally, we substituted the Tyrosine and Tryptophan residues of PlnE and PlnF, 
and constructed four fusion polypeptides to investigate the relative orientation of a 
transmembrane PlnEF dimer in target cell membranes. Through atomistic MD 
simulations, we further investigated the behavior of the dimer at different positions 
across the z-axis of a lipid bilayer in order to study the behavior of such a possible 
dimer. 
The results described in this chapter have been presented in a peer-reviewed 
publication which we coauthored [103]. Our contributions to that publication were the 
designing of the transmembrane dimer-membrane complex, performing and analyzing 
the MD simulations, interpreting the results, and connecting them to the experimental 
observations. The methods we employed are detailed in the next paragraphs, while we 
direct the reader to section Appendix A for a description of the experimental procedures 
used by our collaborators. Similarly, in this chapter we include the results from our work 
while the detailed result of the experiments can be found in section C.   
4.2. Materials and methods 
4.2.1. Experimental methods 
A detailed description of the bacterial strains chosen, their growth conditions, DNA 
isolation and bacteriocin expression can be found in paragraphs B.1 to B.3. The 
mutagenesis analysis protocols are described in paragraphs B.5 and B.4. The fusion 
peptide construction methods and analysis can be found at B.6 and finally the activity 
measurement protocol is described in B.7. 
4.2.2. Building the Dimer Model  
In our previous simulations, we constructed possible dimer models through docking 
of the two peptides PlnE and PlnF. Our criteria for picking the final models was the 
proximity of the suggested GxxxG motifs and the docking score. However, the GxxxG 
motifs did not enhance the peptide-peptide interactions as anticipated. The explanation 
for this could be that the motifs were not active under the conditions of the previous 
simulations, or because the two peptides were not close enough in the initial dimer 
model due to the rigid body nature of the docking calculations. Therefore, this time we 
decided to take a different approach - instead of using the final pdb structures, we used 
the NMR restrains (that the pdb structures were derived from) and added restrictions 
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that would reflect the GxxxG motifs. 
The structure of an antiparallel dimer was calculated using CYANA (operated by Per 
Eugen Kristiansen) [141] and the structural restraints for PlnE (PDB ID Code: 2jui) and 
PlnF (PDB ID Code: 2rlw) were downloaded from the protein data bank. Additional 
restraints were inserted between residues in the G5xxxG9 motif of PlnE and the 
S26xxxG30 motif of PlnF (that was suggested from the mutational results to assist in the 
dimerization of the peptides) and between Arginine 13 of PlnE and Aspartic acid 22 of 
PlnF as well as between Aspartic acid 17 of PlnE and Lysine 15 of PlnF, to have them 
face towards each other. 100 structures were calculated and the lowest energy structure 
was used as a dimer model in the molecular dynamics simulations.  
4.2.3. Molecular Dynamics (MD) Simulation Methods and Parameters 
The dimer was placed into the model membrane using the online server CHARMM-
GUI [119]. Two distinct models were built by positioning the dimer at different distances 
from the center of the membrane along the z-axis. In model one, the dimer was placed 
with the aromatic residues on the surface of the lower leaflet and the peptides 
penetrating through both the upper and lower surface of the model membrane. In model 
two, the residues W23 of PlnF and Y6 of PlnE lie inside the membrane core. 
The lipid bilayer was built to mimic the membrane of Gram-positive bacteria, using 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) and 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoethanolamine (POPE) lipids in a 3:1 ratio. The dimer-membrane 
systems were solvated in a 0.15 M NaCl aqueous solution with the VMD software [117]. 
Counterions were added as necessary to electroneutralize each system.  
NAMD 2.10 [115] was used for molecular dynamics simulations, with the CHARMM 
param36 force field [142]. Systems were first minimized with a conjugate gradient 
algorithm, and then gradually heated to 310 K. Equilibration and production runs were 
carried out at constant temperature and atmospheric pressure, using the Nose-Hover 
algorithm provided in NAMD. 
Simulations were conducted for 200 ns using a 2 fs timestep. The van der Waals 
potential was turned off at 12 Å, introducing a switching function at 10 Å. Electrostatic 
interactions were calculated with the particle mess Ewald summation, with a real space 
cutoff truncated at 12 Å.  
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4.3. Results and Discussion 
4.3.1. Model of Plantaricin EF inserted into membrane bilayer based on mutational 
assays and the known NMR structures of the individual peptides 
The results of the experimental study indicate that PlnE and PlnF interact in an 
antiparallel manner and that the G5xxxG9 motif in PlnE and the S26xxxG30 or G30xxxG34 
motifs PlnF are involved in helix-helix interactions. However, due to Gly34 being the last 
residue in PlnF, the G30xxxG34 motif is an unlikely candidate for helix-helix-stabilization.  
More importantly, an antiparallel interaction between G30xxxG34 in PlnF and G5xxxG9 in 
PlnE results in strong charge repulsion between the peptides. The positively charged 
residues Arg13 in PlnE and Arg29 in PlnF come close in space when the peptides are 
arranged using these GxxxG motifs. This is also the case for the negatively charged 
Asp17 in PlnE and Asp22 in PlnF. Moreover, previous MD simulation of the two Pln-
peptides presented at Chapter 3 Moreover, previous MD simulation of the two Pln-
peptides presented at Chapter 3 revealed that the G5xxxG9 motif in PlnE and the 
G30xxxG34 motif PlnF did not bring the two peptides in close contact: the peptides 
interacted only weakly (only one salt bridge, between Arg13 in PlnE and Asp22 in PlnF, 
was formed), and the potential energy of interaction between the peptides was positive. 
The other possibility, that G5xxxG9 in PlnE and S26xxxG30 in PlnF interact in an 
antiparallel manner, results in a dimer that may be stabilized by two salt bridges between 
Arg13 in PlnE and Asp22 in PlnF and between Asp17 in PlnE and Lys15 in PlnF. This 
conformation is consistent with the observation that changing the charges of these 
residues was detrimental to the antimicrobial activity, shown in Chapter 3. Figure 4-1 
represents a structural model of Plantaricin EF in which the two peptides interact through 
the G5xxxG9 motif in PlnE and the S26xxxG30 motif in PlnF in an antiparallel 
transmembrane orientation in a model lipid bilayer.  
In this structural model, the N-terminus of PlnE and C-terminus of PlnF form a blunt 
end. In contrast, there is a one amino acid overhang on PlnF on the other end, formed 
by the C-terminus of PlnE and N-terminus of PlnF, both of which (according to the 
results obtained with the fusion polypeptides) face towards the cell’s outside (Figure 
4-1). The preference for an aromatic residue at position 6 in PlnE, Tyr6, suggests that 
this end positions itself in or near the membrane interface on the cytosolic side of the 
membrane. Residues Arg8, Arg11 and Lys15 in PlnF are brought close to PlnE Gly20 
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and Gly24 and may explain the detrimental effect of substituting the latter two residues 
with the positively charged Lys, while being able to accommodate all other substitutions 
(Figure 4-1). 
Figure 4-1: Proposed model of the Plantaricin EF dimer 
 
The model of the Plantaricin EF dimer resulting from combining the structural 
restraints from the NMR studies of the individual, the results from activity assays on 
mutants of PlnE and PlnF, and the conclusions from the simulation of the peptides on 
a model membrane surface. PlnF is shown in green, while PlnE is shown in blue. The 
head group atoms of the lipids are shown as grey spheres. Glycine and serine residues 
thought to be important for the interaction between the two peptides are drawn as 
yellow spheres. Other important residues are drawn in stick representation.  
4.3.2. Molecular dynamics (MD) simulation and evaluation of the membrane-
inserted model of Plantaricin EF 
The proposed model was inserted in a lipid bilayer and analyzed using MD 
simulation. In this simulation, only very small changes were observed in the structure 
and orientation during the 200 ns of MD simulation (Figure 4-2). Both peptides are 
mostly helical during the last 150 ns of simulation (Figure 4-3a). 
The distance between the G5xxxG9 motif in PlnE and S26xxxG30 motif in PlnF seems 
to be fairly stable, and it even decreases toward the end of the MD simulation (Figure 
4-3b) indicating that the overall interaction around the suggested interaction motifs 
improves during the simulation. 
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Several interactions between the peptides seem to be of importance during the 
simulation. Importantly, we observe the same intermolecular hydrogen bonds/salt 
bridges as hypothesized, that is, between PlnE R13 and PlnF D22 and (to a lesser 
extent) between PlnE D17 and PlnF K15, as illustrated in Figure 4-4. Interestingly, K15 
seems to switch interaction partners, between PlnE D17 and PlnF N12, back and forth 
throughout the simulation, the latter residue being closer to the outer lipid head groups. 
Figure 4-2: Evolution of the simulation of the Plantaricin EF dimer model 
The plantaricin EF dimer model at different time steps during the molecular 
dynamics simulation. The figures at 0 ns, 50 ns and 200 ns are shown in Figure a, b, and 
c, respectively. PlnF is shown in green cartoon drawing in all the pictures, while PlnE is 
shown in blue. The head group atoms of the lipids are shown as grey spheres 
Figure 4-3: Molecular dynamics simulation trajectories between 50 ns and 200 ns 
 
In a, the % α-helicity of PlnE is shown in blue, and of the PlnF in green.  Distance 
between the center of mass of PlnE G5xxxG9 and center of mass of PlnF S26xxxG30 
motifs are shown in b. Thin lines illustrate the measured distances in each frame, while 
the thick lines illustrate the sliding average.  
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In addition, apart from the strong electrostatic interaction, there is also an intramolecular 
hydrogen bond between PlnE D17 and PlnE R13, further stabilizing the “polar center” of 
the dimer. The combination of hydrogen bonds between PlnE D17, PlnE R13, and PlnF 
D22 that are present throughout the simulation may in fact be a variation of a cluster of 
interhelical hydrogen bonds/salt bridges called “polar clamps”, which is a common motif 
found in transmembrane regions of membrane proteins [143]. There is also a hydrogen 
bond between PlnE R3 and the terminal oxygen at the C-terminal of PlnF on G34 during 
most of the simulation. 
Figure 4-4: Interactions between the peptides. 
 
Stabilizing electrostatic interactions are shown in a. The structures are in cartoon 
drawing, PlnE is in blue and PlnF is in green, and the lipid head groups are shown as grey 
spheres.  Atoms of the residues of importance are colored according to atom type: carbon 
is in light green, hydrogen is white, oxygen is red and nitrogen is blue. In b, we 
calculated the distance between the center of mass of the carboxyl, guanidinium, or 
ammonium groups of the respective residues: the red curve is between PlnE R13 and 
PlnF D22, while the black one is between PlnE D17 and PlnF K15, respectively. Thin 
lines illustrate the measured distances in each frame, while the thick lines illustrate the 
sliding average. 
The MD analysis also reveals that the dimer is further stabilized by aromatic 
interactions and cation-π interactions. Consistent with the results from the mutation 
studies, the aromatic amino acid Tyr at position 6 in PlnE seems to be stably inserted 
into the bottom leaflet of the lipid bilayer (possibly the inner membrane interface based 
on the fusion peptide results) (Figure 4-5). Furthermore, this residue interacts via a 
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staggered (parallel) cation-π interaction with the aromatic residue F31 in PlnF. A T-
shaped cation-π interaction is observed for PlnF W23 and H14 in PlnE as well. In fact, 
W23 seems to coordinate with both PlnE H14 and PlnE K10 in such a way that if one of 
these residues changed slightly in position, the others moved as well, keeping a stable 
internal distance throughout the simulation - the only exception being the distance 
between W23 in PlnF and H14 in PlnE in the timeframe between 115 -150 ns (Figure 7C 
and 7D). The W23-K10 cation-π interaction may help stabilize the dimerization in a 
similar manner as reported by Peter, B. et al. for the chloride intracellular channel protein 
1 transmembrane domain [144]. 
Figure 4-5: Cation-π interactions stabilize the dimer’s position in the membrane. 
 
The important aromatic cation-π interactions that anchor the dimer in the bilayer 
are shown in a, while trajectories showing the variation in distances in the MD 
simulations between 50 ns and 200 ns are shown in b. The structures in a are cartoon 
drawings of PlnE in blue and of PlnF in green, while the lipid head groups are shown 
as grey spheres.  Atoms of the residues of importance are colored according to atom 
type: carbon is light green, hydrogen is white, oxygen is red and nitrogen is blue. The 
curves in b are between the center of mass of the aromatic rings, carboxyl, or 
ammonium groups. The red, blue, and green curves show the distance between PlnE 
H14 and PlnF W23, PlnE K10 and PlnF W23, and between PlnE Y6 and PlnF F31, 
respectively. Thin lines in B) and D) illustrate the measured distances in each frame, 
while thick lines illustrate the sliding average. 
S26 in PlnF is initially hydrogen-bonded with the backbone carbonyl oxygen of G9 in 
PlnE for the first 100 ns of simulation, before it switches to an intramolecular hydrogen 
bond with D22 during the final 100 ns. This is, however, not the only serine in the 
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peptides that is hydrogen-bonded. In both PlnE and PlnF there is a pattern of three Ser 
residues separated by 9 other residues. In PlnE, all of these serine hydroxyl groups are 
hydrogen-bonded at least part of the time to the carboxyl group of residues i-4 (Figure 
4-6). Similar hydrogen bonds are also observed for PlnF between S16 and N12, and 
S26 and D22. These serine interactions may be of importance in internal stabilization of 
the helices, and might explain why Ser instead of Gly is in the S26xxxG30 motif in PlnF. 
Figure 4-6: Serine residues contribution to the hydrogen bond network 
 
Interactions between the sidechain hydroxyl groups of serine residues in PlnE (blue) 
and PlnF (green) observed during the molecular dynamics simulation. The structures are 
in cartoon drawing, PlnE is in blue and PlnF is in green, and the lipid head groups are 
shown as grey spheres.  Atoms of the residues of importance are colored according to 
atom type: carbon is in light green, hydrogen is white, oxygen is red and nitrogen is 
blue 
The transmembrane bacteriocin dimer interacts with the lipid phosphate groups 
through a number of hydrogen bonds Figure 4-7. In PlnE, residues R26, K30, and K33 
in the C-terminal region interact with the top lipid phosphate groups and F1, R3, Y6, 
N7, and K10 in the N-terminal region interact with the top lipid phosphate groups. PlnF 
anchors to the bottom lipid phosphate groups through its C-terminal residues R29, H33, 
and G34, and it anchors to the top lipid phosphate groups through its N-terminal 
residues V1, F2, H3, Y5, S6, A7, R8, R11, N12, N13, Y14, and K15 (Figure S5). The 
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hydrogen bonds formed between hydroxyl groups of PlnF Y5 and PlnF Y14 with the 
lipid phosphate groups may, to some extent, explain why substituting with hydrophobic, 
positively charged, or aromatic amino acids were detrimental to activity. 
Figure 4-7: Number of hydrogen bonds between each residue and the membrane 
 
Hydrogen bonds between a) PlnE and b) PlnF and the membrane lipid head groups 
are shown. The colorbar illustrates how the different colors indicate different numbers 
of hydrogen bonds; the darker the color the more hydrogen bonds there are. 
To determine whether the stability of the Plantaricin EF structure (shown in Figure 4 
3) depends on it being in a transmembrane position and in a predominantly hydrophobic 
environment, we also performed a simulation in which the structure was partly inserted 
into the membrane (instead of as a transmembrane entity - Figure 4 10). In this latter 
simulation, the structure is also in agreement with the results above except that Tyr6 in 
PlnE is no longer in the membrane interface, but rather in the hydrophobic core of the 
membrane. After approximately 50 ns, the peptides moved toward the membrane 
surface and ended up positioned on the surface of the bilayer, a result that was perhaps 
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not unexpected, since substituting Tyr6 with a hydrophobic amino acid was detrimental 
to the bacteriocin activity. Furthermore, the bacteriocin structure lost much of its α-helical 
character during the MD simulation and therefore becomes inconsistent with the NMR 
structures. 
Figure 4-8: Snapshot of the MD simulations of an alternative model  
 
The dimer model positioned perpendicularly to the membrane through the upper 
leaflet of the membrane bilayer at a) 0 ns (the design structure), b) at 50 ns in, and c) at 
200 ns. PlnF is shown in green, while PlnE is shown in blue. The head group atoms of the 
lipids are shown as grey spheres. 
4.4. Conclusions 
PlnEF is a potent two-peptide bacteriocin whose mechanism of action depends on 
the association between PlnE and PlnF. In this chapter, we discussed the effect of 
different mutations on the activity of the peptides and we designed a transmembrane 
model of this that we further investigated with molecular dynamics simulations. 
To begin with, all the GxxxG and GxxxG-like motifs in both PlnE and PlnF were 
mutated to evaluate if any of these motifs is vital for the antimicrobial activity of the 
bacteriocin. These motifs are hypothesized to function as dimerization surfaces, 
therefore, we suggest that if they are important for the activity, then they should be in 
close contact and induce interactions between PlnE and PlnF. We found that in the 
systems where the residues in the G5xxxG9 motif in PlnE and the S26xxxG30 motif in 
PlnF were mutated, there was a significant loss of activity. Therefore, we conjectured 
that the two peptides come in contact around those motifs. 
Four fusion polypeptides were constructed in order to examine what is the possible 
orientation of the dimer. Results from that experiment suggest that the peptides lie 
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antiparallel to each other when they are in a transmembrane conformation. Additional 
mutations of aromatic amino acids guided us into positioning the antiparallel dimer in a 
model lipid bilayer. 
Atomistic molecular dynamics simulation of the dimer model in the bilayer confirmed 
its stability and approved that the two peptides come in close contact through the GxxxG 
motifs. Moreover, it revealed that the peptides interact strongly through a “polar clamp” 
at their middle section, and specific cation-π interactions, which also assist the dimer’s 
anchoring in the membrane. The MD simulations facilitated the visualization of the dimer 
and provided an explanation for most of the detrimental mutations, such as PlnE G20K 
and G24K.  
In this chapter, we discussed how we constructed a transmembrane dimer model of 
the peptides. In the next chapter, we investigate the dimer though a 1μs long atomistic 
simulation and examine the impact of the dimer’s presence to the rest of the system 
(membrane, water, ions). We then pose the question of whether or not the 
transmembrane insertion of the dimer could lead to the membrane permeabilization by 
itself, i.e. by forming a small pore and not through a receptor-mediated mechanism of 
action.  
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Chapter 5  
Could class IIb bacteriocins induce pore 
formation? 
Bacteriocins are antimicrobial peptides (AMPs) produced by bacteria, and they 
show  great potential as novel antibiotic agents [45]. They are typically active at lower 
concentrations and exhibit higher specificity against their targets when compared to 
other AMPs [25]. To exploit the full potential of bacteriocins and use them as a platform 
to develop new antibacterial agents, an understanding of their mechanism of action 
(MOA) is necessary.  
Molecular dynamics simulation is a powerful tool that has shed light into the MOA of 
various AMPs in atomistic or near-atomistic detail [92,93,125,145–148]. These studies 
show that the majority of AMPs kill target cells by forming different types and sizes of 
pores in the cell membrane. In the case of bacteriocins, in most (experimental and 
computational) studies of the last decade, it is assumed that the peptides exert their 
antimicrobial activity by a receptor-mediated mode-of-action, particularly those peptides 
that exhibit high selectivity [68,78,149,150]. Apart from Nisin and class IIc bacteriocin 
AS-48, both of which are broad spectrum bacteriocins, direct interaction of a bacteriocin 
with its receptor and pore-forming evidence have not been demonstrated thus far 
[97,151].   
The activity of PlnEF, like most LAB bacteriocins, was shown experimentally to be 
related to membrane permeabilization, as we summarized in paragraph 2.1. In the 
previous chapters, we explored the behavior of the peptides on the surface of membrane 
models through molecular dynamics simulations and compared it to experimental 
studies.  With this information and additional experimental guidance, we detailed the 
design of a transmembrane dimer structure and its positioning on a lipid bilayer.  
In this chapter, we present the 1 μs long atomistic molecular dynamics simulation 
study that we performed on the transmembrane dimer. We analyze the peptide structure 
and important amino acids that are responsible for the anchoring of the peptide in the 
membrane. We further investigate the impact of the dimer’s presence on the rest of the 
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system (the membrane, water, and ions). Most importantly, we show that the 
transmembrane PlnEF dimer can form a small toroidal pore that allows water permeation 
and suggests possible ion conduction. This is the first time (to our knowledge) that a 
LAB bacteriocin has been shown to form pores on its own. We believe this finding could 
be of importance to the design of new bacteriocins, as it would steer the search for 
better bacteriocins toward peptides that form more stable pores, interact more strongly 
with the membrane in specific regions, and increase water or ion permeability.   
5.1. Materials and methods  
We studied the antimicrobial peptides PlnE and PlnF inside a bacterial cell 
membrane-mimicking model with 1 μs-long atomistic molecular dynamics simulation. 
The system contains lipid molecules, water, ions, and the peptides that are believed to 
form a dimer. We characterized the structure and behavior of the peptides, as well as 
the interactions that took place between them. We also focused on the response of the 
membrane to the presence of the dimer. Finally, we studied how the water and ions act 
with respect to the dimer-membrane morphology. 
5.1.1. System components 
PlnE and PlnF are medium-size bacteriocins with 33 and 34 residues, respectively. 
Their sequences can be found in Table 2-1. The two peptides were structured 
individually and deposited earlier in the pdb database with accession codes 2jui for PlnE 
and 2rlw for PlnF [152]. A detailed description of the dimer structure we created can be 
found in section 4.2.2. The structure of this dimer and its positioning in the membrane 
are described in Figure 4-1. 
In order to create the dimer-membrane complex, the dimer was inserted into the 
membrane using the CHARMM-Gui server [119]. A bilayer consisting of POPG (1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol) and POPE (1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoethanolamine) lipids in a 3:1 ratio was used as a bacterial cell 
membrane-mimicking model of Gram positive bacteria. Each leaflet contains 120 lipids 
that were placed randomly at the 3:1 POPG:POPE ratio.  
To ensure proper hydration of the system, the dimer-membrane complex was 
solvated by adding 3 nm of TIP3P water at the negative and positive direction of the z-
axis, using the VMD solvator plugin [115]. The ion concentration of the system was set 
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to 0.15M NaCl to mimic a physiological salt solution. Additional sodium ions were 
introduced to make the system electroneutral.  The ionization was achieved by randomly 
adding Na+ and Cl- ions with the VMD autoionize plugin [115]. In total, the system 
contains the two dimers (1,035 atoms), 240 lipid molecules (30,360 atoms), 17,269 
water molecules (51,807 atoms), 221 sodium ions, and 49 chloride ions. The total 
system size was approximately 10 nm x 10 nm x 12 nm before the beginning of the 
simulation, and it was reduced to 8.7 nm x 8.7 nm x 10.8 nm after equilibration. 
5.1.2. Molecular dynamics  
The atomistic molecular dynamics simulation was conducted with the NAMD 2.10 
simulation engine [115], using the CHARMM 36 force field [142] under constant pressure 
and temperature (NPT ensemble). All the parts of the simulation were carried out on the 
Stampede supercomputer through the XSEDE portal. 
The system was minimized for 1 ns using the conjugate gradient algorithm provided 
in NAMD. Then the temperature was increased gradually to 310 K while the peptides 
and lipid atoms were subjected to positional harmonic constraints. This was followed by 
four 1 ns equilibration simulations, while the constraints were progressively removed. 
After all the constraints were removed, a final 10 ns equilibration step was performed to 
allow all the components of the system to relax from the previous constraints and 
improve their interactions before the production runs. At this stage, we ensured that 
there was no drastic change in the size and morphology of the system through visual 
inspection. Finally, we ran for a total of 1μs of atomistic molecular dynamics simulation. 
Equilibration and production runs were carried out at atmospheric pressure, using 
the Nosé-Hoover Langevin piston pressure control method as implemented in NAMD. 
After the heating stage, the temperature was kept constant at 310K with a Langevin 
thermostat. Periodic boundary conditions were applied in each simulation. Van der 
Waals potential was truncated at 1.2 nm, introducing a switching function at 1 nm, while 
the real space cutoff distance of the PME electrostatics calculation was also set at 1.2 
nm. A timestep of 2 fs was employed, while coordinate snapshots were recorded every 
10 ps.  
The different types of analysis performed were realized using the VMD software 
through its TCL scripting interface, other VMD plugins, and various in-house Matlab 
scripts [117]. For the Cartesian PCA-based cluster analysis, we used the CARMA 
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software [153]. All the simulation snapshots were recorded using the VMD software 
[117]. Most of the analysis was performed on a 0.1 ns resolution, except for the analysis 
of the water and ion permeation that ware performed at a 0.01 ns resolution. 
5.2. Results  
. Initially we performed structure stability analysis of the peptides to access their 
dynamics. We investigated the different intramolecular interactions between the two 
peptides. We finally examined the dynamics of the membrane, as well as water and ion 
permeation through the bilayer. Snapshots of the simulation are shown in Figure 5-1. 
Figure 5-1: Snapshots of the 1 μs long simulation 
 
Snapshots at different points in time are shown in the pictures above. PlnF is shown 
in green cartoon drawing in all the pictures, while PlnE is shown in blue. The head group 
atoms of the lipids are shown as grey spheres. The N’ and C’ terminai are indicated in the 
0 ns figure and orientation remains unchanged through the simulation. It is important to 
note that the pictures were taken from different viewpoints that would better demonstrate 
the evolution of the peptides and of the membrane. 
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5.2.1. Structural analysis of the peptides 
The stabilities of the structures of each peptide individually and of the dimer were 
analyzed using root mean square deviation (RMSD) and radius of gyration (Rg) 
calculations. For the first 100 ns there is an increase of the backbone RMSD of the 
peptides with respect to the design structure of the dimer (Figure 4-1). However, after 
the 100th ns, and particularly after the 200th ns, the structure of both the peptides 
stabilizes. The average backbone RMSD of PlnE with respect to its structure at 200 ns is 
0.27 ± 0.06 nm, while for PlnF the same RMSD is 0.31 ± 0.06 nm. These values can be 
accepted as low, because they are comparable to RMSD values of structures originated 
from NMR studies [112,130]. The radius of gyration is a more meaningful measure that 
indicates the space that the dimer occupies and how this space varies in time (Figure 
5-2a). PlnE has a constant Rg after the 200 ns mark, while PlnF goes through changes 
until up to about 300 ns. The Rg of the dimer as a whole fluctuates for the first 300 ns, 
probably due to fluctuations of the individual Rg of the peptides. It reaches a minimum at 
~500 ns and increases again later. 
We performed Cartesian principal component analysis (PCA) analysis on the dimer 
to clarify the above observation. Two clusters were identified (cluster I and II) as shown 
in (Figure 5-2b,c,d,e). The first cluster includes most of the frames from ~350 ns to ~650 
ns, while the second cluster includes frames from ~700 ns to 950 ns. The transition in 
the Cartesian space of the peptides that occurred from 650 ns to 700 ns is not directly 
visible and we try to explain it better in the rest of our analysis. The average structure of 
cluster 1 is located at the 554th ns (Figure 5-2d) while for cluster 2 at the 825th ns 
(Figure 5-2e).  
The structure of the peptides is α-helical for most of their length. PlnE has an 
increasing α-helical content after the first 200 ns of the simulation. The helicity of PlnF 
increases after the 200th ns as well, however it drops after the 700th nanosecond. PlnE 
has high helicity from the 6th to the 30th residues. PlnF forms two short α-helices, with a 
flexible center around residues 18 and 19. The loss of the helicity of PlnF during the last 
300 ns of the simulation is due to significant loss of structure at the last few residues in 
its N-terminal. Despite this small loss of structure, the peptides remain anchored to the 
bilayer throughout the simulation ( Figure 5-3). 
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Figure 5-2: Structure analysis of PlnE, PlnF and the dimer PlnEF. 
 
The timeline of the radius of gyration of the peptides is shown in a, individually 
(PlnF in green and PlnE in blue), and of the dimers (black). In b and c we show the 
results of the Cartesian PCA analysis of the dimer. In b, each point that belongs to 
either cluster is plotted against the first two principle components (PC1 and PC2). In c, 
we indicate at which times the cluster was more present. Orange indicates the frames 
that can be grouped as “Cluster I”, while blue indicates the frames that can be grouped 
as “Cluster II”. One can find snapshots in d and e of the average structure of Cluster I 
at 554 ns and of Cluster II at 825 ns, respectively. PlnF is shown in green cartoon 
drawing in all the pictures, while PlnE is shown in blue. The head group atoms of the 
lipids and sodium ions are shown as grey and orange spheres, respectively. 
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Figure 5-3: Distance of each peptide residue from the center of the membrane 
 
Average distance per residue of each peptide from the membrane center is shown 
along the z-direction.  Blue symbols represent PlnE residues, while green symbols 
represent PlnF residues. The error bars represent the standard deviation of the per 
residue distance. The dashed grey lines indicate the upper and lower limits of the 
membrane. 
5.2.2. Intramolecular interactions  
In Chapter 4, three different types of interactions were identified as possibly playing 
an important role in the dimerization of PlnEF: the GxxxG motif, polar and electrostatic 
interactions and cation-π interactions. We performed similar analysis on the 1 μs 
simulation and we examined whatever differences, if any, were present in the two 
clusters. 
The distance between the two GxxxG motifs increases around the time Cluster I 
appears, and it fluctuates later around the time Cluster II appears. When this behavior 
was inspected visually, there was not a significant difference in the structure of the 
peptides or in the way they interacted through the GxxxG motifs (Figure 5-4b). The only 
small difference was observed in the angle between the two helical parts where the 
GxxxG motifs were located - i.e. at 800 ns, the helices were better-aligned with a smaller 
angle between them, while at ~500 ns the angle was somewhat wider. Throughout the 
simulation, the peptides are close enough that they do not allow water or ion molecules 
to go through, which creates a hydrophobic block at the lower part of the dimer.  
During the 1 μs long trajectory, we detected three pairs of electrostatic interactions. 
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Those are the salt bridges that are formed: i) between Aspartic acid 17 of PlnE (E-D17) 
and Lysine 15 of PlnF (F-K15); ii) between Arginine 13 of PlnE (E-R13) and Aspartic 
acid 22 of PlnF (F-D22); and iii) between Arginine 13 of PlnE (E-R13) and Aspartic acid 
17 of PlnE (E-D17).  
Figure 5-4: Intramolecular Interactions 
 
The intramolecular interactions that bring the two peptides in close proximity are 
shown in the figures above. a) The GxxxG motif present in PlnEF: the distance between 
the center of mass of PlnE G5xxxG9 and center of mass of PlnF S26xxxG30 motifs is 
shown in grey. b) The important electrostatic interactions between PlnE and PlnF: the 
distances between the center of mass of the carboxyl, guanidinium, or ammonium 
groups of the respective residues are plotted in figure b. In both graphs the darker lines 
illustrate the sliding average over 10 frames. 
Initially, E-D17 interacts with both F-K15 and E-R13, forming a hydrogen bond with 
each of these residues and thus bringing the middle section of the two peptides closer 
(Figure 5-4b). After about 200 ns, E-D17 ceases to interact with F-K15 and is left to only 
interact with E-R13. The place of F-K15 was taken by other charged entities, such as 
lipid heads and sodium ions, which were increasing inserted from the top of the dimer 
(top is defined as the N-terminal of PlnF and C-terminal of PlnE). As the distance 
between F-K15 and E-D17 was increasing, the distance between E-R13 and F-D22 was 
decreasing, thus bringing the two peptides closer together at the bottom of the dimer. 
The above three-way interactions between E-R13, E-D17, and F-K15 and between E-
R13, E-D17, and F-D22 are a common motif found in transmembrane proteins, called 
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the “Polar Clamp” [143]. In this motif, the side chains of polar amino acids such as Arg, 
Asp, Ser, and Thr, that can form at least two hydrogen bonds, are “clamped” by 
hydrogen bonds formed between them. 
In the simulation, we identified three pairs of cation-π interactions, pictured in 
(Figure 5-5). Tryptophan 23 of PlnF (F-W23) is located on the inside of the bottom 
bilayer, and it interacts with both Lysine 10 of PlnE (E-K10) and Histidine 14 of PlnE (E-
H14). When they are close, the aromatic rings of F-W23 and E-H14 are perpendicular to 
each other, forming a T-like shape. Interestingly, around Cluster I, the distance between 
F-W23 and E-H14 is increased. On the other hand, the consistent cation-π interaction 
between Phenylalanyl 31 of PlnF (F-F31) and Tyrosine 6 of PlnE (E-Y6) ceases to exist 
after the 700th ns, as the aromatic rings of these two residues move further apart and 
face different directions (while before they were facing each other - Figure 5-5b and c).  
Figure 5-5: Network of cation π interactions 
 
In figure a, we plotted the distances between residues that maintained a network of 
cation-π interactions during the simulation. The distances are calculated between the 
center of mass of the aromatic rings or ammonium groups. Darker lines illustrate the 
sliding average over 10 frames. Two snapshots that show the indicative behavior of the 
cation-π interactions are shown in b and c, at 610 ns for Cluster I and at 872ns for 
Cluster II, respectively. PlnE is illustrated in blue cartoon representation, and PlnF in 
green. Atoms of the residues of importance are colored according to atom type: carbon is 
light green, hydrogen is white, oxygen is red, and nitrogen is blue. 
5.2.3. Membrane behavior around PlnEF 
It was expected that the insertion of the peptides in the bilayer will alter its structure 
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and behavior as a response. Therefore, we analyzed various aspects of the membrane 
morphology to determine to what extent the presence of the dimer alters it.  
We first examined the membrane visually to ensure that there was not any 
significant distortion or micelle formation. Indeed, at no point during the 1000 ns was the 
curvature of the membrane altered substantially. Moreover, we used the MEMBPLUGIN 
package to examine different features of the bilayer, such as order parameters, area per 
lipid, and membrane thickness [154]. We compared the results with a simulation of a 
pure POPG:POPE bilayer (in the same 3:1 ratio) and we found that the average values 
(over all lipid molecules) did not deviate considerably. However, there was substantial 
differences in the lipid molecules in the proximity of the dimer.  
Figure 5-6: Membrane thinning around the peptides 
 
The distance of the phosphate atoms of the lipid heads from the center of mass of the 
membrane is shown. At the red colored areas, the lipid headgroups are inserted deeper 
into the bilayer core and they interact more with the peptides. The calculations were 
averaged over 100 ns windows to avoid temporal artifacts. From left to right:  a) initial 
design structure – before any simulation, b) average from 450 ns to 550 ns (Cluster I), c) 
average from 750 ns to 850 ns (Cluster II), and d) average from 900-1000 ns (final 
structure). In all figures, the membrane is centered around the dimer. 
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In order to better visualize the local deformation of the membrane around the 
peptides, we calculated the distance from the center of the mass of the phosphate atoms 
(P) of each lipid molecule on both leaflets of the bilayer, and plotted it as a colored 
surface (Figure 5-6). In Figure 5-6a, one can see that the phosphate atoms (and thus the 
lipid heads) were distributed at equal distance from the center of the mass. As the 
simulation proceeded, water, ions, and lipid headgroups started being attracted to the 
dimer. In the top bilayer, the lipid headgroups interacted with the numerous polar 
residues located in the N-half of PlnF and the C-half of PlnE, toward the middle section 
of the peptides. The headgroups (from the top bilayer that were next to the peptides) 
were steered toward the area between the two dimers, progressively decreasing their 
distance from the center of the bilayer (Figure 5-6b).  
At the bottom leaflet, the lipids interact with aromatic and charged amino acids at 
the end of the C’ of PlnF and N’ of PlnE, and therefore are not inserted significantly into 
the membrane. Interestingly, there are two regions of deformation at the bottom leaflet 
where the phosphate atoms move upward. This happened because the phosphate 
atoms interacted with the side of PlnF and the side of PlnE, but did enter the area 
between the two peptides. At a later time (Figure 5-6c and Figure 5-6d), the area 
affected at the bottom leaflet shrinks, however, the phosphate atoms get closer to the 
center of the bilayer. It is evident that the progressive thinning of the membrane became 
better defined and resembled a pore hole with diameter 0.5-2 nm. 
We follow the definition for the presence of a transmembrane pore proposed by 
Sengupta et al.[155], in that the onset of a toroidal pore is defined when the phosphate 
atoms can no longer be considered as two distinct groups - i.e. a top and a bottom 
leaflet. Two phosphates are in the same group when they are closer than a cutoff 
distance of 1.2nm. In Figure 5-7a, we calculated the minimum distance between 
phosphates, starting at the top and bottom bilayers. When this distance is below 1.2 nm, 
then according to the above definition, the phosphates are clustered in one group. It is 
apparent that there is an insertion of some lipid headgroups into the membrane even 
from the 0 ns mark (which is after the minimization and equilibrations runs). The poration 
of the lipid bilayer started after 200 ns, and for the next 300 ns the minimum distance 
between the two bilayers is about the cutoff distance of 1.2nm. For the remainder of the 
simulation the minimum distance was below the cutoff value, and we can therefore 
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argue that a toroidal pore was formed. 
Figure 5-7: Individual phosphate behavior near the pore 
 
The distance between the phosphate atoms of the lipid heads of the top and bottom 
bilayers are plotted in figure a. The distance between the average position of the 
phosphates in the top and bottom bilayers is colored brown (with the standard deviation 
windows shown in lighter brown). The minimum distance between the phosphates in the 
top and bottom bilayers is shown in purple. The cutoff distance where we consider the 
two bilayers as separate is 1.2 nm (green line). In picture b, there is a snapshot of the 
membrane at 509 ns (Cluster I) while in picture c there is a snapshot at 863 ns (Cluster 
II). The phosphates that initially belonged to the top bilayer are colored black, while the 
ones that belonged to the bottom bilayer are colored red. We show the tails of the lipids 
that insert deeper in the hydrophobic region in grey. Finally, the different poration 
pathways, based on the network of the phosphate atoms, are drawn in yellow. 
During the Cluster I frames (350-650 ns), two poration pathways appeared (Figure 
5-7b), with the lipids accumulating inside the top half and outside the bottom half of the 
dimer, while the minimum distance between the leaflets fluctuated. Interestingly, there 
was a short-term increase of the minimum distance at ~700 ns, and then it was 
stabilized at 0.5 nm for the remainder of the time (Figure 5-7c - Cluster II). During this 
latter part of the simulation, the lipid heads form a single poration pathway that is wider 
in the top and narrower near the bottom leaflet. Finally, we visually examined the tails of 
the lipids that are inserted into the membrane (Figure 5-7b and c). In both snapshots, the 
tails of these lipids have an almost perpendicular orientation to the z-axis, indeed 
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resembling a toroidal pore. 
It is important to note, that the number of phosphates that come close is significantly 
smaller than the total 240 phosphates in the system. This is apparent, as the distance 
between the average position of phosphates in the top and bottom bilayers (which is the 
membrane thickness) remains at 3.96 nm ± 0.4 nm for the entire simulation (Figure 5-7a, 
brown line). Thus, the membrane as a whole is not disturbed significantly by the 
presence of the peptides in the time scale we examine, but there is only a local 
disruption surrounding the dimers.  
5.2.4. Behavior of ions near the dimer 
The thinning of the bilayer and the insertion of lipid heads in the hydrophobic core 
describe only the structure of a pore. To examine the dynamics of the pore, we studied 
the permeation of water and ions through it.  We monitored the trajectories of all the ions 
(both sodium and chloride ions) and the oxygen (from each water molecule). We 
characterized a permeation event as successful if an atom crossed the whole 4 nm long 
membrane area, in contrast to Adelman et al., where they set the cutoff distance at 3 
nm, covering only the hydrophobic core area [156]. Then we considered an insertion in 
the top leaflet to be successful if an atom entered through the top of the bilayer and 
reached at least halfway through the upper quarter of its hydrophobic core (at 0.75 nm 
above the center of the membrane). In an analogous manner, we defined the successful 
insertion through the bottom bilayer. 
As expected, chloride ions did not enter the membrane. Due to their negative 
charge, they are not attracted to the negatively-charged lipid heads present on the 
surface of the bilayer or in the pore. 34 unique sodium ions entered the top bilayer in 49 
successful insertion events (some ions entered multiple times), while only 22 unique 
sodium ions were inserted in the bottom bilayer in 27 successful insertion events. The 
average uninterrupted time an ion spent in the inner hydrophobic core of the membrane 
when entering from the top bilayer was 25 ns, with a maximum of 712 ns. The trajectory 
of the chloride that spent 712 ns in the hydrophobic core is shown in Figure 5-8e. In 
contrast the average time a chloride spent when entering from the bottom was only 5 ns 
with a maximum of 27 ns..  
Moreover, we calculated the time the ions needed to go from the polar surface of 
the membrane (at 1.5 nm from the center of the membrane) to the cutoff distance of 0.75 
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nm (from the center of the membrane). Τhe ions entering through the top bilayer, 
traversed this space in 1.89 ns on average, while in the case of the ions entering through 
the bottom, the trip was  27% longer, averaging at 2.40 ns. 
Figure 5-8: Transmembrane path of cations traversing the membrane 
 
The path that the cation follows through the membrane is described in figures a, b, 
c, and d, alongside the important interactions that drive this behavior. PlnE is illustrated 
in blue cartoon representation and PlnF in green. Atoms of the residues of importance 
are colored according to atom type: carbon is light green, hydrogen is white, oxygen is 
red and nitrogen is blue. The headgroup atoms of the lipids and sodium ions are shown 
as grey and orange spheres, respectively. In figures e and f, the evolution of the 
trajectories of two cations is shown: e) one ion that reached the bottom bilayer starting 
from the top, and f) an ion that successfully inserted in the hydrophobic core of the 
membrane though the top bilayer. The blue, red and green lines indicate a distance of 2, 
1.5, and 0.75 nm from the center of the membrane, respectively. 
No ions successfully permeated the 4 nm long membrane. If we had used the 
Adelman cutoff, we would have had one ion passing through the 3 nm of the membrane 
hydrophobic core (Figure 5-8e), however, this would have been a false positive 
permeation event since the ion ends up being trapped at the surface of the bottom 
bilayer and never exits to the solvent. 
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Initially, a sodium ion enters through the top bilayer as it gets attracted to the polar 
clamp between E-D17, E-R13, and F-D22 (Figure 5-8a). It then moves further down as it 
interacts with F-W23 through cation-π interactions (Figure 5-8b). When it reaches the 
bottom layer it interacts strongly with the lipid heads there, however, the cation-π 
interaction with F-W23 is still present (Figure 5-8c), which leads to the ions re-entrance 
in the hydrophobic core (Figure 5-8d). In the meantime, more ions entered into the pore 
that interacted mostly with the surrounding lipid heads rather than the peptides (Figure 
5-8d,e,f). Through this journey, PlnF shows flexibility around its middle section to 
accommodate for the different interaction networks around the dimer. 
5.2.5. Water permeability through the pore 
Similar analysis was performed on the trajectories of the water molecules. 750 
molecules of water successfully traversed though the 4 nm pore in the bilayer. 
Surprisingly, 374 of them entered through the top bilayer while the rest 376 entered 
through the bottom. Additionally, there were 7,070 successful insertion events through 
the top layer and only 2,920 successful attempts from the bottom leaflet. The path that 
the water molecules followed through the pore was guided from the network of polar 
interactions set up by the inserted lipid heads and polar amino acids. During the frames 
of Cluster I, water would go through the pore via two pathways (Figure 5-9a), avoiding 
the area between the C’ of PlnF and the N’ of PlnE. Later, only a single pathway 
continued (Figure 5-9b) and the flow of water was better defined into one column.  
The average time the water molecules spent travelling through the pore was 14.7 
ns. We noticed that some water molecules resided in the hydrophobic core longer than 
others, interacting with other molecules around them, such as sodium ions lipids 
headgroups and polar residues. To analyze this behavior further, we divided the bilayer 
into 40 0.1 nm bins along its z-axis and performed k-means clustering on the time each 
water molecule spent in the bin. We identified three water types (Figure 5-9c). We also 
calculated the average time that molecules of each water type needed to traverse 
through the membrane (Figure 5-9d).  
291 water molecules were grouped into type A. The average time they needed to 
cross the membrane was 12.5 ns. They spent most of that time near the middle of the 
bilayer, at a distance ~0.1nm from the center. There they interacted strongly with the 
lipids heads that had fallen from the top bilayer, the ion shown in Figure 5-8c and 
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residues Serine 21 and Aspartic acid 17 of PlnE, as well as Glycine 19 of PlnF. 
Figure 5-9: Behavior of water as it traverses the pore 
 
Two different snapshots of the simulation are pictured at a) 580 ns (Cluster I), and 
b) 892 ns (Cluster II), showing the double and single water networks present at each 
cluster. PlnE is illustrated in blue cartoon representation and PlnF in green. Water is 
represented as a red surface, and water molecules located further than 2 nm from the 
center of the mass of the membrane are represented as a lighter red surface. In figure c, 
we calculated the distribution along the z-axis of the water residence time as they move 
through the pore (the average is shown in black dotted line). We used this information 
to cluster the molecules into three groups: A in red, B in green, C in blue. The 
residence time in the membrane of each of these water groups is reported in d. 
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258 molecules belong to water type B. They are different than type A, in that they 
spent 55% more time, ~24 ns, in the hydrophobic core, lingering at 0.4 nm below the 
center of the membrane. They interacted similarly with the ions and lipid heads, however 
this time they were strongly coordinated between Tryptophan 23 and Aspartic acid 22 of 
PlnF, and Arginine 13 and Histidine 14 of PlnE. Finally, there are 201 molecules in group 
C. These water molecules cross the membrane faster, with an average time of 6.6 ns. 
They spent most of their time at both ends of the pore interacting with the polar 
headgroups. 
5.3. Discussion  
In this chapter, we have presented the results of a 1μs long atomistic MD study of a 
class IIb dimer. We have demonstrated for the first time that this two-peptide bacteriocin 
is able to form a small toroidal pore in a model bilayer that allows water permeation and, 
possibly, ion conduction.  
First, we analyzed the evolution of the dimer structure and the space it occupies. 
The transmembrane dimer was stable and did not translocate along the z-axis of the 
bilayer during the simulation. We identified two clusters of dimer structure similarity, one 
around the middle of the trajectory (Cluster I) and one toward its end (Cluster II). 
Through the rest of the analysis we looked for differentiation of the behavior of the 
system components (dimer, lipids, water, and ions) between the two clusters. The only 
perceptible variance in the structure of the dimer was the interchange of two pairs of 
cation-π interactions (Figure 5-5). On the other hand, there was a clear change in the 
behavior of the non-protein molecules around Cluster I versus Cluster II. At Cluster I, the 
pore was divided into two paths below the middle of the dimer, in which the lipid heads, 
ions, and water participated in two distinct interaction networks with polar residues of the 
dimer, while at Cluster II there was only a single path.   
We then further analyzed the motifs that support the interaction between the two 
peptides. GxxxG or GxxxG-like sequences are conserved structural motifs present in 
many transmembrane proteins. It has been suggested that these motifs provide a 
relatively flat dimerization surface, allowing the peptides to come into proximity to them. 
The mutational analysis of PlnEF, described in Chapter 4, revealed which residues, 
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belonging in a few such possible motifs on PlnEF, are vital to the antimicrobial activity of 
the dimer. Based on the dimer structure we designed (shown in Figure 4-1), we allowed 
the G5xxxG9 motif in PlnE and the S26xxxG30 motif in PlnF to come close together. As 
seen in Figure 5-4a, the distance between these two motifs fluctuated from 0.3 to 0.7 
nm. Kleiger et al. calculated the interhelical distance of the GxxxG motifs of various 
transmembrane dimers and found that it varies from 0.57 to 0.7 nm [157]. Therefore, the 
suggested GxxxG motifs in PlnEF (G5xxxG9 motif in PlnE and the S26xxxG30 motif in 
PlnF) can be assumed to successfully contribute to the dimerization of PlnEF. 
Next, we examined how the association of the two peptides around the G5xxxG9 
motif in PlnE and the S26xxxG30 motif in PlnF differed between the two clusters. In both 
cases the motifs were close enough to be considered as dimerization surfaces, yet their 
relative orientation changed slightly. GxxxG motifs are often linked to the formation of 
dimers with negative crossing angles between the peptides (such as −40° in the case of 
the parallel Glycophorin A dimer) [158]. It was shown that the more splayed the crossing 
angle is, the more extended the contact surface between the two peptides appears to be 
[159]. In the case of the epidermal growth factor receptor (EGFR), the change in the 
angle of the transmembrane helices that associate through a GxxxG motif is believed to 
play a key role in the activation of EGFR [159]. Therefore, we assume that even a small 
change on the crossing angle of the peptides could be important. In PlnEF, the exact 
calculation of the crossing angle has significant noise because the helical parts - that the 
motifs are located in - are short, i.e. i) PlnF bends around Proline 20 allowing only a 
short 10 amino acid long helix, that contains the S26xxxG30 motif to approach PlnE, and 
ii) the motifs are close to the terminai of both peptides (in contrast to Glycophorin A and 
other dimers, where the motifs are located closer to the middle of the peptides [80]). 
Nevertheless, we observed that in Cluster II the angle between the peptides was smaller 
and the two helices were better aligned, while in Cluster I the center of mass of the 
motifs were further apart, suggesting a possible two-state mechanism. 
It is important to note, that there is a considerable number of studies utilizing MD in 
order to investigate the behavior of GxxxG motifs and analyze the dimerization process 
of different peptides [160–165]. Yet none of them has investigated the pore-forming 
capacity of dimers associating through the GxxxG motif, and no study has examined 
whether GxxxG motifs facilitate ion or water penetration. Moreover, previous work has 
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been based on coarse-grained MD simulations, in which each particle of the system 
corresponds to more than one atom. Even though coarse-grained MD is a more 
computationally-affordable method, it results in information loss - e.g. distinct hydrogen 
bonds cannot be calculated. 
We also performed a 40 μs long coarse-grained MD simulation of the system using 
the Martini force field (results not shown). We observed that, like in the atomistic MD, the 
dimer structure was stabilized through persistent electrostatic interactions. However, the 
polar interactions we observed in the atomistic model were missing (such as Serine 
residues forming different hydrogen bonds). Moreover, the structure of both peptides 
resembled straighter helices. Most importantly, neither water nor ions could enter the 
area between the peptides, possibly because the Martini water model replaces four 
atomistic water molecules and it may be too bulky to fit efficiently in the pore opening 
[166].  
Nishizawa et al. recently compared the accuracy of the description of the 
dimerization of transmembrane helices between coarse-grained MD and atomistic MD 
simulations [164]. Their analysis revealed that the Potential of Mean force (PMF) of 
dimerization of the peptides was an order of magnitude steeper in coarse-grained MD 
simulations than in atomistic ones, indicating that the peptides have a higher tendency to 
dimerize when modeled with coarse-grained force fields. Interestingly, the atomistic 
simulations agreed very well with the experiments. This discrepancy (i.e. the strong 
dimerization of the peptides) might additionally explain why in our coarse-grained 
simulation the peptides do not allow water to penetrate inside the dimer. 
In many cases the GxxxG motifs might offer a dimerization surface; however other 
interactions possibly provide the sufficient contacts for the peptides association [158]. In 
the previous chapters, charged and polar residues around the upper middle section of 
PlnEF were shown to create important hydrogen bonds and a characteristic “polar 
clamp” between the two peptides and bring them close to each other. Interestingly, the 
interaction between Aspartic acid 17 of PlnE and Lysine 22 of PlnF seized to exist after 
the first 200 ns of the simulation of the transmembrane dimer, as the two residues 
moved further apart and interacted with other components (water and ions) (Figure 5-4b; 
a salt bridge is considered important if the charged side chains are closer than 0.4 nm). 
This interaction might only be important for the initial association of the two peptides and 
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their insertion in the bilayer. 
The rest of the polar and charged residues that are in the hydrophobic core of the 
bilayer create a network of interactions that attract lipid headgroups, water, and ions. It 
has been established that the center of many transmembrane proteins, which induce 
protein permeabilization or are proton channels, include regions rich in hydrogen bond 
donors and acceptors that create a water or proton accessible path [167–169]. 
Additionally, appropriately-spaced basic and acidic residues create high-affinity 
transmembrane domains that are called “charge zippers”. These motifs, which do not 
typically tolerate mutations, are located in the center of transmembrane oligomers and 
create a hollow cavity with “eyelets” that allows ion conduction [169]. An example of 
such a “charge zipper” are the salt bridges formed in the center of PlnEF (Figure 4-4a 
and Figure 5-4b).   
In Chapter 4, we demonstrated that the position of aromatic residues in PlnEF was 
vital to the anchoring of the dimer in the bilayer. Aromatic residues are well known to 
stabilize the placement of transmembrane peptides and proteins in membranes, forming 
cation-π interactions with the positively charged atoms in the lipid heads [170,171]. 
Aromatics can participate in cation-π interactions with other types of molecular groups 
as well, such as positively charged amino acids and cations.  
Moreover, the role of aromatic amino acids in gating ion channels or being near ion 
binding centers has been well-documented [172–174]. For example, aromatic residues 
play  a key role in the ion transport mechanism of different potassium and sodium 
channels: Tryptophan residues are placed near the ion binding site, while Tyrosine and 
Tryptophan pairs are located near the pore rim, gating the channel [172].  
A similar conclusion could be drawn for PlnEF. Tryptophan 23 of PlnF (F-W23) is a 
significant attractor of water and ions, while Tyrosine 6 of PlnE could act as a gate. 
When the distance between Tyrosine 6 of PlnE (E-Y6) and Phenylalanine 31 of PlnF (F-
F31) is small, their interaction locks together the very ends of the C-terminus of PlnF and 
the N-terminus of PlnE, and the angle between the GxxxG motifs is wider (Cluster I, 
Figure 5-5b); but when these residues do not interact, they allow the helices to come 
closer (Cluster II, Figure 5-5c). Interestingly, substitutions of E-Y6 and F-W2 with other 
aromatics were well-tolerated in experiments, indicating that all that is needed in these 
positions are amino acids with aromatic rings (Figure C-2). 
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The polar cavity between the peptides attracted lipid heads near the dimer that in 
turn started bending and progressively getting inserted more into the bilayer, forming a 
toroidal pore. The activity of many AMPs has been associated with pore formation [175]. 
In most well-documented cases, the peptides form well-defined, wider pores, the walls of 
which are lined only by AMPs (barrel stave pore) or by AMPs and lipid headgroups 
(toroidal pore). In both cases, usually more than two AMPs are needed. A different case 
is that of the AMPs Melittin and Magainin-2 [155,176,177]. They both were shown to 
form water-filled, disordered toroidal pores with a diameter of about 1.5-3 nm, which are 
concentration dependent. It was recognized that one or two peptides are needed to line 
the pore, while more are required to aggregate on the surface of the membrane [155]. 
Similarly, we observed a nanometer toroidal pore which is less well-defined than the 
typical wide pores of other AMPs, and is lined with only a few lipid-headgroups and the 
peptides. 
The poration of a cell membrane leads to the passive transport of water and, to a 
lesser extent, ions, while failure of controlling this process results in cell death [177]. 
Leontiadou et al. performed MD simulation of Magainin MG-H2 on a model bilayer: they 
observed that 3 water molecules per ns permeated the membrane unidirectionally (J-3 
waters/ns), and they calculated the single-pore permeability coefficient P = J/C =10-
13 cm3/s (where C=55 mol/L is the concentration of pure water) [176]. In our simulation, 
the water molecules permeate the membrane with a rate only one order of magnitude 
smaller (0.374 waters/ns going from the top bilayer to the bottom, and 0.376 waters/ns 
going the opposite direction). Thus, the average unidirectional single-pore permeability 
coefficient is P≈10-14 cm3/s. This value is on the same order of magnitude with the 
coefficient of a single-aquaporin channel, which is considered to be a highly water-
permeable pore. Moreover the permeation coefficient of the PlnEF dimer is two orders of 
magnitude smaller than that of the octameric Protegrin-1 pore and of the hexameric 
Dermcidin pore, which are two very powerful broad spectrum AMPs that create pores 
with diameters ~4nm and kill their target cells by inducing an uncontrollable ion efflux 
[175,178].  
Interestingly, the passive transport of ions through hydrophilic pores depends 
heavily on the size of the water channel; ions permeate small pores (diameter < 3nm) 
very slowly, while at higher diameters there is an enhanced transport of ions through the 
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pore [179]. Particularly, Tieleman et al. calculated that ions permeate small pores at a 
rate three orders of magnitude slower than water does [180].  If this is true for PlnEF, the 
time an ion requires to travel through the membrane is ~2.7μs, a length of time that 
exceeds our simulation. Nevertheless, during the 1 μs simulation, we did observe one 
ion crossing more than 3.5 nm of the 4 nm long membrane, and we established that 
there is a favorable interaction network for ion conduction to take place. 
The opening of the pore in the top bilayer was more accessible to water and ion 
molecules, as there were more successful attempts to enter the inner hydrophobic area 
of the membrane. Thus, it was expected that there would be more water molecules 
crossing the membrane after they enter from the top. Surprisingly, though, the number of 
water molecules that ended up going through the pore was the same for both directions. 
This is a strange result, as it indicates that the limiting factor is probably the diameter of 
the narrowest part of the pore and how many molecules it will accommodate, rather than 
how many molecules are available at the beginning of the entrance of the pore. Another 
explanation is that the peak of the average residence time (Figure 5-9) is located closer 
to the bottom leaflet, and it therefore did not allow many water molecules to enter and 
reach the cutoff distance (0.75 nm from the center of the mass of the bilayer) to be 
considered a successful attempt. However, the possibility of surpassing the interactions 
around the area where the residence time peaks was the same going either direction.  
Lastly, we analyzed the behavior of the water molecules that permeated the pore. 
Following an observation that some of these molecules spent more time in the pore than 
others, we performed clustering analysis on the residence time of the water molecules 
as they traversed the pore. This analysis revealed that there are three different water 
types that crossed the membrane, with average residence times of 24, 12.5, and 6.6 ns 
respectively. This is an interesting finding, because recently many studies have focused 
on the slow, ordered water molecules that are bound to the newly-solved crystal 
structures of transmembrane proteins. Particularly, over the last five years, there has 
been a significant effort to understand what is the functional role of ultraslow waters on 
the activation of G-protein-coupled receptors (GPCRs) [181,182]. Lee et al. simulated 
such a system and found that the residence time of water molecules in the active state 
of a specific GPCR was at the order 102 ns (an order of magnitude longer than the ones 
observed in the PlnEF simulation), while in the inactive state of the GCPR, the residence 
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time was three times shorter than in the active state [181]. They also found, that in the 
active state the water molecules are located around activity hotspots, while key residues 
control the flow of the water channel. Even though we do not suggest that there are 
similarities between the activation of GPCRs and the MOA of PlnEF, we wish to point 
out that slow water molecules and the interactions in which they participate could be of 
importance and might constitute a criterion for designing optimized peptides. 
5.4. Conclusions  
Plantaricin EF is a class IIb bacteriocin. Similarly, to other bacteriocins, its 
mechanism of action is associated with the dissipation of the transmembrane potential. 
However, it has been suggested that bacteriocins act through a receptor-mediated 
mechanism of action and do not induce pore formation and ion conduction by 
themselves. In this chapter, we demonstrated for the first time that contrary to this 
canonical, widely accepted model, a class IIb bacteriocin can create a small toroidal 
pore (diameter 0.5-2nm) in the bacterial cell membrane that leads to water permeation 
and, possibly, ion conduction.  
The size and morphology of the pore are relevant to pores formed by some other 
broad spectrum AMPs. Water permeates the pore at a rate only one order of magnitude 
smaller that of aquaporin, whose key role is to transfer water across the bacterial 
membrane, and two orders of magnitude smaller than very powerful, large pore-forming 
AMPs. This indicates that the presence of pores induced by PlnEF will have a 
considerable impact on the solute transport across the cell membrane. We evaluated the 
time needed for an ion to travel through the pore and realized it is about three times 
longer than our simulation. Possibly computationally-demanding, longer atomistic MD 
simulations or enhanced sampling techniques would allow the ion transport through the 
dimer-induced pore. This hypothesis is strengthened by the fact that we observed an ion 
going about 90% through the membrane and we recognized a polar-interaction network 
that could lead the path for ion transfer.  
Additionally, we analyzed the interactions and motifs that allow the two peptides, 
PlnE and PlnF, to associate and form a dimer. We witnessed that electrostatic and 
cation-π interactions create a network of polar attractors, allowing ions, lipids 
headgroups, and water to be present in the otherwise hydrophobic core. We believe that 
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some of these interactions might act as “microswitches” that control the structure of the 
dimer and the space it occupies. We also observed the presence of “slow” water 
molecules in the pore that might be important for the activity of the bacteriocin, as 
“ultraslow” water molecules have shown to mediate the activity of some GPCRs.  
We are confident that the results presented in this Chapter could be of importance 
to the designing of new antibiotic agents, as it would steer the search for better 
bacteriocins toward peptides that form stable pores and develop optimal interaction 
networks that enhance the water or ion transfer. Furthermore, we believe that the work 
presented here extends beyond the benefit of understanding the mechanism of action of 
bacteriocins and adds important observations to the literature of transmembrane dimers 
in general. 
One question that is raised in our research is that if we suggest that the mechanism 
of action of PlnEF (and bacteriocins in general) involves direct poration of the 
membrane, then how are these AMPs so selectively active against their target? The 
selectivity of the bacteriocins implies that there is some recognition process that 
enhances their activity. Moreover, it was shown experimentally that the presence of 
specific transmembrane proteins was important for the bactericidal action of some class 
II bacteriocins. Two possibilities among many are that these bacteriocins have multiple 
mechanisms of action, or that the receptors are required for the insertion of the peptides 
in the membrane. Without a detailed structure of the receptors or of the receptor-
bacteriocin complex, we cannot assess any of these potential scenarios. In the next 
chapter, we present our efforts to construct a class II bacteriocin-receptor system and to 
evaluate their suggested interaction.  
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Chapter 6  
A first look at a class II bacteriocin-
receptor complex 
6.1. Introduction 
The examination of the mechanism of action (MOA) of antimicrobial peptides 
(AMPs) has attracted considerable scientific interest, because, in principle, elucidating 
their MOA could allow for the optimization and better control of their activity. However, 
the MOA of the class II bacteriocins in particular has remained quite enigmatic. The 
activity of most class II bacteriocins has been associated with membrane 
permeabilization and deadly solute efflux. Due to their narrow activity spectrum, it has 
been presumed that some type of interaction with a receptor at the target cell is 
responsible for their high sensitivity [183]. However, significantly less is known about 
their detailed, fundamental mechanism of action. 
The only receptor-class II bacteriocin MOA that has been studied in more detail is 
the case of class IIa bacteriocins and their suggested receptor, a major sugar transporter 
system (Man-PTS) [184]. As described in Figure 1-3, it is hypothesized that class IIa 
bacteriocins do not form pores on their own, rather they interact with transmembrane 
extracellular loops of Man-PTS inducing some conformational change on the receptor 
that in turn leads to uncontrollable leakage of the cell contents [68]. This hypothesis 
cannot be further evaluated though, because we are missing an atomistic level 
description of the system.  
Furthermore, different transmembrane proteins have been identified as possible 
receptors for other class II bacteriocins. Resistant mutants to the class IIb bacteriocins 
Lactococcin G and its homologous, Enterocin 1071, had an alteration in the uppP gene, 
encoding for the undecaprenyl pyrophosphate phosphatase (UppP), while an APC 
transporter was recently associated with the activity of class IIb bacteriocin Plantaricin 
JK [78,79]. Similarly, YvjB, a transmembrane Zinc-Metallopeptidase was identified as an 
interaction partner and possible receptor for the class-IId bacteriocin, LsbB [39]. In spite 
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of these developments, the lack of atomistic structure of the receptors hinders the 
thorough investigation of the MOA of bacteriocins, as is the case with many other 
membrane proteins.  
The determination of membrane protein (MP) structure is one of the most 
challenging endeavors in the field of structural biology, yet exceptional progress is being 
made in that field. MPs are encoded by more than 30% of the human genome and is 
estimated that over 50% of all drugs target them [185].. However, the number of solved 
MP structures is considerably smaller than the number of solved globular protein 
structures, due to difficulties in the expression of the former and their required 
reconstruction in membrane mimetics. Indeed, MPs comprise only 2-3% of submitted 
structures in the protein databank (PDB) [185].  
Astonishing progress in crystallography, NMR spectroscopy, and in cryo-electron 
microscopy has significantly increased the frequency and resolution of new MP structure 
being successfully solved [185]. Nevertheless, the next best alternative to an 
experimentally-solved structure is a good prediction using computational methods, and 
this is the method that we will explore in this chapter. 
6.2. Computational protein structure prediction 
Computational MP structure prediction has evolved remarkably over the last fifteen 
years, with different methods and software emerging regularly (a great recent review can 
be found at [185]). In the next paragraphs, we are going to provide a brief overview of 
the current methods. 
The first step of structure prediction is assigning a possible secondary structure to a 
protein. Initially, this was done based on database-derived statistics, however, the 
introduction of multiple sequence alignment and machine learning techniques (such as 
artificial neural networks) have improved the quality of the prediction.  
The second important aspect of MP structure prediction is the identification of their 
topology, i.e. the transmembrane domain-span and the periplasmatic or cytoplasmic 
orientation of those domains. Hydrophobic scales (based on the partitioning energies of 
different amino acids from water to a hydrophobic solvent) were originally used, while 
later evolutionary information, neural network, and hidden Markov model methods were 
incorporated to the topology prediction tools. Nevertheless, sequence-based structure 
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prediction cannot yield detailed information of the structure of MPs because these 
methods are insufficient to predict the contacts between the different structure elements 
and, thus, their tertiary structure. For this purpose, homology-based modelling 
techniques, threading methods, or ab initio protein structure prediction methods are 
employed.  
In the case of homology modelling, the target sequence is aligned with a highly 
similar sequence, whose structure is known; the higher the similarity between the two 
molecules, the more accurate the prediction will be. Therefore, the availability of 
structures of high sequence similarity to the query sequence determines the limitations 
of this method. Threading, or fold recognition, methods rely on constructing the predicted 
structure by recognizing similar folds with solved structures, even in the absence of 
sequence similarity and evolutionary relationship. For sequences with low similarity, ab 
initio folding and de novo structure prediction is employed. In this case, fragments (of the 
sequence of interest) of different lengths are paired with different folding states and then 
undergo Monte-Carlo simulations with a knowledge-based potential. 
Different softwares and platforms have been developed over the years, employing 
one or more of the above methods. These software are evaluated biannually and 
presented at the CASP (Critical Assessment of protein Structure Prediction) meeting, 
where a worldwide scientific experiment takes place [183]. Participants in CASP are 
given the sequence of a recently experimentally-determined structure (which was not 
previously available to them) to test their structure prediction methods. RosettaMP is one 
of the earliest and most reliable packages, while MEDELLER has demonstrated 
remarkable prediction quality of structures with high similarity homologues in the PDB 
database [186,187]. One of the best performing packages, acording to the the CASP 
ranking, that merges secondary structure assignment, homology modelling, fold 
recognition, and ab initio protein prediction, is the I-Tasser suite [188].  
We have attempted to use the above methods to predict the structure of a possible 
receptor of class II bacteriocins. In each case of the class II receptors identified so far 
(the Man-PTS, the UppP, the APC transporter, and YvjB), the structure prediction 
methods yielded low-quality predictions of whole proteins, because homologues or 
proteins with similar folds have not been solved experimentally and the receptor 
sequences are too long for ab initio structure prediction.  
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However, we were able to suggest a topology and a partial structure of the Zn 
metallopeptidase YvjB. YvjB is significantly smaller than all the other receptors, making it 
a better target for structure prediction. In the next section, we provide an overview of all 
the experimental research available for LsbB and YvjB that are relevant to our work. 
6.3. LsbB, a class IId bacteriocin and its hypothesized receptor, the 
Zn Metallopeptidase YvjB 
LsbB is a 30 amino acid long, leaderless, non-pediocin-like bacteriocin that was first 
isolated from Lactococcus lactis subsp. lactis BGMN1-5. It exhibits a narrow activity, 
mostly targeting other lactococcal strains [189]. LsbB, whose sequence can be found at 
Table 6-1 is relatively hydrophilic with a highly cationic C-terminus.  
The gene that encodes for LsbB is located in a gene cluster that also produces 
LsbA, a hydrophobic unclassified bacteriocin that has not been further studied, and 
LmrB, a transporter that renders the producer cells resistant to both LsbA and LsbB [85]. 
Through experimental studies, it was realized that the two peptides do not act 
synergistically against a number of tested targets, as their combined activity was just the 
sum of the individual activities of the peptides, therefore they cannot be considered class 
IIb bacteriocins  [85].  
Table 6-1: Amino acid sequence of the class IId bacteriocin LsbB 
LsbB MKTIL RFVAG YDIAS HKKKT GGYPW ERGKA 
 
In 2013, Uzelak et al. identified YvjB, a Zn metallopeptidase, as a possible receptor 
for LsbB through constructing a cosmic library of an LsbB-sensitive strain [39]. The 
cosmic library method relies on breaking down the chromosomal DNA of the sensitive 
target bacterium (BGMN1-596) and inserting the DNA pieces in Lambda phages to 
create a clone plasmid that next will be introduced to resistant bacteria. If, subsequently, 
some of the resistant bacteria become sensitive, then the plasmid clone that they 
contain, must encode for a receptor of the bacteriocin. After repeating this procedure 
multiple times, Uzelak et al. pinned down the gene that confers sensitivity to the cells. 
This gene, named yvjB, codes for a 428-residue, Zn-dependent membrane bound, 
metallopeptidase, which is named YvjB (Table 6-2).  
YvjB is a highly-conserved Zn protease of the M50 family. Proteins of this family are 
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involved in gene regulation in other species, however the function of YvjB in lactococci is 
yet unclear [190]. Uzelak et al. also performed whole genome sequencing of a few 
spontaneously resistant BGMN1-596 cells and found that these bacteria contained 
alterations at specific residues of YvjB [39].  A G188S mutation was included in five 
mutants, while two mutants had a G414L, a V415G, and an N428K/M mutation, and in 
some cases yvjB had an earlier stop codon.  
They then tested if another function of the bacteria was altered due to the mutations 
and thus hindered the growth of the cells. They introduced cells in an LsbB-free medium 
and observed that both the sensitive and the mutant BGMN1-596 cells had similar 
growth. Finally, they showed that heterologous expression of YvjB in otherwise resistant 
species, such as Lactobacillus paracasei and Enterococcus faecalis, rendered these 
bacteria sensitive to LsbB. In the same study, they examined whether the activity of 
LsbB is associated with Man-PTS or other sugar transporters, and they demonstrated 
that it has no such associations. 
Table 6-2: Amino acid sequence of the Zn Metallopeptidase, YvjB 
1 MIETL ITFII IFGII VAIHE YGHLW WAKRS GILVR EYAVG MGPKI FAHQA 
51 KDGTL YTIRI LPLGG YVRLA GWGDD KTEIK KGQAA SLVVS KSEVV NPEAE 
101 NSVSN IVRRI NLSEH VELEE AIPML ITEYD FEKEL FIEGE VFGEI KRYSV 
151 DHDAT IIEED GTEVR IAPLD VQYQS AGVFH KMLTN FGGPL NNFIL GIIAF 
201 IVLTF VQGGV PSTTN AIGQV EKGTP AYNAG LKAGD KIEAV NGTKT ADWNN 
251 VVTEI SGSKG KELKL EVSRS GKSET LSVTP KKMDG SYRVG IMQSM KTGFF 
301 DKITG GFVQA GQSAT AIFKA LGSLI ARPSL DKLGG PVAIY QLSGQ AARAG 
351 LFPAIV LLAM LSINL GIVNL FPIPV LDGGK IVLNI IEAIR GKALS QEKES 
401 IITMV GVVFM LVLFV AVTWN DILRA FVN 
 
One year after the Uzelak et al. publication, Ovchinnikov et al. determined the 3D 
structure of LsbB and highlighted its possible binding domains through comparative 
activity essays of a series of truncated LsbB peptides, as well as Alanine substitution 
[87].  
Similar to other bacteriocins, LsbB was unstructured in water but that changed in 
TFE and DPC environments. The N-terminus of LsbB forms an amphiphilic α-helix, 
about 18 amino acids long, which contains a series of basic amino acids (HKKK). The C-
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terminus remains unstructured in both water and organic solvents. They found that only 
the last ten C-terminal residues are responsible for the specific activity of LsbB, 
however, they concluded that the basic amino acids series (HKKK) is vital for the initial 
unspecific interaction of the peptide with the membrane. The residues that were found 
(through Alanine scanning) to be crucial for the specificity of LsbB were A30, E26 and 
most significantly W25. Nevertheless, no further conclusion about the mechanism of 
action of LsbB could be made without the detailed atomistic description of its interaction 
with YvjB.   
Lastly, in 2016, Miljkovic et al. investigated further the possible interaction domains 
of both YvjB and LsbB [190]. They performed site-directed mutagenesis on LsbB that 
further confirmed the importance of Tryptophan 25 and Alanine 30 for the activity of the 
peptides. Then, they performed a comparative study between the YvjB produced by a 
sensitive strain (YvjBMN) and a resistant strain (YvjBMG), which had different amino 
acids at 31 positions. In vitro experiments revealed that LsbB interacts with both YvjBMN 
and YvjBMG, however, the interaction with the latter are significantly less potent. In 
contrast, in vivo experiments with immunofluorescently-labeled antibodies showed that 
LsbB interacts specifically only with bacteria having YvjBMN.  
Miljkovic et al. created hybrid proteins of YvjBMN and YvjBMG and expressed them 
in otherwise insensitive cells, in order to identify the domains that are important for LsbB-
receptor interaction [190]. This experiment revealed that the last ¾ section of YvjBMN is 
what renders the cells sensitive, and thus is most likely responsible for the interaction 
with LsbB. Six residues are different between YvjBMN and YvjBMG in this section; 
residues Phe351, Ala353, Val354, Tyr356, Gln396, and Met404 in YvjBMN change to 
Leu351, Thr353, Ile354, Gln356, Pro396, and Leu404 in YvjBMG.  
They performed site-directed mutagenesis where they mutated each of these six 
residues of YvjBMG to the respective amino acid of YvjBMN to examine which residue 
will deliver sensitivity to the target cells. They observed that a single mutation on Tyr356 
was sufficient to make cells sensitive, however, the LsbB activity was lower in that 
mutation than it was against the wild type YvjBMN. Then they tried different 
combinations of mutations, that matched (and with some even improving) the activity of 
LsbB, however, clear conclusions could not be drawn.  
Finally, they used a transmembrane domain prediction tool, which predicted that 
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YvjB has four transmembrane helices: 5 to 27, 188 to 210, 354 to 376, and 401 to 423. 
Thus, they conclude that YvjB interacts with LsbB through its third transmembrane helix, 
because Tyr356 is located there. 
Interestingly, in their work, Miljkovic et al. revealed that the domain that contains 
Glycine 188 does not seem to be an important factor for the activity. The location of this 
Gly is in a domain of YjvB whose structure we could not successfully predict. As such, 
the previous computational investigation of the LsbB-YvjB complex had necessarily been 
halted. However, with the emergence of the data of the Miljkovic et al., we were able to 
move further and design a model of LsbB interacting with a partial structure of YvjB, 
using protein prediction tools, molecular dynamics simulations and docking.  
6.4. Methods  
6.4.1. Topology recognition and structure protein prediction 
For the structure prediction, we used the online version of the I-TASSER suite [191]. 
Moreover, for the topology recognition we extensively employed the PSSred subroutine 
included in the suite [191].  
We started with the sequence of YvjB that can be found at Table 6-2, and we then 
used domains of the protein of different lengths as well as truncated sequences as 
described in the results section. We considered a structure prediction to be successful if 
their TM-Score, calculated by I-TASSER, was larger than 0.5. The TM-score was 
proposed by Zhang et al. in order to quantify the structural similarity between two 
structures, and it is used by I-TASSER as an indication of how similar the prediction 
would be to the solved structure of the protein, if that existed. A TM-score larger than 0.5 
indicates a correct topology prediction, while TM<0.17 indicates that the protein 
prediction of the model is random. 
6.4.2. Design of the Transmembrane YvjBT models  
After we concluded that the best model was YvjBT, we had to determine the 
orientation of the protein with respect to a membrane-mimicking model. For this we used 
the structure of the Site-2 Protease (pdbid:3b4r) - that has a 42% similarity with YvjBT -  
embedded in a bilayer, that was obtained by the MemProtMD server [192,193]. 
MemProtMD is an online server where one can find the structures of all the membrane 
proteins (solved experimentally so far) inserted in an explicit bilayer. The membrane-
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protein complexes in the MemProtMD server have undergone coarse-grained and 
atomistic MD simulation to allow the protein structure to relax in the membrane 
environment. 
It is important to note that the crystallization of mjS2P, which is a Zn 
metalloprotease of an archaea, revealed that two molecules of mjS2P associate and 
form an antiparallel homodimer [192]. However, it is not clear if this is the state in which 
the protein exists on the cell membrane, or if this is a pseudo-dimer that was created as 
a crystal-packing artifact. Biochemical studies of different intramembrane 
metalloproteases support the hypothesis that they form dimers [194]. Due to this 
uncertainty, we modelled structures of both a monomer and a dimer. In the case of the 
YvjBT monomer, we aligned it to the structure of the chain A of the mjS2P dimer. 
We performed the 3D structure alignments of the YvjBT monomer and dimer to the 
mjS2P-bilayer, using the VMD software and the Multiseq plugin [115,195]. We moved 
the center of the mass of the bilayer (of the mjS2P-bilayer complex) to the center of the 
axis in order to retain the relevant placement of the YvjBT molecule to a bilayer.  
We then inserted the aligned YvjBT model in a POPG and POPE lipid bilayer at a 
3:1 ratio, using the CHARMM-Gui server [119]. In the case of the YvjBT monomer, the 
upper leaflet of the bilayer had a total of 140 lipids, while the bottom had 144, because 
YvjBT occupied more space close to the top bilayer. The bilayer is symmetrical and 
includes the YvjBT dimer, which had 180 lipid molecules on each leaflet. The YvjBT-
bilayer complexes were solvated and ionized using the VMD solvator and autoionize 
plugin [115]. The ion concentration of the systems was set to 0.15 M NaCl, and 
additional ions were introduced to electroneutralize the systems.   
6.4.3. Design of the surface LsbB model 
The structure of LsbB has previously been solved and deposited on the PDB 
database with accession id 2MLU [87]. In order to define the orientation of LsbB on the 
membrane, we used the PPM Server [196]. PPM predicts the position of a protein with 
respect to a membrane surface, taking into account possible hydrophobic, electrostatic, 
and hydrogen bond interactions, and implicitly representing the water-lipid environment. 
We aligned the output of the PPM server to a pre-equilibrated bilayer that contains 
POPG and POPE lipids at a 3:1 ratio and 120 lipids per leaflet (created by the 
CHARMM-Gui server), using the VMD software. Finally, we solvated and autoionized the 
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LsbB-bilayer system with a similar protocol to what was described above for the YvjBT 
models. 
6.4.4. Molecular dynamics and docking 
The atomistic molecular dynamics simulation was conducted with the NAMD 2.11 
simulation engine [115] using the CHARMM 36 force field [142] under constant pressure 
and temperature (NPT ensemble). Each part of the simulation was carried out on the 
Stampede supercomputer through the XSEDE portal. The MD protocol is identical to the 
one we used for the simulation of the PlnEF transmembrane dimer in Chapter 5 (see 
paragraph 5.1.2). The only difference is that the simulation of the YvjBT monomer and 
dimer systems were run for 200 ns, while the LsbB simulation was run for 100ns 
Finally, we performed a simple docking calculation using the HADDOCK server, 
which employs rigid-body energy minimization and a semi-flexible refinement in the 
torsion angle space. HADDOCK is experimentally knowledge-driven and requires the 
user to input the residues that might act as binding hotspots. Based on the previous 
experimental studies described in paragraph 0, we used W25 of LsbB and Y356 of YvjB 
(or Y146 of YvjBT) as possible interaction surfaces.  
6.5. Results and Discussion 
We started our effort to investigate the interaction between a class II bacteriocin, 
LsbB, with its receptor, YvjB, by employing structure prediction methods. After numerous 
iterations, we were able to identify a detailed topology of YvjB and determine the 
structure of its N- and C-termini - the latter is proposed by experiments to be the region 
of interaction with LsbB.  
We then inserted YvjB (which is a membrane-bound protein) in a model lipid bilayer 
and performed molecular dynamics (MD) simulations in order to allow the protein to 
relax in an environment closer to its natural state. For the same reason, we performed 
MD simulations of LsbB on a surface bilayer. Finally, we docked LsbB on YvjB to identify 
the best LsbB-YvjB complex. We hope this project will be continued in the future by 
other students who can better refine the LsbB-YvjB complex and study in detail the 
interaction between these two partners.  
100 
 
6.5.1. Topology and structure prediction of YvjB 
Initially, we attempted to perform 3D structure prediction of the whole sequence of 
YvjB on the I-TASSER server. The TM-score of the best predicted model was 0.47±0.15, 
which indicates a successfully predicted topology. However, after visual inspection, we 
noticed that pieces of the structure had unnatural-looking folds, i.e. extended long coils 
connecting two well-defined regions. In order to avoid this problem, we proceeded to 
dismantle the sequence of YvjB into distinct structural sub-domains through a detailed 
secondary structure prediction with PSSred and by comparison with the current literature 
and available homologous structures in the PDB database. We then performed 3D 
structure prediction for each subdomain. The results are detailed in Table 6-3. We then 
combined this information into a suggested topology that is illustrated in Figure 6-1 
which is significantly improved when compared to the one suggested by Miljkovic et al. 
[190]. 
Figure 6-1: Suggested topology of YvjB 
 
According to the domain analysis presented inTable 6-3, we create the topology of 
YvjB. The transmembrane helices are colored blue, while the intramembrane stretches 
are colored green and the PDZ domains are yellow. The location of the Zn binding 
residues is marked red. In purple, we point to the location of Y356 that was suggested 
to be the binding site of LsbB. NT and CT denote the N- and C- terminai, respectively 
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Table 6-3: Domain analysis of the Zn metallopeptidase YvjB 
Sub-domains Res # Sec. Structure  Conf. Function  
Domain I: N-terminal TM domain 
TM core of Zn 
metalloprotease  
H1 1-30 TM helix (oi) 8-9 
C1 30-90 TM beta sheet and coil (i) 8-9 
H2 90-120 TM helix (io) 6-9 
Domain II: Possible extracellular PDZ domains 
PDZ domains of 
intramembrane proteases  
P1 120-220 beta sheet & helix (o) 2-5 
P2 220-280 beta sheet & helix (o) 9 
P3 290-350 unknown 0 
Domain III: C’ terminal TM domain 
TM core of Zn 
metalloprotease  
H3i 350-370 TM helix (oi) 8-9 
C2 370-380 Coil (i) 8-9 
H3ii 380-390 TM helix (oi) 8-9 
H4 395-420 TM helix (io) 8-9 
C3 420-428 Coil (o) 5-8  
 
The names of the individual sub-domains are located in the first column, and the 
residues that they approximately include are in the second. The predicted secondary 
structure of each sub-domain can be found on column three. In parenthesis, we note the 
orientation of each segment: i=intramembrane, oi= starting from the periplasm (out of 
the cell) and ending at the cytoplasm (in the cell) while io denotes the opposite 
orientation. The confidence level of each prediction can be found in column four, and it 
ranges from 0 to 9. Finally, in the fifth column we suggested the possible function of 
each domain. 
This analysis revealed that YvjB is an M50, Zinc Metallopeptidase. In general, 
peptidases (otherwise called proteinases or proteases) are enzymes that cleave the N-
terminal domains of other proteins by hydrolyzing a peptide bond [194]. In the case of 
metalloproteases, the hydrolytic reaction is catalyzed by a metal (Zinc, in the majority of 
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cases). The domain I of YvjB is the characteristic N-terminal catalytic domain found in 
metalloproteases that contains the catalytic zinc-binding motif HExxH. Similarly to other 
Zn metalloproteases, this motif is found on a transmembrane helix (H1) that is followed 
by a hydrophobic stretch (C1) and a second transmembrane helix (H2). The orientation 
(whether the structural elements begin at the periplasmic or cytoplasmic side of the 
membrane) of these helices is conserved in all metalloproteases. 
Domain II contains 3 subdomains that could possibly be classified as PDZs, which 
are extracellular parts of membrane enzymes that are abundant in all cells and serve as 
recognition domains [195]. Finally, domain III is the C-terminal conserved domain of Zn 
metallopeptidase, and it is comprised of H3i and H3ii, two transmembrane helical parts 
that are separated by an intramembrane coil region C2. This is followed by the last 
transmembrane helix H4, while the final few amino acids of the C-terminus are possibly 
located outside the membrane, in the periplasmatic space. In the HExxH motif found in 
H1, the two Histidine residues are ligands of the Zinc ion while the Glutamic acid 
activates a water molecule that is considered to be a third ligand. However, the Aspartic 
acid (D77) (located in the H3ii intramembrane helix) is also required as a fourth ligand. 
Domains I and II have highly-conserved features of intramembrane proteases and 
their individual structure prediction was successful. The template that was used most for 
the prediction was the crystallized structure of another Zn metalloprotease, mjS2P, 
isolated from the archaea species, Methanocaldococcus jannaschii [192]. The similarity 
between domains I and II of YvjB and mjS2P is ~42%, while the identity is ~24%. MjS2P 
has one more N-terminal and one more C-terminal helices, while it contains no PDZ 
domains. Out of the three hypothesized PDZ subdomains, only the structure prediction 
of the second (P2) was successful, due to its high similarity to two available PDZ 
structures - one of them being isolated from another intramembrane protease RseP 
[195]. Additionally, the structure of P1 was predicted to an extent with the ab initio folding 
subroutine of I-Tasser, while similar calculation on the structure of P3 yielded no 
valuable results. 
 Since the structure of large pieces of YvjB could not be predicted, we decided to 
create numerous truncated protein sequences where subdomains of the YvjB were 
removed. In all cases, we needed to include domain III because it was concluded from 
experiments that domain III possibly interacts with LsbB, as described in paragraph 6.3. 
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YvjBT, was the longer sequence that produced a successfully predicted structure (TM-
score 0.56±0.15), and it includes only domains I and III (residues 1 to 213 and 334 to 
423), which are the transmembrane core of YvjB. More of the last five residues of YvjB 
are missing in YvjBT, because they were disturbing the structure prediction and they are 
not expected to contribute to the interaction with LsbB. The sequence of YvjBT can be 
found in Table 6-4 and its predicted 3D structure in Figure 6-2a.  
Table 6-4: Amino acid sequence of the truncated protein, YvjBT 
1 MIETL ITFII IFGII VAIHE YGHLW WAKRS GILVR EYAVG MGPKI FAHQA 
51 KDGTL YTIRI LPLGG YVRLA GWGDD KTEIK KGQAA SLVVS KSEVV NPEAE 
101 NSVSN IVRRI NLSEH VELEE AIP123G334G PVAIY QLSGQ AARAG  DKITG GFVQA 
151 GQSAT AIFKA LGSLI ARPSL LFPAIV LLAM LSINL GIVNL FPIPV LDGGK 
201 IVLNI IEAIR GKALS QEKES IITMV GVVFM LVLFV AVTWN DIL423 
With superscript, we note the residue number of amino acids at the cut sites  
 
Figure 6-2: 3D structure of YvjBT and insertion in the membrane. 
 
The 3D structure of YvjBT, as predicted by the I-TASSER server, is pictured with a 
cartoon representation in a. Each color indicates a different sub-domain: H1-red, C1-
yellow, H2-orange, H3i-white, C2-cyan, H3ii-green, H4-pink, and the residues that 
linked H2 and H3i are transparent grey. In b, the transmembrane YvjBT monomer is 
shown in blue, while the antiparallel dimer is shown in c (monomer A is colored blue, 
while monomer B is colored green). The headgroup atoms of the lipids of the bilayer 
are shown as grey spheres. Tyrosine 356 is green in b and yellow in c, based on the 
VDW radii of its atoms. 
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We then inserted YvjBT in a model lipid bilayer as described in paragraph 6.4.2. 
Previous structural and biochemical studies suggested that Zn metalloproteases might 
be packed as antiparallel homodimers in the membrane. Therefore, we designed both a 
monomer and a dimer YvjBT transmembrane structure, Figure 6-2b and c respectively. 
Interestingly, in both models, Y356 is close to the membrane and as such it might be 
easily accessible to LsbB. 
6.5.2. MD simulations  and docking 
In order to create a possible structure of the YvjBT-LsbB complex, we first performed 
atomistic molecular dynamics simulation on each component (LsbB and YvjBT) 
individually, with the intention to allow the molecules to relax in a membrane 
environment. We performed 200 ns of MD simulations of both the monomer and dimer 
YvjBT inserted in a lipid bilayer (Figure 6-3), while we performed only 100 ns of LsbB on 
the surface of a lipid bilayer (Figure 6-4).  
Figure 6-3: Snapshot of the transmembrane YvjBT after 200 ns of MD simulations. 
 
Final snapshots after 200 ns of atomistic MD simulation of the YvjBT monomer (a) 
and dimer (b). The monomer YvjBT is colored blue in a, while in b monomer A is 
colored blue and monomer B is green. The headgroup atoms of the lipids of the bilayer 
are shown as grey spheres. Tyrosine 356 (that is hypothesized to interact with the 
bacteriocin) is green in a and yellow in b, based on the VDW radii of its atoms. 
The structure of both the monomer and dimer YvjBT did not diverge significantly 
from their initial structure. The backbone RMSD of the monomer was 0.65±0.07 nm, with 
most deviation being around the coil regions; the backbone RMSD of the helical regions 
was ~0.3 nm. However, visual inspection revealed that the relevant positon between the 
helices changed and, in fact, H3ii became almost perpendicular to the z-axis, which 
suggests that in future simulation, it might get expelled from the membrane.  
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In contrast, the structure of the dimer seems more stable - the whole dimer 
backbone RMSD was 0.48±0.09 nm, while the backbone RMSD of monomer A was 
0.51±0.1 nm, and that of monomer B was 0.38±0.08 nm. The two monomers did not 
translocate in the membrane significantly, as they were anchored in the bilayer and they 
approached each other closely. 
LsbB exhibited an α-helical structure through the whole 100 ns simulation. 
Interestingly, LsbB adopts a perpendicular orientation to the surface of the bilayer, even 
though it starts from a parallel one. Structural analysis of the trajectory revealed that 
there was a bend around G11 that did not disrupt the continuity of the α-helix. This may 
have happened because there is a cluster of cation-π interactions among Tryptophan 
25, Tyrosine 23 and 11, and Phenylalanine 7. The backbone RMSD of LsbB was 
0.35±0.12 nm. 
Figure 6-4: MD simulation of LsbB on the surface of a bilayer. 
 
Initial (a) and final (b, after 100 ns) snapshots of the MD simulation of LsbB on the 
surface of a lipid bilayer. LsbB is colored red and is pictured in cartoon representation. 
W25 (believed to interact with the receptor) is shown in blue. The headgroup atoms of 
the lipids of the bilayer are shown as grey spheres.  
Finally, we employed the HADDOCK server to dock LsbB to both the YvjBT 
monomer and dimer. As input structures, we used the final frame of the respective MD 
simulation. The possible binding sites, i.e. W25 of LsbB and Y356 of YvjB, were 
provided to the server so as to guide the docking calculations. The complexes that were 
produced are pictured in Figure 6-5. In both cases, LsbB penetrated the bilayer and was 
able to come in close proximity to the Tyrosine 356 of the receptor.  
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Figure 6-5: Suggested LsbB-YvjBT complex based on docking 
Docking results of LsbB on the YvjBT monomer (a) and dimer (b). LsbB is colored 
red. YvjBT in a and the YvjBT-monomer A in b are colored blue, while the YvjBT-
monomer B in b is colored green. The hypothesized important residues for the 
interaction between LsbB (W25) and YvjB (Y356) are colored green in a and yellow in 
b. The headgroup atoms of the lipids of the bilayer are shown as grey spheres.  
 
6.6. Conclusions and future directions 
The bactericidal activity of some class II bacteriocins has been associated with the 
presence of specific proteins in the target cells. This, alongside the fact that most 
bacteriocins have high selectivity, leads to the hypothesis that class II bacteriocins could 
act through a receptor-mediated mechanism of action (MOA).  
Even though there are experimental studies that describe to an extent the key 
elements of this MOA, its thorough examination is not possible. In this chapter, we 
attempted, for the first time, to design a class II bacteriocin-receptor complex and to 
propose that computational structure prediction and molecular simulations can be 
powerful tools in the endeavor of unravelling the MOA of class II bacteriocins.  
We started by reviewing the current literature about the membrane-protein 
structure-prediction options and the available experimental data that suggest a 
relationship between class II bacteriocins and their receptors. We then evaluated which 
receptor-bacteriocin system might have the best potential for computational structure 
prediction. We concluded that the Zn metallopeptidase, YvjB, which is considered a 
hypothetical receptor for the class IId bacteriocin LsbB, was a good candidate to 
proceed with because it had decent initial prediction scores and a relatively smaller size, 
compared to similar systems. In addition, there is a significant amount of data indicating 
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the binding sites between the two interaction partners, YvjB and LsbB. 
We first analyzed the sequence of YvjB in detail and broke it down into sub-
domains. We identified the possible structure and function of each sub-domain, and thus 
we were able to propose a detailed topology for the protein that was different than what 
had been previously proposed. Then we truncated parts of YvjB for which we could not 
obtain a satisfactory 3D structure prediction and that we knew from previous studies are 
not required for the interaction with LsbB. We named the truncated protein YvjBT.  
Next, we introduced YvjBT in a model lipid bilayer based on the structure of S2P, a 
different metallopeptidase. Interestingly S2P is packed into antiparallel homodimers in its 
crystal structure, and it is unclear if this is the biological assembly of metallopeptidases 
or just an artifact of crystallization. We therefore concluded that we should examine both 
a YvjBT monomer and a dimer. We then performed atomistic molecular dynamics (MD) 
simulation of the system in order to allow YvjB to relax in the membrane environment. 
Similarly, we positioned LsbB, which has a structure that was previously solved 
experimentally, on the surface of a model bilayer and performed atomistic MD 
simulations. Finally, we obtained the ultimate structure of each system and subsequently 
fed them to a docking server that in turn produced possible structures of the YvjBT-LsbB 
complex. In both the monomer and dimer cases, LsbB approaches YvjBT around the 
suggested interaction surfaces.  
Creating a bacteriocin-receptor complex structure was a significant first step in 
elucidating the mechanism of action of these interesting antimicrobial peptides. 
Nevertheless, there is a lot more that can be investigated in the future. To begin with, it 
would be of great interest to investigate in greater detail which of the YvjB monomer or 
dimer is more stable, and what exactly is the function of this protein. Then an extended 
atomistic MD simulation of the LsbB-YvjBT complex could verify if these two proteins do, 
in fact, interact and if so, which residues are important for this interaction. A study similar 
to the one conducted in Chapter 3 (where we compare the biophysical image of different 
systems with known experimental activity) could provide a better understanding of the 
structure-activity relationship of LsbB and its interaction with YvjB. Moreover, 
experimental mutation on residues that are deemed important through our model could 
exam the accuracy of our prediction. Lastly, the structure of the receptor could further 
improve with more detailed structure prediction and a more thorough docking protocol.  
108 
 
Chapter 7  
Summary and concluding remarks  
The discovery of antibiotics in the mid-20th century revolutionized modern medicine, 
improved our quality of life, and increased longevity. However, bacteria would soon fight 
back and develop resistance. Different government issued reports warn that we are 
quickly approaching a “post-antibiotic era”, where even minor bacterial infections could 
be deadly. As the number of cases of antibiotic resistance is increasing, the effective 
utilization of conventional antibiotics is rapidly decreasing. Therefore, there is an urgent 
need to identify and take advantage of sources of new antibiotic drugs.  
Antimicrobial peptides (AMPs) are a promising alternative to conventional 
antibiotics, and they may provide a solution to the emerging problem of antibiotic 
resistant infections. Class II bacteriocins are bacteria-produced AMPs that do not 
contain post-translational modifications. These bacteriocins show great potential as 
novel antibiotic agents because they are active against different microorganisms with 
high specificity and they are amenable to bioengineering.  
 Two decades ago, researchers entered a race to understand and optimize the 
bactericidal activity of bacteriocins in general. However, before the full potential of 
bacteriocins can be unlocked, it is imperative that we gain a detailed understanding of 
their mechanism of action (MOA). The great potential for future use of bacteriocins 
motivated us to explore the mechanism of action of class II bacteriocins through 
atomistic molecular dynamics simulations.  
Information is limited regarding the mechanism(s) by which class II bacteriocins kill 
their target. It has been shown that their bactericidal activity is associated with ion or 
solute efflux, which ultimately leads to the death of the target organism. Our primary goal 
in this work was to investigate the interaction of class II bacteriocins with model 
membranes and determine the likelihood of pore formation that leads to an ion efflux. 
However, due to their narrow target spectrum, it has also been suggested that class II 
bacteriocins might act instead through a receptor-mediated MOA. It became apparent 
that it would be impossible to build a complete and accurate picture of the MOA of class 
II bacteriocins without having a detailed understanding of the bacteriocin-receptor 
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complex – specifically, without possessing an accurate, 3-Dimensional structure of a 
receptor. In response to missing that piece of the puzzle, and with the goal of coming to 
a more holistic conclusion, we continued our research by examining the hypothesized 
class II bacteriocin receptors. 
We began by exploring the mechanism of action of Plantaricin EF (or PlnEF). PlnEF 
is a class IIb, two-peptide bacteriocin comprised of peptides Plantaricin E (PlnE) and 
Plantaricin F (PlnF). As is the case with other class IIb bacteriocins, the two peptides are 
hypothesized to former a dimer. Previous experiments have demonstrated that PlnE and 
PlnF are unstructured in water, while they form α-helical structures in membrane-
mimicking environments, such as DPC micelles. We performed atomistic MD simulations 
of PlnE and PlnF both in water and in a DPC micelle environment. We observed that in 
water, each individual peptide had significant loss of structure only when interacting with 
the complimentary peptide, which seemingly indicates that more than 85 ns are required 
to reproduce the unfolding dynamics of these peptides. We observed that the two 
peptides interacted with each other through amino acids in their middle sections. These 
simulations provided a first insight of the regions of the peptides that interact with a 
membrane, and suggested that the amphiphilic nature of these peptides would probably 
not allow them to get inserted individually in a membrane. 
Although bacteriocins are hypothesized to act through a receptor-mediated MOA, 
there is speculation that an initial, unspecified interaction with the target membrane 
takes place that is facilitated by electrostatic interactions. To test this theory, we 
simulated PlnEF on the surface of a model lipid bilayer. The relevant orientation of the 
two peptides on the surface of the membrane is unclear, so we examined both a parallel 
and an antiparallel surface dimer. The simulations revealed that the peptides associated 
with each other through their middle section in both models, while they interacted with 
the membrane through their terminal residues. Interestingly, we observed that in the 
parallel model there are stronger peptide-peptide interactions than there were in the 
antiparallel model. Such interactions are prerequisite for a bacteriocin’s antimicrobial 
activity. Therefore, we concluded that a parallel orientation is more probable for the two 
peptides when they are on the surface of a membrane. To connect the atomistic 
behavior of PlnEF to its experimentally-observed activity, we performed a series of MD 
simulation of PlnEF mutants of known activity. There was an apparent tendency for 
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decreasing peptide-membrane interactions in systems of higher activity, in favor of 
interactions between the peptides. This seems to suggest that a parallel dimer model is 
not associated with insertion in the membrane. 
New experiments indicated that PlnEF forms an antiparallel transmembrane dimer, 
and that the two peptides that comprise PlnEF associate through a GxxxG motif (a 
common motif found in abundance in the sequence of transmembrane proteins), located 
at the C-terminal of PlnF and N-terminal of PlnE. Using these conclusions, we were able 
to design a transmembrane dimer of PlnEF and position it successfully inside a model 
lipid bilayer. We subsequently performed MD simulation on this system. That simulation 
revealed that in addition to the GxxxG motif, the peptides’ association can be attributed 
to a polar “clamp” of interactions between the middle sections of the peptides, and to 
cation-π interactions that also anchor the dimer in the membrane. 
We furthered the analysis of the transmembrane PlnEF dimer through a 1μs long 
atomistic MD simulation. We observed that the cation-π and polar interactions not only 
assist the peptide-peptide interaction, but also create a network of polar attractors that 
lures water molecules, ions, and lipid headgroups in the otherwise hydrophobic 
membrane core. This leads to the formation of a toroidal pore, which is comparable to 
pores created by other AMPs that exhibit broader activity. This is the first time that it has 
been demonstrated that a class II bacteriocin can form a pore independent of a receptor. 
It could be hypothesized that PlnEF (and by extension other class II bacteriocins) 
has a dual MOA: it forms pores on a membrane, irrepressibly increasing the permeation 
by water and ions, while it also interacts with a receptor, hindering some vital function for 
the cell. This would explain why in many cases, bacteriocins are highly active against 
some microorganisms (that possibly have a receptor), while much higher concentrations 
of the bacteriocin are required to kill different microorganisms (where only the poration 
MOA is effective). Alternatively, the receptor could act as a trojan horse, enabling the 
insertion of the class II bacteriocin in the membrane, which can then form pores. Yet 
another possible scenario is that the receptor enables the enlargement of the dimer-
formed pore or the oligomerization of several dimers, which in turn might increase the 
permeability of solutes, leading to the cell death. 
In order to evaluate these hypotheses, knowledge of the receptor, or ideally the 
receptor-bacteriocin complex structure, is required. Lacking this foundation of 
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information, we used protein structure prediction methods to design the topology and 
predict the partial 3D structure of YvjB (a Zn, metallopeptidase), which has been 
identified as a possible receptor to LsbB (a class IId bacteriocin). We then employed 
atomistic MD simulation and docking calculation to create a receptor-bacteriocin 
complex. In the future, this complex can be studied to elucidate the role that a receptor 
plays in the MOA of class II bacteriocins. Ideally, we would have studied the receptor of 
PlnEF or another class IIb bacteriocin, however, in the former case no receptor has yet 
been identified, and in the latter, the structure of receptors of other class IIb bacteriocins 
could not be successfully predicted. 
In conclusion, we set out with this work to employ different computational methods, 
with the goal of shedding light into the mechanism of action of class II bacteriocins. We 
believe that the insights provided by our research may enable the optimization of 
bacteriocin-based antibiotic drugs that will exhibit potent activity against specific 
pathogens. Such drugs will indisputably attract the interest of the pharmaceutical 
industry, ultimately leading to commercial bacteriocin-based applications that will go on 
to assist in the fight against antimicrobial resistance.   
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 Appendix 
A. Experimental material and methods related to Chapter 3 
Peptide mutants with purity equal to or higher than 80% were purchased from 
GenScript. The peptides were dissolved in sterile dH2O containing 40% isopropanol. 
The absorption was measured spectrophotometrically at 280 nm and the concentration 
was determined based on the molar extinction coefficients of the amino acids Tyr and 
Trp (PlnE, Ɛ280 = 1,200 M-1 cm-1 and PlnF, Ɛ280 = 11,320 M-1 cm-1). 
The indicator strains used were Lactobacillus curvatus LTH1174, Pediococcus 
pentosaceus NCDO 990 and Pediococcus acidilactici NCDO 521. All strains were grown 
over night at 30 °C in MRS medium without agitation. The overnight cultures were 
diluted 1:50 and applied to microtiter plates containing MRS medium to a final volume of 
200 μl together with wild type peptides in combination with its complementary mutated 
variants in a 1:1 molar ratio. The concentration of the peptide combinations was twofold 
dilution going from one well to the next. The microtiter plates were incubated for 5 hours 
at 30 oC. The growth of the indicator cells was measured spectrophotometrically at 600 
nm by use of a Sunrise™ Remote microplate reader (Tecan).  
The minimum inhibitory concentration (MIC) value was defined as the total amount 
of peptide mutants together with the complementary wild type peptide that inhibited the 
growth of the indicator strain by 50%. The relative MIC value was quantitated in terms of 
fold increase or decrease in activity compared to the wild type combination. 
B. Experimental material and methods related to Chapter 4 
B.1 Bacterial strains and growth conditions 
Lactobacillus plantarum C11 was grown overnight at 30 °C without agitation in de 
Man-Rogosa-Sharpe (MRS) medium (Oxoid). Escherichia coli DH5α and BL21(DE3) 
cells were used for plasmid amplification and production of fusion polypeptides, 
respectively. The cells were grown at 37 °C in Lysogeny Broth (LB) medium in baffled 
flasks with vigorous agitation. The medium contained either 150 µg/ml erythromycin for 
selection of the plasmids pPlnE100/pPlnF100 or 100 µg/ml ampicillin for selection of 
pET22b(+) and pGEM®-T Easy Vector derivatives. For growth of E. coli DH5α on agar 
plates, the LB medium was solidified with 1.5% (w/v) agar.  
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Lactobacillus sakei Lb790, containing pSAK20 and either pPlnE100 or pPlnF100, 
was used for production of, respectively, PlnE or PlnF and their mutated variants. The 
plasmids pSAK20 and pPlnE100/pPlnF100 contain a marker for chloramphenicol and 
erythromycin resistance, respectively, and the cells were consequently grown (30 °C 
without agitation) in MRS medium containing 10 µg/ml of each antibiotic.  
The indicator strains used in the bacteriocin activity assays were Lactobacillus 
viridescens NCDO 1655, Lactobacillus curvatus LTH 1174, Pediococcus pentosaceus 
NCDO 990 and Pediococcus acidilactici NCDO 521. All strains were grown at 30 °C in 
MRS medium without agitation.  
B.2 DNA isolation  
Genomic DNA from L. plantarum C11 was isolated using the QIAGEN DNeasy® 
Tissue Kit according to protocol. Plasmids were isolated from E. coli DH5α cells using 
the Macherey-Nagel NucleoSpin® Plasmid Kit. 
B.3 A two-plasmid expression system for production of bacteriocins 
A two-plasmid expression system [197,198] consisting of pSAK20 and the 
pLPV111-derived plasmids pPlnE100 or pPlnF100 was used to produce wild type and 
mutant variants of PlnE and PlnF. The two plasmids were introduced into the bacteriocin 
deficient strain L. sakei Lb790. pSAK20 contains the orf4-sapKRTE operon needed for 
activation of the sakacin A promoter and processing and export of the bacteriocin 
[197,198]. pPlnE100 and pPlnF100 contain the genes encoding PlnE or PlnF, 
respectively, and PlnI (the plantaricin EF immunity protein) and the genes are placed 
under the control of the sakacin A promoter. The plnE- and plnF-genes are fused to the 
sakacin P leader sequence. Previous studies have demonstrated that the sakacin A 
secretion machinery encoded in pSAK20 recognizes both the sakacin A and sakacin P 
leader peptides equally efficient [198]. 
For construction of the pPlnF100 plasmid, the plasmid pLT100α (a pLPV111-
derivate used for expression of lactococcin Gα [69]) was used as a template for 
amplification of the sakacin A promoter region and the sakacin P leader sequence using 
the primers PlnFA and SakPB. The resulting PCR product (Megaprimer 1F) contains the 
restriction site for MluI, the sakacin A promoter, the sakacin P leader sequence as well 
as a tail complementary to the beginning of the plnF-gene. In the following PCR reaction, 
genomic DNA from L. plantarum C11 was used as template to amplify the plnF- and 
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plnI-genes using the primers PlnEFimm and Megaprimer 1F. The PCR product (flanked 
by restriction sites for MluI and ClaI) was sub-cloned into the pGEM®-T Easy Vector due 
to incomplete restriction digestion and the restriction site for ClaI was changed into an 
XbaI restriction site by use of the QuikChange site-directed mutagenesis method and the 
primers PlnEFXbaIF and PlnEFXbaIR. The fragment was subsequently cloned into the 
MluI and XbaI sites of pLPV111, resulting in pPlnF100.  
The pPlnE100 plasmid was constructed in a similar manner. Primers PlnEC and 
Megaprimer 1E (containing the sakacin A promoter, the sakacin P leader sequence and 
the beginning of plnE) were used to amplify the plnE-gene. The resulting PCR-product 
(Fragment 1) also contains the beginning of plnI. The plnI-gene and the end of the plnE-
gene were amplified in a separate PCR reaction using primers PlnEFimmstart and 
PlnEFimm (Fragment 2). Fragment 1 and Fragment 2 were spliced by PCRSOEing 
[199]. The spliced PCR product was amplified by adding the two external primers 
PlnEFimm and SakPB. The final PCR product consists of the entire plnI-gene, the plnE-
gene fused to the leader sequence of sakacin P and the sakacin A promoter region, 
flanked by the restriction sites MluI and ClaI. The PCR product was sub-cloned into the 
pGEM®-T Easy Vector due to incomplete restriction digestion. Finally, the fragment was 
cloned into the MluI and ClaI sites of pLPV111 resulting in pPlnE100.  
B.4 Preparation of competent cells and cell transformation 
E. coli cells were made competent by the CaCl2-method (protocol II), basically as 
described by Sambrook et al. 30 The plasmids were introduced into E. coli DH5α cells 
according to the QuikChange® site-directed mutagenesis protocol. Preparation of 
competent L. sakei Lb790/pSAK20 cells and transformation were performed as 
previously described by Aukrust et al. (procedure 2) [199].  
B.5 Site-directed mutagenesis and DNA sequencing 
In order to introduce point mutations in plnE and plnF, Quik Change site-directed 
mutagenesis was performed according to manufacturer’s protocol. 
The DNA sequences of all the mutated plasmids were verified by DNA sequencing 
using an ABI PRISM® 3730 DNA Analyzer and a BigDye® Terminator v3.1 Cycle 
Sequencing Kit. 
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Production and purification of peptides 
The two-plasmid expression system described above was used for the production of 
wild type and mutant variants of PlnE and PlnF.  
The peptides were purified from 1 L overnight cultures, basically as previously 
described. 33 The overnight cultures were applied directly to a cation exchange column 
equilibrated with 20 mM phosphate buffer (pH 6). The column was washed with 100 ml 
of the phosphate buffer before the peptides were eluted in 40 ml of 20 mM phosphate 
buffer (pH 6) containing 1 M NaCl and 20% (v/v) 2-propanol. The eluate was sterile-
filtrated through a 0.20 µm non-pyrogenic sterile filter (Sarstedt) and subsequently 
diluted four-fold with H2O/0.1% (v/v) trifluoroacetic acid (TFA) and applied to a reverse 
phase column (3 ml RESOURCETM RPC, GE Healthcare). The peptides were eluted 
with a linear 2-propanol-gradient containing 0.1% TFA. The absorbance at 280 and 214 
nm was recorded as a function of ml eluent. The molecular masses of the peptide 
variants were confirmed by MALDI-TOF mass spectrometry at the MS/Proteomics Core 
Facility at the Department of Chemistry, Biotechnology and Food Science, Norwegian 
University of Life Sciences. Due to the relatively weak absorbance at 280 nm (only one 
Tyr residue in the PlnE-peptide), the relative amount of peptides added to the bacteriocin 
activity measurements was estimated based on the absorbance peak at 214 nm 
obtained after purifying the peptides on a reverse phase column. 
Some mutant peptides were ordered synthetically from GenScript. The synthetic 
peptides were ordered with a purity of >80 % and dissolved in 40% 2-propanol upon 
arrival. The absorption was measured spectrophotometrically at 280 nm and the 
concentration was estimated based on the molar extinction coefficients of the amino 
acids Tyr (ε280 = 1200 M-1 cm-1) and Trp (ε280 = 5560 M-1 cm-1). 
B.6 Construction, production and purification of the PlnE and PlnF fusion 
polypeptides 
Synthetic genes (from GenScript) encoding PlnE or PlnF fused to a hexahistidine 
(His6)-tag, the immunoglobulin-binding domain of streptococcal protein G (GB1-domain; 
56 aa) and a non-helical linker of five consecutive Gly residues between the GB1-
domain and the sequence encoding either of the two peptides were cloned into the NdeI 
and BamHI sites of pET-22b(+). The fusion polypeptides were designed in such a way 
that the fusion-partner was either fused to the N- or C-terminus of the peptides. This 
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resulted in four different vectors. Cloning into pET-22b(+) was performed by GenScript.  
The vectors were introduced into competent E. coli BL21 (DE3) cells from 
Invitrogen. Expression of the fusion polypeptides was induced with 1 mM isopropyl β-D-
1-thiogalactopyranoside (IPTG) when the OD600 of the cell culture had reached 
approximately 1. The culture was then grown overnight at 250 rpm and 25 °C. 
Approximately 20 g of cells were harvested by centrifugation, frozen and lysed using an 
X-press [200]. The lysed cells were dissolved in 100 ml of 50 mM phosphate buffer, pH 
7.4, containing a cocktail of protease inhibitors (cOmplete ULTRA Tablets, EDTA-free; 
Roche). DNA was removed from the solution with 2% streptomycin sulfate and the 
proteins were precipitated with ammonium sulfate (0.33 g/L). The pellet was dissolved in 
20 mM phosphate buffer, pH 7.4, and desalted using a 5 ml Hi Trap Desalting column 
(GE Healthcare) using the ÄKTA chromatography system (GE Healthcare). NaCl and 
imidazole were added to the eluate to final concentrations of 0.5 M and 20 mM, 
respectively. The solution was applied to a 5 ml HisTrap HP column (GE Healthcare) 
equilibrated with 20 mM phosphate buffer (pH 7.4), 0.5 M NaCl and 20 mM imidazole. 
The fusion polypeptides were eluted using a linear gradient of 20 mM phosphate buffer, 
pH 7.4, 0.5 M NaCl and 0.5 M imidazole. Buffer exchange to 50 mM phosphate buffer, 
pH 7.4, and concentration of the fusion polypeptides were performed using Amicon 
Ultra-15 Centrifugal Filter Units with a molecular mass cut-off at 3 kDa (Millipore), at 4 
°C. The correct molecular masses of the fusion polypeptides were confirmed by mass 
spectrometry at the Proteomics Facility at the Department of Biosciences, University of 
Oslo. The fusion polypeptides were digested with trypsin and the resulting peptide 
fragments were analyzed by high performance liquid chromatography-tandem mass 
spectrometry (HPLC-MS/MS).  
   The concentration of the fusion polypeptides was determined by UV absorption 
at 280 nm and calculated using molar extinction coefficients based on the Trp and Tyr 
residues. The extinction coefficients for the PlnE and PlnF fusion polypeptides were 
calculated to be 11,560 M-1 cm-1 and 18,320 M-1 cm-1, respectively.  
B.7 Bacteriocin activity assay 
For detection of antimicrobial activity of the wild type and mutant variants of PlnE 
and PlnF as well as the fusion polypeptides, a microtiter plate assay system was used, 
essentially as described by Nissen-Meyer et al. [129]. Each well of the microtiter plate 
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contained MRS medium to a final volume of 200 μl, combinations of wild type and 
mutated variants of PlnE and PlnF (in 1:1 ratio), and one of the four indicator strains. 
The fusion polypeptides were added at a 10:1 molar ratio with respect to the 
concentration of the complementary wild type peptide. The dilution factor of the peptide 
combinations was two-fold going from one well to the next. Stationary phase cultures of 
indicator strains were diluted 1:50 and the microtiter plates were incubated for 5 hours at 
30 C. The growth of the indicator cells was measured spectrophotometrically at 600 nm 
by use of a Sunrise™ Remote microplate reader (Tecan). 
The minimum inhibitory concentration (MIC) was defined as the total amount of wild 
type or peptide mutants of PlnE and PlnF, at a 1:1 ratio, that inhibited the growth of the 
indicator strain by 50%. The relative MIC value was quantitated in terms of fold increase 
or decrease in activity compared to the wild type combination.  
C. Experimental results related to Chapter 4 
The first set of experiments involved mutation of the Gly and Ser residues that are 
located in possible GxxxG and GxxxG-like motifs to evaluate which of these motifs are 
essential for the bactericidal activity of PlnEF. The residues were mutated into different 
small amino acids (Ala, Gly, Ser), large hydrophobic amino acids (Ile and/or Leu), or 
hydrophilic amino acids (Gln, Lys). Altogether, 39 and 26 mutated variants of PlnE and 
PlnF, respectively, were assayed against the indicator strain, L. curvatus LTH1174. The 
activity of the bacteriocins that contain single point mutations was compared with the 
wild-type PlnEF, and the results are shown as relative MIC values in Figure C-1. The 
activities of the peptides were tested against three more different strains [103]. Overall, 
the relative MIC values for all four strains were comparable, but the effects of mutations 
on relative MIC values are overall greater when using L. curvatus LTH1174 because of 
its higher sensitivity to wild-type Plantaricin EF. 
C.1 The GxxxG and GxxxG-like motifs in PlnE 
The effect the mutations had on the antimicrobial activity varied considerably 
between the two GxxxG motifs in PlnE; nearly all replacements of the glycine residues in 
the G5xxxG9 motif were detrimental, while nearly all similar replacements in the 
G20xxxG24 motif were tolerated.  
130 
 
Figure C-1: Relative MIC of the peptides with single-point mutations at the 
GxxxG and GxxxG-like motifs 
 
The relative MIC values from activity measurements of four independent parallels 
of GxxxG and GxxxG-like mutant peptides together with the wild-type complementary 
peptide against the indicator strain L. curvatus LTH 1174. The activity is as good as or 
better than the wild-type peptide combination when the number is equal to or less than 
1, respectively. Green illustrates mutant peptides with low or no reduction in activity 
compared to the wild-type bacteriocin. Red illustrates peptides where the mutation had 
a highly detrimental effect on activity (e.g. a value of 30 means a 30-fold reduction in 
activity). 
The only mutations that were tolerated in the G5xxxG9 motif were the G5A and G5S 
mutations, as almost all activity was retained with these replacements (Figure C-1). In 
contrast, replacing this glycine residue with large hydrophilic (G5K and G5Q) or 
hydrophobic (G5I and G5L) residues reduced the activity 10 to 200-fold. Replacement of 
the other glycine residue, Gly9, in the G5xxxG9 motif was not tolerated at all. Even 
replacements with small residues (G9A and G9S) caused a 30 to 200-fold reduction in 
the activity, while replacements with large hydrophilic (G9Q and G9K) or hydrophobic 
(G9I and G9L) residues reduced the activity 100- to 1000-fold. This indicates that these 
two Gly residues are in a structurally restricted environment, possibly needed for close 
interhelical contact with the complementary peptide.  
In contrast, the glycine residues in the G20xxxG24 motif in PlnE tolerated nearly all 
substituents quite well. Individual replacements of these glycine residues with small (Ala 
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and Ser) and large hydrophobic (Ile and Leu) and hydrophilic (Gln) residues resulted in 
similar or somewhat higher activity than the wild-type combination (Figure C-1). 
Introducing a positive charge at positions 20 and 24 was, however, detrimental. The 
G20K and G24K mutations resulted in approximately a 50-fold reduction in activity. 
These results indicate that Gly20 and Gly24 (in contrast to Gly5 and Gly9) are not in a 
structurally restricted environment, nor in a strictly hydrophobic or hydrophilic 
environment, and that the G20xxxG24 region is not in close interhelical contact with the 
complementary peptide.  
The same tendency is also seen for the two GxxxG-like motifs, A23xxxG27 and 
G27xxxS31. Substituting the small residues with other amino acids such as small large 
hydrophilic or large hydrophobic residues did not seem to greatly affect the antimicrobial 
activity (Figure C-1).  
Except for the A21S mutation, which was well tolerated, all replacements of the two 
alanine residues in the GxxxG-like motif A17xxxA21 in PlnF were unfavorable. Even 
replacements with a small glycine residue were detrimental, as the A17G and A21G 
mutations reduced the activity 30-to-60-fold and 15-to-30-fold, respectively (Figure C-1). 
Notably, replacing these alanine residues with a large hydrophobic residue (Leu) was 
somewhat less detrimental than replacement with a glycine residue, as the A17L and 
A21L mutations reduced the activity only 10-to-30-fold. Replacements with a large 
hydrophilic residue were more detrimental than replacement with a leucine residue, as 
the A17K and A21Q mutations reduced the activity 30-to-60-fold and the A17Q and 
A21K mutations reduced the activity 60-to-130-fold. The fact that replacements with 
leucine residues were less detrimental than replacements with glycine residues indicate 
that the A17xxxA21 region is not in close interhelical contact with the complementary 
peptide. However, the detrimental effect of the glycine substitutions does indicate that 
the increased flexibility induced in the helix is non-beneficiary for the function of the 
bacteriocin, thus the helix in this region of the peptide is important for function. 
  The OH-group in Ser26, which is part of the GxxxG-like motif S26xxxG30, is 
apparently involved in hydrogen bonding, since replacement with a threonine residue – 
which also contains an OH-group – resulted in only a 4-to-15-fold reduction in the activity 
and was the substitution that was best tolerated (Figure C-1). Replacement of Ser26 
with a glycine or alanine residue reduced the activity about 15-to-30-fold, while 
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replacement with a large hydrophilic (Lys and Gln) or a large hydrophobic residue (Leu) 
caused, respectively, a 30-to-130-fold and 60-to-250-fold reduction in the activity.  A 
small residue with hydrogen bonding properties seems to be preferred in position 26. 
All the replacements of Gly30, which is in both the S26xxxG30 and G30xxxG34 motifs, 
were detrimental, indicating that Gly30 is in a structurally-restricted environment. 
Substituting Gly30 with small residues such as Ala and Ser were the least detrimental 
replacements, causing a 15-to-30- and 60-to-130-fold reduction in activity, respectively 
(Figure C-1). The other mutations, G30K, G30Q and G30L were highly detrimental, 
causing more than a 500-fold reduction in the activity (Figure C-1). The other glycine 
residue, Gly34, in the G30xxxG34 motif was, however, less restricted, as replacement with 
Ser resulted in wild-type or better than wild-type activity and replacement with Ala and 
the larger hydrophilic Gln residue reduced the activity 2-to-15-fold (Figure C-1). 
Replacement with a hydrophobic leucine residue (G34L) and a hydrophilic-charged 
lysine residue (G34K) reduced the activity, respectively, 10-to-30-fold and 15-to-130-fold 
(Figure C-1). The greater flexibility of Gly34 in PlnF compared to Ser26 and Gly30 in 
PlnF and to Gly5 and Gly9 in PlnE is possibly due to the fact that Gly34 is the last 
residue in PlnF, and this enables the residue to fluctuate to a greater extent than internal 
residues. The highly-restricted environment of Gly30 suggests that Gly30, as part of the 
S26xxxG30 or G30xxxG34 motif in PlnF, might be in close interhelical contact - in either a 
parallel or antiparallel orientation - with the G5xxxG9 motif in PlnE.  
C.2 Orientation of Plantaricin EF in Target-Cell Membranes 
In order to determine the orientation of PlnE and PlnF in target-cell membranes and 
whether the two peptides interact in a parallel or anti-parallel manner, we constructed 
four fusion polypeptides in which the hydrophilic GB1-domain was fused to either the N- 
or C-terminal ends of PlnE and PlnF. The two fusion polypeptides in which the GB1-
domain is attached to the ends of the Pln-peptides that enter into or traverse the target-
cell membrane are expected to be inactive. In contrast, the two fusion polypeptides in 
which the GB1-domain is attached to the ends of the Pln-peptides that do not enter into 
the hydrophobic part of the membrane may still have some antimicrobial activity. The 
activity may, however, be greatly reduced compared to the wild type peptides due to 
possible steric interference by the GB1-domain. The penta-Gly linker between the GB1-
domain and the Pln-peptides was included in order to increase the structural flexibility 
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and thus reduce steric obstructions. The indicator strain, L. curvatus LTH 1174, that is 
most sensitive to plantaricin EF was used when assaying the activity of the four fusion 
polypeptides. A similar approach has earlier been successfully used to study the 
orientation in membranes of the class-IIa bacteriocin pediocin PA-1 and the class IIb 
bacteriocin Lactococcin G [201,202].  
The four fusion polypeptides were named according to the side of the peptide to 
which the GB1-domain was attached; for N-PlnE and N-PlnF the GB1-domain is 
attached at the N-terminus of PlnE and PlnF, respectively, and for C-PlnE and C-PlnF 
the GB1-domain is attached at their C-termini. When applied together with the 
complementary wild-type peptide, PlnF, the C-PlnE fusion polypeptide displayed 
bacteriocin activity at 0.2 M concentrations and higher, whereas the N-PlnE fusion 
polypeptide showed no significant activity even at concentrations up to 20M. The N-
PlnF fusion polypeptide together with its complementary wild wild-type, PlnE, displayed 
bacteriocin activity at 10 M concentrations and higher, whereas the C-PlnF fusion 
polypeptide showed no significant activity at concentrations up to 20M. These results 
indicate that the C-terminus of PlnE and the N-terminus of PlnF are located on the outer 
part of the target-cell membrane, and that the two peptides thus interact in an antiparallel 
manner when integrated in the membrane. The two active fusion polypeptides, C-PlnE 
and N-PlnF, resulted in greatly reduced activity compared to the wild-type peptides; 
whereas the latter display activity at nM concentrations, the former were only active at 
concentrations in theM range. In view of the possibility for steric interactions between 
the GB1-domain and either the membrane, the complementary peptide, or (possibly) a 
transmembrane receptor, this result is not unexpected. 
C.3 Effects of aromatic substitutions 
It is known that the aromatic residues Tyr and especially Trp prefer to position 
themselves in the membrane interface and may therefore be important contributors to 
the anchoring of the peptides in the membrane [144,203,204]. To test the role of these 
residues, Trp and Tyr were substituted with either a large hydrophobic residue (Leu), a 
large, positively charged residue (Arg), the hydrophobic aromatic residue Phe, as well as 
either Trp or Tyr. 
 Replacement of Tyr at position 6 in PlnE with a Leu or Arg (Y6L and Y6R) resulted 
in a 15-to-60-fold reduction in activity (Figure C-2). All activity was retained when 
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substituting Tyr with the aromatic residues Phe and Trp (Y6F and Y6W). The preference 
for an aromatic residue at this location in PlnE indicates a positioning in the membrane 
interface, possibly on the inner part of the membrane, since the results obtained with the 
fusion polypeptides suggests that the C-terminus of PlnE is on the outer part of the 
membrane. 
Figure C-2: The relative MIC values of aromatic substitution 
 
The relative MIC values from activity measurements of aromatic mutant peptides 
complemented with the wild-type peptide against the indicator strain L. curvatus 
LTH1174. The activity is as good as or better than the wild-type peptide combination 
when the number is equal to or less than 1, respectively. Green illustrates mutant peptides 
with low or no reduction in activity compared to the wild-type bacteriocin. Red illustrates 
peptides where the mutation had a highly detrimental effect on antimicrobial activity. 
Substituting the two Tyr residues in PlnF at positions 5 and 14 with either a Leu or 
an Arg reduced the activity 30-to-130-fold, whereas replacing it with Phe caused a 10-to-
50-fold reduction in activity (Figure C-2). Replacing these Tyr residues with a Trp, 
however, was very detrimental to the activity, reducing it 100-to-300-fold, implicating a 
spatial restriction on these sites and possibly also hydrogen bonding opportunities 
mediated by the OH-group of Tyr.  
The Trp residue at position 23 in PlnF did not seem to have any specific 
preferences for an aromatic side chain, since replacing it with either Leu, Phe, or Tyr 
resulted in equal or better than wild-type activity. The positively charged Arg residue 
(W23R) resulted in an 8-to-15-fold decrease in activity, suggesting a preference for 
hydrophobicity and a possible positioning in or near the hydrophobic core of the 
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membrane.  
The Trp residue at position 23 in PlnF did not seem to have any specific 
preferences for an aromatic side chain since replacing it with either Leu, Phe or Tyr 
resulted in equal or better than wild type activity. The positively charged Arg residue 
(W23R) resulted in 8- to 15-fold decrease in activity, suggesting a preference for 
hydrophobicity and a possible positioning in or near the hydrophobic core of the 
membrane.  
 
